WO2023216238A1 - Composition and use thereof, and materials comprising same - Google Patents

Composition and use thereof, and materials comprising same Download PDF

Info

Publication number
WO2023216238A1
WO2023216238A1 PCT/CN2022/092725 CN2022092725W WO2023216238A1 WO 2023216238 A1 WO2023216238 A1 WO 2023216238A1 CN 2022092725 W CN2022092725 W CN 2022092725W WO 2023216238 A1 WO2023216238 A1 WO 2023216238A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
composition
mask
present
disinfectant
Prior art date
Application number
PCT/CN2022/092725
Other languages
French (fr)
Chinese (zh)
Inventor
李平
黄亦成
卜书红
杨玲
孙朝荣
胡燕锋
杜毅
张健
Original Assignee
李平
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 李平 filed Critical 李平
Priority to PCT/CN2022/092725 priority Critical patent/WO2023216238A1/en
Publication of WO2023216238A1 publication Critical patent/WO2023216238A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00Materials specially adapted for outerwear
    • A41D31/02Layered materials
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00Materials specially adapted for outerwear
    • A41D31/04Materials specially adapted for outerwear characterised by special function or use
    • A41D31/12Hygroscopic; Water retaining
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00Materials specially adapted for outerwear
    • A41D31/04Materials specially adapted for outerwear characterised by special function or use
    • A41D31/14Air permeable, i.e. capable of being penetrated by gases
    • AHUMAN NECESSITIES
    • A62LIFE-SAVING; FIRE-FIGHTING
    • A62DCHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
    • A62D3/00Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
    • A62D3/02Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by biological methods, i.e. processes using enzymes or microorganisms
    • AHUMAN NECESSITIES
    • A62LIFE-SAVING; FIRE-FIGHTING
    • A62DCHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
    • A62D9/00Composition of chemical substances for use in breathing apparatus

Definitions

  • the present invention relates to the field of material technology, and in particular to a composition that adsorbs and neutralizes volatile gases of disinfectants, its use, and materials containing the same.
  • High-efficiency disinfectants refer to disinfectants that can kill various microorganisms (including bacterial spores).
  • Currently widely used disinfectants include chlorine-containing disinfectants (such as chloroisocyanuric acid disinfectant tablets, 84 disinfectant, bleaching powder, sodium hypochlorite, Chloric acid air disinfectant, liquid chlorine, and new chlorine dioxide, etc.), peroxide disinfectants (such as peracetic acid, hydrogen peroxide), aldehyde disinfectants, ethylene oxide, etc.
  • chlorine-containing disinfectants and peroxide disinfectants are oxidizing disinfectants, also known as high redox potential disinfectants, which have broad-spectrum and efficient killing of microorganisms.
  • this type of high-efficiency disinfectant is much more oxidative, corrosive, irritating, and allergenic to mucous membrane tissues such as skin, respiratory tract, and eyes than conventional medical skin and mucous membrane disinfectants such as iodine, benzalkonium bromide, and chlorhexidine.
  • There have been reports of adverse reactions and physical damage to epidemic prevention personnel after being exposed to chlorine-containing disinfectants reports of occupational asthma caused by peracetic acid, and reports of people accidentally taking peracetic acid disinfectant and chlorine dioxide disinfectant tablets. Reports of poisonings. Therefore, the occupational exposure injuries of high-efficiency disinfectants and the rescue of accidental poisoning are issues involving the safety of global anti-epidemic chemicals.
  • CN 2109208U discloses an anti-virus and anti-bacteria activated carbon fiber with strong adsorption force, which enables it to have efficient adsorption capacity and anti-toxic effect on harmful gases such as benzene, sulfur dioxide, chlorine, ammonia and bacteria, as well as bacteria.
  • activated carbon usually needs to be in contact with tap water for more than 2 minutes to fully adsorb residual chlorine in tap water.
  • the time it takes for volatile chlorine to pass through the mask is only a few milliseconds.
  • the thin activated carbon fiber layer does not have time to capture inorganic small molecule gases such as chlorine. Only professional canisters or cartridges can filter them out. Therefore, activated carbon masks are mainly used to adsorb organic vapor and particulate matter with larger molecular volumes.
  • CN 111394728A discloses a further treatment method for chlorine gas in an acid etching copper recovery system.
  • the chlorine gas and the etching liquid are mixed with gas and liquid, and then sent into the first-stage iron absorption tank to react with metallic iron to produce ferric chloride.
  • this technology is not suitable for use on masks because reduced iron powder is likely to be inhaled into the lungs, causing diseases similar to pulmonary hemosiderosis.
  • CN 111330419A discloses a method for jointly absorbing chlorine gas using water and sodium hydroxide (liquid alkali).
  • this technology is not suitable for use on masks. Alkaline substances may cause serious damage to facial skin and respiratory tract.
  • the "Technical Specifications for Disinfectants” discloses a technical solution for using sodium thiosulfate to neutralize chlorine-containing disinfectants and peroxide disinfectants.
  • Sodium thiosulfate is a weakly alkaline and strongly reducing substance that is basically not absorbed when taken orally and can neutralize the acidity and oxidation of oxidizing disinfectants.
  • the irritation of this substance to the respiratory mucosa is unknown, and there is no safety study on airway inhalation of this strongly reducing inorganic substance.
  • sodium thiosulfate may produce elemental sulfur particles under the action of weak oxidants, such as Cl 2 +Na 2 S 2 O 3 +H 2 O ⁇ 2NaCl+S ⁇ +H 2 SO 4 .
  • This kind of new elemental sulfur particles are tiny and are inhalable particles. They may have adverse effects on lung tissue, so they are not suitable for use in masks involving respiratory protection.
  • the "Expert Consensus on Health Emergency Rescue and Clinical Treatment at the Site of Sudden Mass Chlorine Gas Leak Accident (2017)" further pointed out that there is currently no specific antidote for chlorine gas poisoning.
  • the present invention relates to a composition characterized by comprising, based on the total weight of the composition,: (A) about 0.1-99% by weight of biosorbent and (B) about 0.0001-99% % by weight of moisture attractant.
  • the biosorbent is selected from one or more of the following: (a) compounds containing enol structures; (b) compounds containing sulfhydryl groups; (c) amino acids; (d) biological enzymes.
  • the moisture-absorbing agent is selected from the group consisting of diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyether, xylitol, sorbitol, propylene glycol glucoside, and sodium lactate. and combinations thereof.
  • the composition further includes at least one of the following ingredients, based on the total weight of the composition: (e) about 0.00000001-1% by weight of a preservative; (f) about 0.00001-90% by weight of a preservative Acid-base buffer; (g) about 0.000001-5 wt% antioxidant; (h) about 0-1 wt% emulsifier; (i) about 0-20 wt% liquid sealant; (j) about 0 - 20% by weight of protein coagulant; (k) about 0-20% by weight of plant extract; (l) about 0.0001-2% by weight of odor masking agent.
  • the invention relates to an aqueous solution, characterized in that it contains the composition of the invention.
  • the composition is present in an amount of about 30-80% by weight, based on the total weight of the aqueous solution.
  • the invention in another aspect, relates to a substrate, characterized in that the substrate contains the composition of the invention, and the substrate is selected from the group consisting of non-woven cloth, metal mesh, glass fiber, cotton cloth, and linen cloth. and filter cotton, preferably non-woven fabric.
  • the present invention relates to a multi-layer material A, characterized in that the multi-layer material includes the base material of the present invention as a base material; and an activated carbon layer as the first filter layer.
  • a second filter layer is further included between the base material and the first filter layer.
  • the present invention relates to a multi-layer material B, characterized in that the multi-layer material includes the base material of the present invention as a first base material; an intermediate isolation layer including a porous breathable material that is not wetted by water. ;
  • the second base material includes biological enzymes, moisture absorbing agents, preservatives and acid-base buffers.
  • the invention relates to a mask, characterized in that the mask contains the base material or multi-layer material of the invention.
  • the present invention relates to a method for preparing a mask of the present invention, which includes: (1) providing a composition solution of the present invention; (2) spraying the composition liquid of step (1) onto The inside and/or outside of the mask.
  • Figure 1 shows the structural diagram of the mask A of the present invention
  • Figure 2 shows the structural diagram of the mask B of the present invention
  • Figure 3 shows the structural diagram of the mask C of the present invention
  • Figure 4 shows the structural diagram of the mask D of the present invention
  • Figure 5 shows the thermal imaging thermometer when wearing a disposable medical non-woven nursing mask or removing the above mask
  • Figure 6 shows the thermal image temperature measurement chart when wearing cotton or removing the above mask
  • Figure 7 shows the thermal image thermometry when wearing the mask A of the present invention or taking off the above mask
  • Figure 8 shows a spray bottle storing a solution of the composition of the present invention
  • Figure 9 shows a schematic diagram of using a spray bottle to prepare the mask of the present invention.
  • 101 represents the base material
  • 102 represents the ear hanging rope
  • 201 represents the activated carbon layer
  • 302 represents the middle isolation layer
  • 301 represents the second base material
  • 401 represents the base material
  • 1001 represents a transparent plastic bottle
  • 1002 Indicates the spray bottle button
  • 1003 indicates the nozzle
  • 1004 indicates the pipette
  • 1005 indicates the liquid sealant
  • 1006 indicates the composition solution.
  • selected from refers to one or more elements from the group listed thereafter, selected independently, and may include combinations of two or more elements.
  • one or more or “at least one” as used herein means one, two, three, four, five, six, seven, eight, nine or more.
  • the terms “optionally” or “optionally” mean that the subsequently described event or circumstance may or may not occur, and that the description includes both the occurrence and absence of the stated event or circumstance.
  • alkyl refers to a straight or branched saturated aliphatic hydrocarbon group consisting of carbon atoms and hydrogen atoms connected to the rest of the molecule by a single bond.
  • Alkyl may have 1-10 carbon atoms, that is, "C 1 -C 10 alkyl", such as C 1 -C 4 alkyl, C 1 -C 3 alkyl, C 1 -C 2 alkyl, C 3 alkyl, C 4 alkyl, C 3 -C 6 alkyl.
  • alkyl groups include, but are not limited to, methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, 2- Methylbutyl, 1-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, neopentyl, 1,1-dimethylpropyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 2-ethylbutyl, 1-ethylbutyl, 3,3-dimethylbutyl, 2,2-di Methylbutyl, 1,1-dimethylbutyl, 2,3-dimethylbutyl, 1,3-dimethylbutyl or 1,2-dimethylbutyl, or their isomers body.
  • cycloalkyl when used herein alone or in combination with other groups, refers to a saturated, non-aromatic monocyclic or polycyclic (such as bicyclic) hydrocarbon ring (e.g., monocyclic, such as cyclopropyl, cyclobutyl , cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl; or bicyclic, including spiro, fused or bridged systems (such as bicyclo[1.1.1]pentyl, bicyclo[2.2.1] Heptyl, bicyclo[3.2.1]octyl or bicyclo[5.2.0]nonyl, decahydronaphthyl, etc.).
  • C 3-10 cycloalkyl refers to having 3-10 ring carbon atoms (such as 3, 4, 5, 6, 7, 8, 9 or 10) cycloalkyl groups.
  • 3-18 membered ring when used herein alone or in combination with other groups, refers to a ring containing 3-12 atoms. Such rings may be saturated or unsaturated (ie, contain one or more double or triple bonds).
  • “3-12-membered ring” can cover, for example, 3-6-membered, 6-9, 9-12, 12-15-membered and 15-18-membered rings, such as 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 or 18 membered rings.
  • 0, 1 or 2 additional heteroatoms may optionally be included in the carbocyclic ring. Examples of heteroatoms are oxygen, sulfur, and nitrogen.
  • 3-18 members in “3-18 membered ring” only refer to the number of carbon atoms therein. When additional heteroatoms are included, the number of heteroatoms is not counted in the number of ring atoms. For example, when it contains 1 heteroatom, a "3-18-membered ring" contains 4-19 ring atoms, of which 1 ring atom is a heteroatom and the rest are carbon atoms.
  • halo or "halogen” or “halo” is understood to mean a fluorine (F), chlorine (Cl), bromine (Br) or iodine (I) atom, preferably a fluorine, chlorine, bromine atom.
  • aryl refers to an all-carbon monocyclic or fused polycyclic (eg, bicyclic) aromatic ring group having a conjugated ⁇ electron system.
  • an aryl group may have 6-14 carbon atoms, suitably 6-10, more suitably 6 or 10.
  • Examples of aryl groups include, but are not limited to, phenyl, naphthyl, anthracenyl, and the like.
  • amino acid refers to an organic compound or moiety consisting of amino and carboxyl functional groups and attached side chains, such as amino acids and their stereoisomers with the following chemical formula: H 2 N-(CR a R b ) t CO 2 H; wherein, R a and R b are each independently hydrogen or any substituent, and t is an integer greater than or equal to 1, such as 1, 2, 3, 4 or 5. Substituents may be linear or branched structures.
  • R a and/or R b each independently correspond to, but are not limited to, hydrogen or side chains on naturally occurring amino acids, such as methyl, benzyl, hydroxymethyl, thiomethyl, carboxyl, carboxymethyl, Guanidinopropyl, etc.
  • Amino acids include naturally occurring amino acids, unnatural amino acids, imino acids such as proline, amino acid analogs, and amino acid mimetics that function in a manner similar to naturally occurring amino acids, and also include their D and L stereoisomers form.
  • Naturally encoded amino acids are protein amino acids known to those skilled in the art, including 20 common amino acids, namely alanine (Ala), arginine (Arg), asparagine (Asn), aspartic acid (Asp) ), cysteine (Cys), glutamine (Gln), glutamic acid (Glu), glycine (Gly), histidine (His), isoleucine (Ile), leucine (Leu) , Lysine (Lys), methionine (Met), phenylalanine (Phe), proline (Pro), serine (Ser), threonine (Thr), tryptophan (Trp), Tyrosine (Tyr) and valine (Val).
  • moisture attractant refers to an agent used to absorb moisture.
  • exemplary moisture attractants include, but are not limited to, diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyethers, xylitol, sorbitol, propylene glycol glucoside, and sodium lactate.
  • acid-base buffer refers to a solution used to control the pH of a solution to keep the pH within a certain range.
  • exemplary acid-base buffers include, but are not limited to, citrate buffer, ammonium buffer, acetate buffer, phosphate buffer, and bicarbonate buffer.
  • porous breathable material refers to a material that contains internal porosity with interconnected pores to allow airflow through the material.
  • exemplary porous breathable materials include, but are not limited to, polyester filter wool, glass wool, rock wool, air filter cotton, and foam sponge.
  • oxidizing disinfectant refers to a disinfectant containing oxidizing active substances, wherein exemplary oxidizing active substances include but are not limited to chlorine, hydrogen peroxide, aldehydes, peracetic acid, etc.
  • the term "irritant gas” used herein refers to gases that are irritating to the eyes and respiratory mucosa, and are usually toxic gases commonly encountered in the chemical industry.
  • the irritating gas refers to the gas contained in the oxidative disinfectant, which includes but is not limited to chlorine, chlorine dioxide, hydrogen peroxide, aldehydes, peracetic acid, etc.
  • multilayer material A and multilayer material B used herein are only used to distinguish the above two multilayer materials containing different structures, but not in terms of nature, use or order.
  • first base layer material “second base layer material”, “first filter layer” and “second filter layer” used herein are only used to distinguish them from other layers in the multi-layer material, and do not indicate the nature or use of the materials. or order, etc.
  • the present invention relates to a composition for adsorbing and neutralizing irritating gases in an oxidative disinfectant, the composition comprising: (A) about 0.1-99 based on the total weight of the composition % by weight of biosorbent and (B) about 0.0001 to 99% by weight of moisture attractant.
  • the composition includes: (A) about 26-46 wt% biosorbent and (B) about 44-64 wt% moisture attractant, based on the total weight of the composition. In a preferred embodiment, the composition contains: (A) about 36 wt% biosorbent and (B) about 54 wt% moisture attractant, based on the total weight of the composition.
  • a biosorbent is a biological material capable of adsorbing and neutralizing irritating gases.
  • exemplary biosorbents include, but are not limited to, small molecule compounds, high molecular polymers, amino acids, proteins, enzymes, etc.
  • neutralizing irritating gases means that the biosorbent chemically reacts with the irritating gas to form environmentally friendly substances, or the biosorbent decomposes the irritating gas into environmentally friendly substances.
  • the biosorbent is selected from one or more of the following:
  • the enol structure refers to a chemical moiety with an alkene, which has a hydroxyl group attached to one end of the alkene double bond, and can be represented by the following chemical formula.
  • the substituents R 1 and R 2 are the same or different substituents, or they are connected to form a cyclic compound with an enol structure.
  • exemplary enol structure-containing compounds include, but are not limited to, vitamin C, vitamin B6, vitamin B9, catechol, vinyl alcohol, acetol, stigmastenol, tocotrienol, euphorbienol, isoenol, Ascorbic acid, ascorbyl palmitate, ascorbic acid glucoside, etc.
  • the compound containing an enol structure has reducing properties and can adsorb oxidative and irritating gases in the air and undergo redox reactions with them to form environmentally friendly products. It can remove oxidative and irritating gases in the environment without affecting the environment and human health.
  • some enol-containing compounds eg, vitamin C
  • vitamin C will change color, for example, yellow, after being oxidized. Therefore, compounds containing an enol structure can act as indicators. For example, when a compound containing an enol structure turns yellow, it can be known that the content of the active ingredient (the unoxidized compound containing an enol structure) is low. It helps to remind people to timely update the compounds containing enol structure used.
  • the compound containing an enol structure is a 3-18 membered cyclic enol compound containing 0, 1 or 2 additional heteroatoms independently selected from oxygen, sulfur, nitrogen and phosphorus and derivatives thereof substance, the ring may be optionally substituted by one or more substituents selected from the following, C 1-10 alkyl, C 3-10 cycloalkyl, aryl, aryl-C 1-4 alkyl, Wherein each alkyl, cycloalkyl, aryl group is unsubstituted or is independently selected from at least one group consisting of hydroxyl, CN, amino, acyl, carboxyl, halogen, C 1-10 alkyl, C 3-10 cycloalkyl , C 1-10 alkoxy substituent substituted.
  • the compound containing an enol structure is a 3-18 membered cyclic enol compound containing 0, 1 or 2 additional heteroatoms independently selected from oxygen, sulfur and nitrogen, and derivatives thereof substance, the ring may be optionally substituted by one or more substituents selected from the following, C 1-10 alkyl, aryl, wherein each alkyl, aryl is unsubstituted or is independently substituted by at least one Substituted with a substituent selected from hydroxyl, amino, acyl, carboxyl, halogen, C 1-10 alkyl; vinyl alcohol; acetol.
  • the compound containing an enol structure is selected from one or more of the following: vitamin C, vitamin B6, vitamin B9, catechol, vinyl alcohol, acetol, stigmasterene Alcohol, tocotrienol, euphorbienol, isoascorbic acid, ascorbyl palmitate, ascorbyl glucoside and its derivatives.
  • the compound containing an enol structure is selected from one or more of the following: vitamin C, vitamin B6, and vitamin B9.
  • the compound containing an enol structure is vitamin C.
  • the content of the enol structure-containing compound is about 0.01-95% by weight based on the total weight of the composition. In a preferred embodiment, the content of the enol structure-containing compound is about 1 to 50% by weight based on the total weight of the composition. In a more preferred embodiment, the content of the enol structure-containing compound is about 13.2-14.8% by weight based on the total weight of the composition. For example, about 13.2% by weight, about 13.3% by weight, about 13.4% by weight, about 13.5% by weight, about 13.6% by weight, about 13.7% by weight, about 13.8% by weight, about 14% by weight, about 14.2% by weight, about 14.4% by weight. , about 14.6% by weight, about 14.8% by weight.
  • the composition will produce a large amount of ketones and organic acid compounds after the redox reaction, which will increase the pH value of the composition system and make it easy to precipitate and crystallize at low temperatures. If the content of compounds containing an enol structure is too low, the oxidative irritating gases cannot be completely neutralized, and the discoloration of the mask is not obvious and it cannot function as an indicator.
  • Thiol refers to the -SH group.
  • the sulfhydryl group is reducing, so compounds containing sulfhydryl groups can be oxidized. Therefore, thiol-containing compounds can be used to adsorb oxidative and irritating gases in the air and undergo redox reactions with them to form environmentally friendly products. It can remove oxidative and irritating gases in the environment without affecting the polluted environment and human health.
  • mercapto compounds have a strong affinity for heavy metal ions (such as Cu 2+ , Pb 2+ , Ag +, etc.) (its affinity is much higher than that of ethylenediaminetetraacetic acid EDTA), allowing it to combine with the above heavy metal ions to form Metal sulfides precipitate, thereby removing heavy metal ions from the environment.
  • heavy metal ions such as Cu 2+ , Pb 2+ , Ag +, etc.
  • EDTA ethylenediaminetetraacetic acid
  • the thiol-containing compound is selected from the group consisting of cysteine, thioglycolic acid, dimercaprol, sodium dimercaprol, tiopronin, disodium dimercaptosulfate, cysteamine, penicillamine , lipoic acid, captopril, glutathione, alpha-lipoic acid, dithiothreitol and combinations thereof.
  • the thiol-containing compound is selected from the group consisting of N-acyl-cysteine, N-alkyl-cysteine, dimercaprol, disodium dimercapto, and dithiothreose Alcohols and their combinations.
  • the thiol-containing compound is selected from the group consisting of N-acetyl-L-cysteine, N-methyl-L-cysteine, N-ethyl-L-cysteine Acid, dimercaprol, disodium dimercapto, dithiothreitol and combinations thereof.
  • the thiol-containing compound is N-acetyl-L-cysteine.
  • the thiol-containing compound is present in an amount of about 0.0001 to 99% by weight, based on the total weight of the composition. In a preferred embodiment, the thiol-containing compound is present in an amount of about 0.1 to 20% by weight, based on the total weight of the composition. In a more preferred embodiment, the thiol-containing compound is present in an amount of about 3.0 to 3.4% by weight, based on the total weight of the composition. For example, about 3.0% by weight, about 3.02% by weight, about 3.06% by weight, about 3.1% by weight, about 3.12% by weight, about 3.16% by weight, about 3.20% by weight, about 3.23% by weight, about 3.26% by weight, about 3.28% by weight. , about 3.3% by weight, about 3.32% by weight, about 3.34% by weight, about 3.38% by weight, about 3.4% by weight. For example, about 1% by weight, about 1.125% by weight, and about 2.28% by weight.
  • sulfhydryl-containing compounds themselves have a special odor, such as a garlic-like sulfide odor, too high a content of sulfhydryl-containing compounds can easily irritate the eyes and respiratory mucosa and should not be used in production practice, such as in daily necessities.
  • An excessively low content of thiol-containing compounds makes the composition of the present invention insufficiently reducible, unable to adsorb and neutralize sufficient oxidative irritating gases, unable to reduce the activity of proteins, and is also unfavorable to the stability of compounds containing enol structures. .
  • the primary amino groups in amino acids can react with aldehydes to obtain Schiff base compounds. Therefore, adding amino acids to the composition of the present invention can effectively adsorb and neutralize aldehyde-based compounds in the air, thereby reducing the damage caused by aldehyde compounds to the human body.
  • the amino acid is selected from the group consisting of alanine, valine, leucine, isoleucine, methionine, proline, tryptophan, serine, tyrosine, cysteine Acid, phenylalanine, asparagine, glutamine, threonine, aspartic acid, glutamic acid, lysine, arginine, histidine, glycine and combinations thereof.
  • the amino acid is selected from the group consisting of glycine, glutamic acid and combinations thereof.
  • the amino acid is glycine.
  • the amino acid is present in an amount of about 0.0001-95% by weight, based on the total weight of the composition. In a preferred embodiment, the amino acid is present in an amount of about 0.0001 to 85% by weight, based on the total weight of the composition. In a more preferred embodiment, the amino acid is present in an amount of about 20-25% by weight, based on the total weight of the composition.
  • Bio enzymes refer to catalytic organic substances produced by living cells, which can specifically catalyze the transformation of substances. Different types of biological enzymes can be selected and used according to actual production or work purposes. For example, in order to absorb and break down hydrogen peroxide, catalase is used in the actual work process.
  • the biological enzyme is selected from the group consisting of catalase and horseradish peroxidase.
  • the biological enzyme is catalase.
  • An exemplary catalase may be food-grade catalase with a specification of 50,000 U/g.
  • the biological enzyme is present in an amount of about 0.0000001-20% by weight based on the total weight of the composition. In a preferred embodiment, the biological enzyme is present in an amount of about 0.02-0.2% by weight based on the total weight of the composition.
  • Too high or too low biological enzyme content will reduce the speed of hydrogen peroxide catalytic decomposition.
  • Hygroscopic agents are agents used to absorb moisture.
  • Exemplary moisture attractants include, but are not limited to, diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyether, xylitol, sorbitol, propylene glycol glucoside, sodium lactate, and the like.
  • the hygroscopic agent in the composition of the present invention can absorb moisture in the air or additional added moisture, so that the composition becomes a moist or solution state, thereby dissolving the biosorbent in the moisture, thereby increasing the biosorbent
  • the contact area with the adsorbed gas (such as chlorine, hydrogen peroxide, peracetic acid, aldehyde compounds, etc.) improves the efficiency of gas adsorption.
  • the moisture attracting agent is selected from the group consisting of diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyether, xylitol, sorbitol, propylene glycol glucoside, and sodium lactate. and combinations thereof.
  • the moisture attractant is selected from the group consisting of glycerin, propylene glycol and combinations thereof.
  • the moisture attracting agent is glycerol.
  • the moisture attractant is present in an amount of about 0.0001-99% by weight. In a preferred embodiment, the moisture attractant is present in an amount of about 44 to 64% by weight. In a more preferred embodiment, the content of the moisture attractant is about 50-54% by weight, such as about 51% by weight, about 51.3% by weight, about 51.8% by weight, about 52% by weight, about 52.2% by weight, about 52.6% by weight. % by weight, about 53% by weight, about 53.5% by weight, about 53.8% by weight, about 54% by weight.
  • Excessively high moisture attractant content will cause the composition to absorb a large amount of water, causing a sudden increase in liquid volume, reducing the breathability of the composition, thereby increasing the breathability resistance of the composition.
  • a moisture absorbing agent when used in a protective mask, an excessively high moisture absorbing agent content will lead to a reduction in the breathability of the composition, thereby reducing the comfort of the protective mask.
  • an excessively high moisture-drawing agent content will increase the viscosity of the composition, making it difficult to atomize and spray the composition solution. Too low a moisture attractant content cannot form a sufficient aquifer to effectively absorb water-soluble irritating gases.
  • composition of the present invention also contains other components according to the needs of the actual situation and the optimal working environment required by the biosorbent.
  • the compositions of the present invention may include a preservative.
  • the composition of the present invention in order to make the biosorbent (such as amino acid) more susceptible to adsorbing aldehyde-based compounds, can include an acid-base buffer, wherein the acid-base buffer can adjust the working environment of the composition to be alkaline or alkaline. acidic.
  • the composition further includes at least one of the following ingredients, based on the total weight of the composition:
  • Preservatives refer to components that increase the stability of the compositions of the present invention.
  • the preservative is selected from the group consisting of parahydroxybenzoic acid preservatives (parabens), benzoic acid preservatives, sorbic acid preservatives, benzalkonium bromide, chlorhexidine acetate, ortho Phenylphenols, hexamethyleneguanidine hydrochloride preservative, dehydroacetic acid, sodium diacetate, polylysine, sodium lactate, natamycin.
  • the preservative is selected from paraben-based preservatives and sorbic acid-based preservatives.
  • the preservative is a paraben catalyst.
  • the preservative is ethylparaben (also known as ethylparaben).
  • adding a preservative to the composition of the present invention can improve the stability of the composition and inhibit the growth of microorganisms.
  • microorganisms that can inhibit growth include bacteria and fungi.
  • the bacteria may be, for example, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, hemolytic Streptococcus, etc.
  • the preservative is present in an amount of about 0.00000001-1% by weight, based on the total weight of the composition. In a preferred embodiment, the preservative is present in an amount of about 0.001 to 0.5% by weight, based on the total weight of the composition. In a more preferred embodiment, the preservative is present in an amount of about 0.05 to 0.3% by weight, based on the total weight of the composition. For example, about 0.05% by weight, about 0.1% by weight, about 0.15% by weight, about 0.2% by weight, 0.25% by weight, and about 0.3% by weight.
  • Acid-base buffer refers to a mixed solution composed of weak acid and its salts or weak base and its salts. It can offset and reduce the influence of external strong acid or strong base on the pH of the solution to a certain extent, thereby maintaining the pH value of the solution relatively Stablize.
  • different acid-base buffers are selected to provide a suitable working environment for the biosorbent and other components, improve the adsorption of the biosorbent and neutralize stimulation. Efficiency of sexual gas.
  • the acid-base buffer is selected from the group consisting of sodium bicarbonate buffer, phosphate buffer, sodium acetate, and sodium citrate buffer.
  • the acid-base buffer is selected from phosphate buffer.
  • the acid-base buffer is selected from sodium dihydrogen phosphate-disodium hydrogen phosphate buffer.
  • the acid-base buffer is sodium bicarbonate buffer.
  • the acid-base buffer used in the present invention can adjust the pH of the composition system to about 3-10. In a preferred embodiment, the acid-base buffer used in the present invention can adjust the pH of the composition system to about 5.0-6.2. In a more preferred embodiment, the acid-base buffer used in the present invention can adjust the pH of the composition system to about 5.8 (the average pH of the skin). A pH value that is too low is not conducive to the Schiff base reaction of amino acids and aldehyde compounds, and a pH value that is too high will cause the stability of compounds containing enol structures (such as vitamin C) to decrease.
  • enol structures such as vitamin C
  • the acid-base buffering agent is present in an amount of about 0.00001-90% by weight, based on the total weight of the composition. In a preferred embodiment, the acid-base buffering agent is present in an amount of about 0.01 to 5% by weight, based on the total weight of the composition. In a more preferred embodiment, the acid-base buffering agent is present in an amount of about 1.0-2.5% by weight, based on the total weight of the composition. For example, about 1.0% by weight, about 1.3% by weight, about 1.5% by weight, about 1.8% by weight, about 2.0% by weight, about 2.2% by weight, about 2.5% by weight.
  • Antioxidants are substances that can delay, reduce, inhibit or prevent the oxidation of oxidizable substances.
  • the biosorbent may be an enol structure-containing compound or a sulfhydryl group-containing compound with reducing properties. Therefore, in order to extend the storage time of the composition, antioxidants can be added to the composition to improve the durability of the composition.
  • the antioxidant is selected from the group consisting of sodium metabisulfite, sodium bisulfite, sodium thiosulfate, vitamin E, L-ascorbyl palmitate, alkyl gallate, butylated hydroxyanisole, and butylated hydroxytoluene.
  • the antioxidant is sodium metabisulfite.
  • the antioxidant is present in an amount of about 0.000001-5% by weight, based on the total weight of the composition. In a preferred embodiment, the antioxidant is present in an amount of about 0.001 to 0.04% by weight, based on the total weight of the composition. In a more preferred embodiment, the acid-base buffering agent is present in an amount of about 0.01 to 0.03% by weight, based on the total weight of the composition. For example, about 0.01% by weight, about 0.013% by weight, about 0.015% by weight, about 0.017% by weight, about 0.02% by weight, about 0.023% by weight, about 0.025% by weight, about 0.027% by weight, about 0.029% by weight, about 0.03% by weight. .
  • antioxidant content will exceed the upper limit of the amount of food additives, which is not conducive to the application of the composition of the present invention in daily necessities.
  • Antioxidant content that is too low is insufficient to prevent enol compounds from being oxidized.
  • Emulsifier refers to a class of compounds that can mix two or more mutually immiscible components to form a stable emulsion.
  • an organic compound such as ethyl hydroxyphenyl ester
  • its solubility in water is poor. Therefore, in order to improve the solubility of the preservative in water so that the composition of the present invention can have a longer shelf life, an emulsifier is added to the composition.
  • the emulsifier is selected from polysorbate, triethanolamine, sorbitan oleate (Span), alkylphenol polyoxyethylene ether (OP), glyceryl stearate, lauryl Sodium sulfonate.
  • the emulsifier is polysorbate.
  • the emulsifier is polysorbate-80 (Tween-80).
  • the emulsifier is present in an amount of from about 0 to 1% by weight, based on the total weight of the composition. In a preferred embodiment, the emulsifier is present in an amount of about 0.001 to 0.01% by weight, based on the total weight of the composition. For example, about 0.001% by weight, about 0.002% by weight, about 0.003% by weight, about 0.004% by weight, about 0.005% by weight, about 0.006% by weight, about 0.007% by weight, about 0.008% by weight, about 0.009% by weight, about 0.01% by weight. .
  • Excessive emulsifier content will affect the preservative effect of the preservative. Too low emulsifier content is not conducive to the dissolution of preservatives. For example, when the composition of the present invention is stored under low temperature conditions, the preservative may precipitate from the composition system, so the preservative cannot effectively play a preservative role.
  • the preservative used is a water-soluble preservative
  • no emulsifier may be added to the composition.
  • the composition of the present invention is easily in contact with air during storage and retrieval, forming an aqueous solution, and the compounds containing an enol structure and the compounds containing a thiol structure in the composition are easily oxidized by the air above the solution. Therefore, in order to reduce the losses caused by the above reasons to the composition and enhance the stability of the composition of the present invention, a liquid sealing agent is added to the solution of the composition to isolate the composition of the present invention from air.
  • the liquid sealing agent is selected from edible oil, mineral oil, silicone oil, dimethicone and liquid paraffin (paraffin oil). In a preferred embodiment, the liquid sealing agent is liquid paraffin.
  • the liquid sealant is present in an amount of about 0-20% by weight based on the total weight of the composition. In a preferred embodiment, the liquid sealant is present in an amount of about 1 to 10% by weight based on the total weight of the composition. For example, about 1% by weight, about 2% by weight, about 3% by weight, about 4% by weight, about 5% by weight, about 6% by weight, about 7% by weight, about 8% by weight, about 9% by weight, about 10% by weight. .
  • liquid sealant The purpose of using a liquid sealant is to prevent the composition from being oxidized by air when it is taken out when the composition is stored in a rigid container (such as a stainless steel barrel). Excessively high liquid sealing agent content will cause low-polarity substances in the composition (such as fat-soluble preservatives) to dissolve in the liquid sealing agent, affecting the performance of the composition. Too low a liquid sealant content will prevent the liquid sealant from completely covering the surface of the composition. When packaging materials with air-isolating functions (such as vacuum bottles and ampoules with a piston AS plastic at the bottom) are used for retail packaging, liquid sealing agent does not need to be added.
  • preservatives are only effective against microorganisms with cellular structures such as bacteria and fungi, but are not effective against microorganisms such as viruses that are composed of nucleic acid and protein shells. Therefore, adding a protein coagulant to the composition of the present invention can destroy the spatial conformation of the protein, prompting the protein shell of the virus to coagulate and lose biological activity, thereby possibly producing an antiviral effect.
  • the protein coagulant is selected from sodium sulfate, ammonium sulfate, picric acid, phosphotungstic acid, phosphomolybdic acid, tannic acid, trichloroacetic acid, sulfosalicylic acid, urea, berberine, Tetrandrine, guanidine hydrochloride, gluconic acid and its salts, glucono-delta-lactone and combinations thereof.
  • the protein coagulant is glucono-delta-lactone.
  • the protein coagulant is present in an amount of about 0-20% by weight, based on the total weight of the composition. In a preferred embodiment, the protein coagulant is present in an amount of about 0.0001 to 20% by weight, based on the total weight of the composition. In a more preferred embodiment, the protein coagulant is present in an amount of about 0.1-0.3% by weight, such as about 0.1% by weight, about 0.13% by weight, about 0.15% by weight, about 0.18% by weight, about 0.18% by weight, based on the total weight of the composition. 0.2% by weight, about 0.25% by weight, about 0.3% by weight.
  • Protein coagulant levels that are too low can reduce the bioactive ability of the antiviral protein coat of the composition.
  • lower-content protein coagulants are less irritating and can be used for respiratory aerosol inhalation.
  • compositions of the present invention may enhance the overall antimicrobial effectiveness of the compositions.
  • the main component molecules of the plant extract contain at least 4 hydroxyl groups, which are selected from the group consisting of chlorogenic acid, luteolin, luteolin, and luteolin-7-O- ⁇ -D- Glucuronide and a plant extract of one of the proanthocyanidin components.
  • the proanthocyanidin component can be selected from, for example, the leaves of Eucommia ulmoides, Lonicera japonica (honeysuckle), Lonicera erythricum, flowers of Honeysuckle or Lonicera tomentosa, Lonicera vine, and English hawthorn.
  • the plant extract is grape seed extract (the main component of which is proanthocyanidins).
  • the plant extract is present in an amount of about 0-20% by weight, based on the total weight of the composition. In a preferred embodiment, the plant extract is present in an amount of about 0.0001 to 20% by weight, based on the total weight of the composition. In a more preferred embodiment, the plant extract is present in an amount of about 0.5-0.9% by weight, based on the total weight of the composition. For example, about 0.5% by weight, about 0.6% by weight, about 0.7% by weight, about 0.8% by weight, and about 0.9% by weight.
  • Plant extracts are usually brown, ultraviolet-blue-violet light-absorbing substances that can act as sunscreens. Too high a content of plant extracts will make the composition too dark, thus affecting its aesthetics. Too low a content of plant extracts will reduce the light absorption properties of the composition, which is not conducive to the stable storage of compounds containing enol structures that are sensitive to light, and will result in weakened antimicrobial activity. However, reducing the content of plant extracts can reduce irritation, making it suitable for respiratory aerosol inhalation.
  • the odor masking agent may be a fruity flavor.
  • the odor masking agent is selected from volatile oils from tangerine peels of the family Rutaceae, such as lemon oil, whose main component is limonene, and its minor components also include pinene, myrcene, terpinene, etc.
  • lemon oil-containing botanicals such as tangerine peel, traditional Chinese medicine pieces
  • eucalyptus lemon and pinole enteric-coated soft capsules (National Drug Approval No. H20052401) can improve the ciliary movement of tracheal mucosa, promote the secretion of respiratory glands, reduce phlegm, and promote self-purification of the respiratory tract.
  • Pharmacological effects It is a classic auxiliary medicine for respiratory diseases.
  • the odor masking agent is present in an amount of about 0.0001-2% by weight, based on the total weight of the composition. In a preferred embodiment, the odor masking agent is present in an amount of about 0.01 to 0.9% by weight, based on the total weight of the composition. In a more preferred embodiment, the odor masking agent is present in an amount of about 0.2 to 0.5% by weight, based on the total weight of the composition. For example, about 0.2% by weight, about 0.3% by weight, about 0.4% by weight, and about 0.5% by weight.
  • composition of the present invention contains a relatively high concentration of compounds containing enol structures and compounds containing sulfhydryl groups, which can have a good protective effect on the above-mentioned polyphenols. Therefore, the combination of the composition of the present invention and the above-mentioned substances It also helps the above-mentioned substances to realize their commercial value.
  • the isoelectric point of the S protein of 2019-nCoV is 6.24
  • the isoelectric point of S1/S2/His is 4.41-5.87
  • the isoelectric point of the key binding protein of hACE2/His is 5.19-6.11 through protein models. (average pH 5.60).
  • the pH value of the composition of the present invention is set to 5.6-6.0 (preferably pH is 5.8). During use, the pH will gradually increase (when the composition is exposed to the air, the CO2 content will gradually decrease) , the pH of the composition will slowly rise to near the isoelectric point of the S protein, thereby precipitating the protein. Therefore, the composition of the present application may have the effect of inhibiting the activity of viral surface proteins.
  • sulfhydryl structure in sulfhydryl-containing compounds can also act on the disulfide bonds of proteins, thereby destroying the protein conformation and reducing the viscosity of sputum.
  • N-acetylcysteine aerosol inhalation has been regulated by European and Chinese drug regulators. Approved by the bureau for the treatment of phlegm (such as: acetylcysteine solution for inhalation, National Drug Approval H20150548, JX20020133, ZAMBON S.p.A.). Therefore, since the composition of the present invention contains a sulfhydryl compound, it can also achieve a long-lasting protein activity inhibition effect.
  • the invention relates to an aqueous solution, characterized in that it contains the composition of the invention.
  • the composition is present in an amount of about 30-80% by weight, based on the total weight of the aqueous solution. In a preferred embodiment, the composition is present in an amount of about 56-76% by weight, based on the total weight of the aqueous solution. In a more preferred embodiment, the composition is present in an amount of about 66% by weight, based on the total weight of the aqueous solution. For example, about 30% by weight, about 35% by weight, about 40% by weight, about 43% by weight, about 45% by weight, about 50% by weight, about 55% by weight, about 60% by weight, about 63% by weight, about 65% by weight. , about 66% by weight, about 67% by weight, about 70% by weight, about 76% by weight, about 75% by weight.
  • an appropriate water content is conducive to the composition of the present invention achieving its technical effects, such as adsorbing and neutralizing irritating gases in oxidizing disinfectants, purifying the air, inhibiting biological protein activity, etc.
  • Excessively high water content results in a low content of the composition, which is insufficient to achieve the technical effects of the present invention.
  • Too low water content is not conducive to the full dissolution of the components, so that each component of the composition cannot be fully contacted with the adsorbed gas, so it cannot effectively adsorb and neutralize the irritating gases in the oxidizing disinfectant, and is not conducive to other Realization of technical effects.
  • the composition aqueous solution of the present invention can absorb and neutralize irritating gases (such as irritating gases in oxidative disinfectants) more effectively, and the adsorption efficiency can be significantly improved.
  • the invention relates to a substrate, characterized in that it contains a composition of the invention.
  • the substrate is used to adsorb and neutralize irritating gases in oxidative disinfectants.
  • composition of the invention is adsorbed onto the substrate.
  • the base material of the present invention refers to a material product, such as sheet, metal plate, non-woven fabric, glass fiber, etc.
  • a material product such as sheet, metal plate, non-woven fabric, glass fiber, etc.
  • different materials can be attached to the surface of the substrate.
  • activated carbon can be attached to the surface of the substrate.
  • a weakly alkaline compound such as sodium bicarbonate
  • reducing compounds such as compounds containing enol structures or compounds containing thiol groups, may be attached to the surface of the substrate.
  • the substrate may be a metal mesh.
  • the base material can be a non-woven fabric in a mask or a filter membrane in a gas mask.
  • the substrate is selected from the group consisting of non-woven cloth, metal mesh, fiberglass, cotton cloth, linen cloth, and filter cotton.
  • the substrate is non-woven fabric.
  • the present invention relates to a multi-layer material A, characterized in that the multi-layer material A includes: the base material of the present invention as the base material; and the activated carbon layer as the first filter layer.
  • the base material as the base material is selected from non-woven cloth, metal mesh, glass fiber, cotton cloth, linen cloth, and filter cotton.
  • the substrate is non-woven fabric.
  • the base material is attached with the composition of the present invention and can be used to adsorb and neutralize irritating gases.
  • the irritating gases can be, for example, volatile gases in oxidizing disinfectants, such as chlorine in chlorine-containing disinfectants, The volatilized hydrogen peroxide in hydrogen peroxide disinfectants or the volatilized peracetic acid in peracetic acid-containing disinfectants.
  • the irritating gas may be an aldehyde-based compound volatilized in a disinfectant containing an aldehyde-based compound.
  • the multi-layer material A also includes an activated carbon layer as the first filter layer, where the activated carbon layer is used to adsorb peracetic acid, a volatile gas in the air, but does not have the effect of neutralizing peracetic acid.
  • the multi-layer material A of the present invention further includes a second filter layer between the base material and the first filter layer.
  • a second filter is also included between the base material of the multi-layer material A of the present invention and the first filter layer. layer.
  • the substrate may be a metal mesh.
  • the base material can be a non-woven fabric in a mask or a filter membrane in a gas mask.
  • the second filter layer is selected from the group consisting of non-woven cloth, metal mesh, glass fiber, cotton cloth, linen cloth, and filter cotton.
  • the second filter layer is non-woven fabric.
  • the second filter layer is melt-blown non-woven fabric.
  • the present invention relates to a multi-layer material B, characterized in that the multi-layer material B includes: the base material of the present invention as a first base material; an intermediate isolation layer; and a second base material.
  • the first base material is the base material of the present invention, wherein the base material is as defined above.
  • the middle isolation layer is composed of a porous breathable material that is not wetted by water, and is used to isolate the first base material and the second base material so that the two base materials can work in different environments.
  • the first base layer material and the second base layer material have different working environments, for example, the pH of the two is different.
  • the temperatures of the two are different.
  • the humidity of the two is different.
  • the middle isolation layer includes a porous breathable material that is not wetted by water.
  • the porous breathable material is selected from the group consisting of polyester filter cotton, glass wool, rock wool, air filter cotton, and foam sponge.
  • the porous breathable material is polyester filter cotton.
  • the porous breathable material is an ethylene vinyl acetate (EVA) breathable sponge.
  • the thickness of the intermediate isolation layer is about 0.1-15 mm. In a preferred embodiment, the thickness of the intermediate isolation layer is about 3 mm.
  • the second base material includes biological enzymes, moisture absorbing agents, preservatives, and acid-base buffers, wherein the types of biological enzymes, moisture absorbing agents, acid-base buffers, and second base materials are as defined above.
  • the biological enzyme is catalase.
  • catalase is used to adsorb and decompose the volatile gas hydrogen peroxide.
  • the biosorbent in the first base material and the catalase in the second base material need to work under different pH conditions, they can fully exert their respective adsorption and neutralization of irritating gases. Therefore, an intermediate isolation layer is provided between the first base material and the second base material, which can effectively isolate the components in the two materials.
  • the middle isolation layer uses a porous breathable material that is not wetted by water. Gas can still pass through the middle isolation layer smoothly and be further adsorbed and neutralized by the active ingredients in the second base material.
  • the present invention relates to a mask comprising the base material, multi-layer material A or multi-layer material B of the present invention, wherein the base material, multi-layer material A and multi-layer material B are as defined above.
  • the present invention also relates to a method for preparing the mask of the present invention, which includes the following steps:
  • step (3) Drying the base material obtained in step (2) under a protective gas atmosphere;
  • the types and contents of the active ingredients or other ingredients in the first base layer material, the second base layer material, the second filter layer, the first filter layer, and the intermediate isolation layer are as defined above.
  • the protective gas used in step (3) and step (5) is selected from nitrogen, helium, neon and carbon dioxide. In a preferred embodiment, the protective gas used in step (3) and step (5) is nitrogen.
  • the protective gases used in step (3) and step (6) may be the same or different.
  • the drying temperature in step (3) and step (6) is about 50-80°C or room temperature. In a preferred embodiment, the drying temperature in step (3) and step (6) is about 60°C.
  • the present invention also relates to a method for quickly preparing the mask of the present invention, which includes the following steps:
  • step (2) Spray the composition liquid of step (1) onto the inside and/or outside of the mask by spraying.
  • composition solution of step (1) is stored in a spray bottle as described in Figure 8.
  • step (2) the composition of step (1) is sprayed via a spray bottle as shown in FIG. 8, see FIG. 9 for the spraying process.
  • the composition spraying position is about 5-10 cm above the mask.
  • the volume of the composition solution sprayed in step (2) is about 3.2 mL.
  • spray the inner and outer sides of the mask about 15-20 times to complete the spraying of the composition solution.
  • the inner and outer sides of the mask are sprayed about 17-19 times to complete the spraying of the composition solution. For example, about 15 times, about 16 times, about 17 times, about 18 times, about 19 times, and about 20 times.
  • composition of the present invention The stability of the composition of the present invention and its ability to adsorb and neutralize irritating gases in oxidizing disinfectant solutions
  • composition of the present invention to adsorb and neutralize irritating gases in oxidizing disinfectant solutions
  • composition of the present invention to neutralize irritating gases in the oxidizing disinfectant solution is tested by the following method A.
  • the ability of the composition of the present invention to adsorb and neutralize irritating gases in oxidative disinfectants is determined by the method described above.
  • the adsorption of chlorine gas in the disinfectant by the composition of the present invention is determined by titration of the aqueous solution of the composition of the present invention with trichloroisocyanuric acid disinfectant, sodium hypochlorite disinfectant and chlorine dioxide disinfectant aqueous solution. and ability.
  • the ability of the composition of the present invention to adsorb and neutralize hydrogen peroxide in the disinfectant is determined by titration of an aqueous solution of the composition of the present invention with a hydrogen peroxide wash solution.
  • the adsorption and neutralization ability of the composition of the present invention on the peracetic acid in the disinfectant is determined by titration of the aqueous solution of the composition of the present invention with an oxyacetic acid disinfectant solution.
  • titration indicator when titrating chlorine-containing disinfectants, use chlorine test paper as a titration indicator.
  • chlorine test paper For another example, when titrating hydrogen peroxide disinfectant, use hydrogen peroxide test paper as a titration indicator.
  • hydrogen peroxide test paper For another example, when titrating peracetic acid disinfectant, use peracetic acid test paper as a titration indicator.
  • a secondary indicator is used in determining the titration end point.
  • chlorine test paper is used as an auxiliary indicator to help determine the titration endpoint of hydrogen peroxide and peracetic acid disinfectants.
  • the ability of the composition of the present invention to neutralize irritating gases in the oxidative disinfectant solution is tested by the following method A1.
  • composition aqueous solution of the present invention wherein the content of the active ingredient (enol structure-containing compound and/or thiol structure-containing compound and/or amino acid) in the composition aqueous solution is about 2-8% by weight;
  • step (3) Use the disinfectant solution obtained in step (1) to titrate 1 mL of the composition aqueous solution in step (2), and record the volume of disinfectant solution consumed at the end point of the titration.
  • the trichloroisocyanuric acid aqueous solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of the trichloroisocyanuric acid aqueous solution consumed by the titration is about 5-50 mL. In a preferred embodiment, the trichloroisocyanuric acid aqueous solution is prepared by the above method to perform a titration experiment. At the titration end point, the volume of the trichloroisocyanuric acid aqueous solution consumed by the titration is about 10-30 mL.
  • the sodium hypochlorite disinfectant aqueous solution is prepared by the above method to perform a titration experiment. At the titration end point, the volume of the sodium hypochlorite disinfectant aqueous solution consumed by the titration is about 5-50 mL. In a preferred embodiment, the sodium hypochlorite disinfectant aqueous solution is prepared by the above method for a titration experiment. At the end point of the titration, the volume of the sodium hypochlorite disinfectant aqueous solution consumed by the titration is about 10-30 mL.
  • a chlorine dioxide disinfectant aqueous solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of the chlorine dioxide disinfectant aqueous solution consumed by the titration is about 50-150 mL.
  • the sodium hypochlorite disinfectant aqueous solution is prepared by the above method for a titration experiment. At the end point of the titration, the volume of the sodium hypochlorite disinfectant aqueous solution consumed by the titration is about 70-130 mL.
  • the hydrogen peroxide wash solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of hydrogen peroxide wash solution consumed by the titration is about 0.08-1 mL. In a preferred embodiment, the hydrogen peroxide wash solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of hydrogen peroxide wash solution consumed by the titration is about 0.08-0.5 mL.
  • the peracetic acid disinfectant solution is prepared by the above method for a titration experiment. At the end point of the titration, the volume of the peracetic acid disinfectant solution consumed by the titration is about 0.4-2.5 mL. In a preferred embodiment, the peracetic acid disinfectant solution is prepared by the above method for a titration experiment. At the end point of the titration, the volume of the peracetic acid disinfectant solution consumed by the titration is about 0.4-2.0 mL.
  • the glutaraldehyde disinfectant solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of the glutaraldehyde disinfectant solution consumed by the titration is about 3-5 mL. In a preferred embodiment, the glutaraldehyde disinfectant solution is prepared through the above method for a titration experiment. At the end point of the titration, the volume of peracetic acid disinfectant solution consumed by the titration is about 3.5-4.5 mL.
  • composition of the present invention is tested by the following method.
  • step (3) Use the disinfectant aqueous solution of step (1) to titrate the composition aqueous solution of step (2), and record the volume C 0 of the disinfectant aqueous solution consumed at the end point of the titration;
  • step (1) Store the aqueous composition solution of step (1) in a closed space at a constant temperature for a period of time;
  • step (1) Use the disinfectant aqueous solution of step (1) to titrate the composition aqueous solution of step (4), and record the volume C of the disinfectant aqueous solution consumed at the end point of the titration;
  • k represents the rate constant (d -1 )
  • C 0 represents the initial concentration
  • C represents the concentration at t
  • t-time is days (d)
  • t 1/2 represents the half-life.
  • composition of the invention is tested by the following method:
  • composition aqueous solution of the present invention wherein the content of the active ingredient (enol structure-containing compound and/or thiol structure-containing compound and/or amino acid) in the composition aqueous solution is about 2-3% by weight;
  • step (3) Use the disinfectant solution obtained in step (1) to titrate 1 mL of the aqueous composition solution of step (2), and record the volume C 0 of the disinfectant solution consumed at the end point of the titration;
  • step (2) Store the aqueous composition solution of step (2) in a room temperature space (such as an indoor room with a north-facing window, no direct sunlight, but with natural light and fluorescent indoor lighting) for about 60-365 days.
  • a room temperature space such as an indoor room with a north-facing window, no direct sunlight, but with natural light and fluorescent indoor lighting
  • step (1) Use the disinfectant solution obtained in step (1) to titrate 1 mL of the aqueous composition solution of step (4), and record the volume C of the disinfectant solution consumed at the end point of the titration;
  • an aqueous solution of trichloroisocyanuric acid is prepared by the above method and subjected to a titration experiment. After calculation, the half-life of the composition of the present invention is approximately 360-3600 days. In a preferred embodiment, an aqueous solution of trichloroisocyanuric acid is prepared by the above method and subjected to a titration experiment. After calculation, the half-life of the composition of the present invention is approximately 361-3300 days. For example, 365 days, 443 days, 443 days, 682 days, 1000 days, 2000 days, 3000 days, 3253 days.
  • compositions of the present invention are used to adsorb and neutralize irritating gases.
  • WHO recommends disinfectants containing ethanol or isopropyl alcohol as the main ingredient (i.e., alcohol-based disinfectants) for skin disinfection.
  • alcohol-based disinfectants i.e., ethanol or isopropyl alcohol as the main ingredient
  • the present invention designs relevant tests to test the compatibility of the composition with alcohol-based disinfectants.
  • the disinfection effect of the composition of the present invention and its compatibility with alcohol-based disinfectants were tested by the following method.
  • step (3) Shake the container in step (3) for 5 minutes, and then observe the protein denaturation and precipitation effect.
  • the pH of Composition 1 as well as Composition 2 is about 5.5-6.2.
  • composition 2 or the combination of composition 2 and disinfecting alcohol when added in step (2), the effect of protein denaturation and precipitation can be observed.
  • the ability of the mask of the present invention to neutralize irritating gases in the oxidative disinfectant solution is tested through the following two methods, namely qualitative testing and quantitative testing.
  • step (3) Place the disinfectant aqueous solution of step (2) in a closed container, and shake the container to fill the container with volatile irritating gas;
  • the disinfectant aqueous solution configured in step (2) of method B and step (3) of method C is selected from the group consisting of chlorine-containing disinfectant aqueous solution, hydrogen peroxide wash solution, peracetic acid disinfectant solution, and chlorine dioxide disinfection and glutaraldehyde disinfectant.
  • the chlorine-containing disinfectant aqueous solution is selected from the group consisting of trichloroisonitrile uric acid disinfectant solution and sodium hypochlorite disinfectant solution.
  • the concentration of the disinfectant aqueous solution configured in step (2) of method B and step (3) of method C is selected from the group consisting of 1000ppm, 30000ppm, 5000ppm, 100ppm and 20000ppm.
  • the disinfectant aqueous solution configured in step (2) of method B and step (3) of method C includes 1000 ppm chlorine-containing disinfectant solution, 30000 ppm hydrogen peroxide wash solution, 5000 ppm peracetic acid disinfectant solution, 100ppm chlorine dioxide disinfectant and 20000ppm glutaraldehyde disinfectant.
  • the closed container used in Method B is a 100 ml iodine flask.
  • the amount of disinfectant used is about 5-10 mL.
  • the amount of disinfectant used is about 5-10 mL.
  • the test paper used in Method C is selected from the group consisting of chlorine test paper, chlorine dioxide test paper and glutaraldehyde test paper.
  • the test paper used in method B is chlorine test paper
  • the test paper used in method C is chlorine dioxide test paper
  • glutaraldehyde disinfectant the test paper used in method C is glutaraldehyde test paper.
  • the distance between the two pieces of detection test paper is 3-5 mm to facilitate the passage of airflow.
  • the tester before wearing the mask of the present invention, can smell a strong irritating smell in the closed container; after wearing the mask of the present invention, the tester can smell the smell in about 2- No pungent odor can be smelled in the closed container within 5 minutes.
  • the detection is only carried out by method C.
  • test paper changes color on the outside of the mask of the present invention, but does not change color on the inside of the mask of the present invention.
  • step (2) Dissolve the mask in step (1) in water to obtain a mask extract
  • step (3) Use the disinfectant aqueous solution from step (3) to titrate the mask extract from step (2), and record the disinfectant aqueous solution consumed at the end point of the titration.
  • the ability of the mask of the present invention to neutralize irritating gases in the oxidative disinfectant solution is quantitatively tested by the following method D1:
  • step (2) Dissolve the mask in step (1) in 100 mL of water to obtain the mask extract;
  • step (2) Take 10 mL of the mask extract from step (2), titrate the mask extract with the disinfectant aqueous solution from step (3), and record the disinfectant aqueous solution consumed at the end point of the titration;
  • step (4) Amplify the titration result of step (4) 10 times to obtain the mask's ability to neutralize irritating gases in the oxidizing disinfectant solution.
  • the titration indicator is selected as described in Method A.
  • the mask of the present invention may contain liquid in an amount of about 3-4 mL.
  • liquid in an amount of about 3-4 mL.
  • the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of the trichloroisocyanuric acid aqueous solution consumed is about 90-100 mL.
  • the mask extract of the present invention is titrated by the above method, and at the end point of the titration, the volume of hydrogen peroxide wash solution consumed is about 1-2 mL.
  • the mask extract of the present invention is titrated by the above method, and at the end point of the titration, the volume of peracetic acid disinfectant consumed is about 8-10 mL.
  • the mask extract of the present invention is titrated by the above method.
  • the volume of the consumed chlorine dioxide disinfectant aqueous solution is about 350-450 mL.
  • the mask extract of the present invention is titrated by the above method, and at the end point of the titration, the volume of glutaraldehyde disinfectant solution consumed is about 10-15 mL.
  • the stability of the mask of the present invention is tested through the following three methods, including qualitative testing, quantitative testing and microbial content determination.
  • the stability of the mask of the present invention was qualitatively tested by the following methods E and F.
  • step (1) Place the mask in step (1) in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for 14 days;
  • step (3) The tester wears the mask obtained in step (3) for 30 minutes;
  • step (1) Place the mask in step (1) in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for 14 days;
  • step (3) The tester wears the mask obtained in step (3) for 30 minutes;
  • the disinfectant solution, the concentration of the disinfectant solution, and the amount of the disinfectant solution used in Methods E and F are as described above.
  • the tester before wearing the mask of the present invention, can smell a strong pungent odor in the closed container; after wearing the mask of the present invention, the tester can smell a weak smell The smell of disinfectant is non-irritating.
  • test paper changes color on the outside of the mask of the present invention, but does not change color on the inside of the mask of the present invention.
  • the stability of the mask of the present invention is tested by the following method G.
  • step (1) Place the mask in step (1) in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for 14 days;
  • the titration indicator is selected as described in Method A.
  • the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of the trichloroisocyanuric acid aqueous solution consumed is about 30-40 mL.
  • the mask extract of the present invention is titrated by the above method, and at the end point of the titration, the volume of hydrogen peroxide wash solution consumed is about 0.3-0.4 mL.
  • the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of peracetic acid disinfectant consumed is about 3-4 mL.
  • the mask extract of the present invention is titrated by the above method.
  • the volume of the consumed chlorine dioxide disinfectant aqueous solution is about 170-180 mL.
  • the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of glutaraldehyde disinfectant solution consumed is about 10-12 mL.
  • the stability of the mask of the present invention is tested by the following method H.
  • the detected flora species include bacteria, fungi, and the like.
  • Exemplary bacteria can be, for example, coliforms, Pseudomonas aeruginosa, Staphylococcus aureus, hemolytic Streptococcus, etc.
  • the mask extract of the present invention is detected by the above method. After 14 days, the number of coliform bacteria is 0.
  • the mask extract of the present invention is detected by the above method. After 14 days, the number of Pseudomonas aeruginosa bacterial colonies is 0.
  • the mask extract of the present invention is detected by the above method. After 14 days, the number of Staphylococcus aureus colonies is 0.
  • the mask extract of the present invention is detected by the above method. After 14 days, the number of hemolytic streptococci is 0.
  • the mask extract of the present invention is detected by the above method. After 14 days, the number of fungal colonies is 0.
  • the mask extract of the present invention is tested by the above method. After 14 days, the total number of bacterial colonies is 250 CFU/g, wherein the bacteria are non-pathogenic Paenibacillus urinae.
  • the color development ability of the mask of the present invention is tested by the following method I.
  • the above-mentioned method I is used to simulate the scenario of the mask of the present invention after repeated use.
  • the method of heating the mask in Method 1 is fumigation, and the fumigation temperature is about 40-94°C.
  • the method of heating the mask in Method 1 is fumigation, and the fumigation time is about 2-6 hours. In a preferred embodiment, after heating and fumigation, it is continued to be placed in a residual heat environment for about 16-18 hours.
  • the type and concentration of the disinfectant solution are as described in methods B and C above.
  • the mask of the present invention will turn red after passing through the gas environment of high-concentration chlorine-containing disinfectant (such as hypochlorous acid disinfectant, chlorine dioxide disinfectant).
  • high-concentration chlorine-containing disinfectant such as hypochlorous acid disinfectant, chlorine dioxide disinfectant.
  • the mask of the present invention will turn into deep yellow after passing through the gas environment of high-concentration peroxide disinfectant.
  • the mask of the present invention after passing through the gas environment of high-concentration glutaraldehyde disinfectant solution, the mask of the present invention will turn into dark brown.
  • step (3) of method 1 before heating in step (3) of method 1, the following steps are also included:
  • the detection test paper is selected as described in method C above.
  • test paper on the inside of the mask of the present invention does not change color.
  • test paper on the inside of the mask of the present invention slightly changes color.
  • test paper on the inner side of the mask of the present invention after passing through the gas environment of high-concentration peracetic acid disinfectant solution, partially changes color.
  • test paper on the inside of the mask of the present invention does not change color.
  • test paper on the inside of the mask of the present invention does not change color.
  • the heat dissipation ability of the mask of the present invention is tested by the following method J.
  • the tester wears a mask and takes a thermal image temperature measurement
  • the tester takes off the mask and takes a thermal image temperature measurement.
  • the temperature of the area of the mask of the present invention that contacts the skin is about 2-3°C lower than the area below the nostrils that does not contact the skin. For example, about 2°C, about 2.2°C, about 2.4°C, about 2.6°C, about 2.8°C, and about 3°C.
  • the composition of the present invention uses a biosorbent and a hygroscopic agent. Through the adsorption effect of the hygroscopic agent on water, the composition becomes a moist or solution state, thereby increasing the contact area between the active ingredient biosorbent and irritating gases. , effectively improve the efficiency of adsorbing and neutralizing irritating gases, and can effectively reduce the concentration of certain irritating gases in the air, such as chlorine, chlorine dioxide, hydrogen peroxide, peracetic acid and aldehyde compounds, etc. In addition, since the composition of the present invention can be changed into a moist or solution state, which increases the contact surface between the active ingredients and irritating gases, the composition of the present invention can absorb and neutralize it more effectively than vitamin C itself. Irritating gas.
  • the aqueous composition solution of the present invention can also effectively absorb and neutralize irritating gases, especially irritating gases in oxidative disinfectants. Compared with the aqueous solution of vitamin C, the aqueous solution of the composition of the present invention can significantly improve the absorption capacity of irritating gases.
  • the base material containing the composition of the present invention can also effectively absorb and neutralize the irritating odor gas generated by the volatilization of high-efficiency disinfectants in the air, and is suitable for disinfection workers such as hospital infection control and epidemic prevention.
  • the base material containing the composition of the present invention can also effectively absorb and neutralize the irritating odor gas generated by the volatilization of high-efficiency disinfectants in the air, and is suitable for disinfection workers such as hospital infection control and epidemic prevention.
  • it provides protective effects on the respiratory tract, skin, and mucous membranes; it can also be used as an antagonist for those who accidentally ingest or misuse high-efficiency disinfectants, leading to disinfectant poisoning.
  • the base material containing the composition of the present invention can also be used in many technical fields such as daily cleaning disinfection products and air freshening equipment (such as reducing the concentration of formaldehyde and glutaraldehyde in the environment), and may be used for microbial protection in certain specific fields. or play a role in air purification.
  • the multilayer material containing the composition of the present invention can adsorb and neutralize a variety of irritating gases, so it can be applied to different occasions and effectively adsorb and neutralize chlorine, hydrogen peroxide, peracetic acid, and aldehydes. Compounds and other gases.
  • masks containing the composition of the present invention may reduce the use of activated carbon masks in some specific fields, and the components in the composition are mostly edible or harmless substances to the human body.
  • masks containing the composition of the present invention may reduce the risk of activated carbon powder in traditional activated carbon masks being inhaled by the human body or polluting the working environment. This is because activated carbon requires high energy consumption in the production process, and old activated carbon that has adsorbed toxic and hazardous substances is considered hazardous solid waste by current regulations in some countries.
  • the active ingredients in the base material, multi-layer material or mask containing the composition of the present invention can be extracted by solvent to obtain an extract of the above-mentioned materials. Therefore, in an emergency, it is also possible to quickly extract the active ingredients from the material of the present invention.
  • the extract of the active ingredient biosorbent can be used for on-site detoxification of those who accidentally ingested or misused the disinfectant through oral administration, skin and mucous membrane rinses, wet compresses, etc.
  • the multi-layer material containing the composition of the present invention can achieve a hygroscopic agent-water concentration gradient balance between the center and edge positions of the multi-layer material, which is conducive to the volatilization of moisture and taking it away. heat, thereby lowering the temperature around the multilayer material.
  • the wearer's facial temperature will be lower and the wearer will not feel stuffy.
  • the facial skin temperature is lower than the skin temperature under the nostrils.
  • composition of the present invention has the property of color development and indication, and the composition will change color after high-intensity use in the air. Therefore, when the composition of the present invention is used in products such as masks and multi-layer materials, it can provide timely feedback on the status of active ingredients and facilitate replacement of the composition.
  • the composition of the present invention has excellent stability.
  • the composition of the present invention contains bioactive ingredients such as enol-containing compounds, sulfhydryl-containing compounds, and amino acids. Even if it is left standing in the air for a long time, the composition can still absorb and neutralize irritating gases in the air. , such as chlorine, chlorine dioxide, hydrogen peroxide, peracetic acid and aldehyde compounds, etc.
  • adding plant extracts to the composition of the present invention can have a light-shielding effect and greatly increase the shelf life of the active ingredients, allowing them to absorb and neutralize irritating gases in the air after long-term storage.
  • the composition of the present invention has better stability.
  • compositions of the present invention do not affect the performance of disinfecting alcohols.
  • the composition also contains protein coagulant and plant extract components.
  • the corresponding composition may have the effect of inhibiting the activity of surface proteins of microorganisms such as viruses, bacteria, fungi, etc., and may enhance and prolong the activity of surface proteins of microorganisms such as viruses, bacteria, and fungi when used in conjunction with disinfectant alcohol.
  • the disinfection effect of alcohol also reduces the irritation of disinfectant alcohol to the skin.
  • Trichloroisocyanuric acid disinfectant tablets Hangzhou Langso Medical Disinfectant Co., Ltd. Available chlorine content is 500 ⁇ 50mg/tablet.
  • Sodium hypochlorite disinfectant Hangzhou Langso Medical Disinfectant Co., Ltd. Concentration 4.5-5.5% by weight.
  • Chlorine dioxide disinfectant tablets Beijing Hualong Xingyu Technology Development Co., Ltd. Chlorine dioxide content is 100 ⁇ 10mg/tablet.
  • Hydrogen peroxide lotion Shandong Ruitaiqi Washing and Disinfection Technology Co., Ltd. Concentration 2.5-3.5% by weight.
  • Peracetic acid disinfectant (binary packaging): Shandong Anjie Hi-Tech Disinfection Technology Co., Ltd. Concentration 15-18% by weight.
  • Glutaraldehyde disinfectant Shanghai Likang Disinfection High-Tech Co., Ltd. Concentration 2.1-2.6% by weight.
  • Chlorine test paper Hangzhou Langso Medical Disinfectant Co., Ltd. The concentration is 0-2000ppm.
  • Hydrogen peroxide test paper Hangzhou Luheng Biotechnology Co., Ltd. The concentration is 0-25ppm.
  • Peracetic acid test paper Hangzhou Luheng Biotechnology Co., Ltd. The concentration is 0-40ppm.
  • Glutaraldehyde test paper Hangzhou Luheng Biotechnology Co., Ltd. The concentration is 0-3% by weight.
  • Chlorine dioxide test paper Changsha Shangqing Environmental Protection Technology Co., Ltd. The concentration is 0-20ppm.
  • Formaldehyde solution Sinopharm Chemical Reagent Co., Ltd. Analytically pure (contains methanol inhibitor). Content 37-40% by weight.
  • NaHCO 3 sodium bicarbonate: Tianjin Zhiyuan Chemical Reagent Co., Ltd. Analytically pure.
  • Vitamin C (ascorbic acid): purchased from Fuchen (Tianjin) Chemical Reagent Co., Ltd. Analytically pure.
  • Acetylcysteine injection (4g: 20ml): for content analysis, Hangzhou Minsheng Pharmaceutical Co., Ltd., national drug approval number H20051788.
  • N-acetylcysteine for preparation, Henan Jimei Chemical Products Co., Ltd., food additive.
  • EDTA Na 2 (disodium ethylenediaminetetraacetate): Shanghai Chemical Reagent Co., Ltd. Analytically pure.
  • Glycerin Hunan Erkang Pharmaceutical Co., Ltd. medical supplements.
  • Propylene glycol (1,2 propylene glycol): Hunan Erkang Pharmaceutical Co., Ltd. medical supplements.
  • Sodium hydrogen phosphate-disodium hydrogen phosphate buffer Nanjing Chemical Reagent Co., Ltd. Analytically pure, self-prepared.
  • Ethylparaben Hunan Erkang Pharmaceutical Co., Ltd. medical supplements.
  • Activated carbon layer fabric (carbon sandwiched non-woven fabric): Kunshan Green Chuang Electronic Technology Co., Ltd.
  • Polyester filter cotton primary air filter cotton, thickness 0.3-1mm.
  • Catalase Henan Yangshao Biochemical Engineering Co., Ltd. food ingredients.
  • L-Alanine Henan Jiazhi Chemical Products Co., Ltd. Food grade additives.
  • L-serine Henan Jiazhi Chemical Products Co., Ltd. Food grade additives.
  • Polysorbate-80 Taicang Pharmaceutical Factory. medical supplements.
  • Triethanolamine Sinopharm Chemical Reagent Co., Ltd. Analytically pure.
  • Disinfection alcohol Prepare your own with absolute ethanol and water, or use commercially available finished products directly, with an ethanol content of 70-75% (V/V). Changshu Yangyuan Chemical Co., Ltd. Analytically pure.
  • Egg white The egg white part of commercially available raw eggs is rich in a variety of proteins, with the main component being ovalbumin.
  • Cotton masks The weight is about 9.8g/piece, double-layer pure cotton knitted fabric. It is a washable and reusable daily knitted mask mainly used for decoration, cleaning, and warmth.
  • the estimated cotton thread specification is 40S, and the density of each layer of fabric is about 200g/ m2 . , filter layer area is about 105.2cm 2 , neutral packaging, selling price is about 0.63RMB/piece.
  • Disposable non-woven masks robust Medical nursing masks. ROBUST MEDICAL LIMITED. The price is about 0.8RMB/piece.
  • Glucono-delta-lactone Anhui Xingzhou Pharmaceutical Food Co., Ltd., food additive.
  • Grape seed extract proanthocyanidins: Xi'an Rongzhen Biotechnology Co., Ltd., proanthocyanidin content 95% OPC (UV), [CAS No]: 84929-27-1.
  • Lemon oil Guangzhou Huixin Biotechnology Co., Ltd., [CAS No]: 8008-56-8, the main component is limonene.
  • 3M TM 8246 Occupational Protective Mask R95 activated carbon anti-particle mask, used for acid gas and oily/non-oily particle protection, Minnesota Mining and Manufacturing.
  • the retail price is about 28RMB/piece.
  • 3M TM 8247 Occupational Protective Mask R95 activated carbon anti-particle mask, used for organic vapor odor and oily/non-oily particle protection, Minnesota Mining and Manufacturing. Retail price is about 28RMB/piece.
  • composition A aqueous solution
  • Composition B aqueous solution
  • composition C aqueous solution
  • composition D aqueous solution
  • composition A aqueous solution
  • composition B aqueous solution
  • 6 mg of glycerin aqueous solution
  • 6 mg of glycerin aqueous solution
  • Ethyl hydroxyphenyl ester stir evenly. After the above solution is evenly infiltrated into the base material of the mask, it is dried in a nitrogen atmosphere to obtain mask A.
  • 102 represents the ear strap of the mask
  • 101 represents the base material of the mask, which has the above composition adsorbed thereon.
  • composition A aqueous solution
  • composition B aqueous solution
  • glycerin aqueous solution
  • 6 mg of ethyl hydroxyphenyl ester 6 mg
  • the above solution is uniformly infiltrated into the base material of the mask, it is dried in a nitrogen atmosphere to obtain the base material 101 of mask B.
  • the activated carbon layer 201 is fixed on the outside of the base material 101 by hot melting to obtain the mask B.
  • 102 represents the ear strap of the mask
  • 101 represents the base material of the mask
  • 201 represents the activated carbon layer of the mask.
  • a melt-blown cloth filter layer can also be inserted between the activated carbon layer 201 and the base material 101 to block fine particles. Since peracetic acid is an organic vapor, adding an activated carbon layer to mask B can effectively strengthen the physical adsorption of the mask, thereby achieving a combined filtration effect of physical adsorption and chemical adsorption neutralization.
  • the above solution is evenly infiltrated into the base material of the mask, it is dried in a nitrogen atmosphere to obtain the second base material 301 of the mask C.
  • Polyester filter cotton with a thickness of 3 mm is used as the middle isolation layer 302. Arrange the first base material 101, the middle isolation layer 201 and the second base material 301 in order from the outside to the inside, and prepare a multi-layer mask C by hot melting.
  • 102 represents the ear strap of the mask
  • 101 represents the first base material of the mask
  • 302 represents the second base material
  • 301 represents the second base material. Since the active substances in the first base material 101 and the second base material 302 need to work in different pH environments, the active substances in the first base material 101 are relatively stable in a weakly acidic environment of pH 5.0-6.2, while peroxidation Hydrogenase can maximize the catalytic decomposition of hydrogen peroxide in a pH 7.0 environment. Therefore, the middle isolation layer 302 can effectively isolate the active substances of the two base materials, and the use of polyester filter cotton will not affect the air circulation. . In addition, arranging the second base material 301 on the inside close to the person's face can make the second base material 301 have a relatively high temperature, which is more conducive to the decomposition of hydrogen peroxide by catalase.
  • the measured pH of 5000ppm peracetic acid disinfectant is 2.1, which is highly acidic and exceeds the color development conditions of peroxide test paper. It needs to be neutralized by acid and alkali before using test paper to detect the peroxide concentration.
  • the neutralization product of peracetic acid and acetylcysteine can cause the peroxide detection test paper to fade, and the maximum value of the color change at the moment when the test paper is put into the solution is taken as the reading.
  • Peroxide disinfectants are more oxidizing than chlorine-containing disinfectants and can cause the chlorine test paper to turn brown and then further oxidize, causing the brown product to fade. Therefore, the chlorine test paper cannot be directly put into the reaction system.
  • the reaction between glycine and glutaraldehyde can be carried out at room temperature.
  • the reaction condition is pH>5.0.
  • a yellow product is usually generated within 5-10 seconds and gradually becomes darker.
  • the detection range of currently commercialized glutaraldehyde test paper is 0 -3%, most are also glycine colorimetric methods. Since the color reaction of the test paper is also yellow-orange, the test paper reading is easily disturbed.
  • reaction rate constant K 2 is 1.0 ⁇ 10 5 M -1 s -1 , which is much lower than the cysteine side chain K 2 of 3.0 ⁇ 10
  • the reaction rate constant is 7 M -1 s -1 , so this slow neutralization effect cannot be observed in titration experiments.
  • aqueous solutions of vitamin C and N-acetylcysteine can effectively neutralize hypochlorous acid in chlorine-containing disinfectants, while aqueous solutions of glycine can effectively neutralize glutaraldehyde-containing disinfectants. agent.
  • the moisture absorbing agent has the function of absorbing water and can change the composition into a moist state or a solution state, that is, corresponding to the vitamin C aqueous solution, N-acetylcysteine aqueous solution and Glycine aqueous solution, while the moisture attractant will not participate in the reaction between the above compounds and chlorine, and will not affect the efficiency of the neutralization reaction.
  • the above results confirm that the compounds of the present invention can effectively adsorb and neutralize chlorine-containing disinfectants, peroxide-containing disinfectants and glutaraldehyde-containing disinfectants, and can adsorb and neutralize the irritating gases volatilized by the above-mentioned disinfectants. .
  • (II) Prepare the disinfectant according to the medical disinfection concentration in Table 1, transfer 5 mL of disinfectant into a 100 mL iodine bottle through a pipette, and slightly add iodine to the bottle to evaporate the disinfectant.
  • the mask A of the invention is placed in the central area of the above-mentioned iodine bottle.
  • the front and back sides of the central area of the mask are respectively pasted with test paper with a length of about 10mm.
  • the two test papers are 3-5mm apart to facilitate the passage of airflow.
  • the test paper used is chlorine test paper; for chlorine dioxide disinfectant, the test paper used is chlorine test paper Chlorine oxide test paper; for glutaraldehyde disinfectant, the test paper used is glutaraldehyde test paper.
  • the mask of the present invention can effectively absorb and neutralize irritating gases in various disinfectants.
  • mask A is adsorbed with the composition of the present invention, which contains bioactive ingredients such as vitamin C, N-acetylcysteine, glycine, etc. Therefore, the above qualitative experiment can also confirm that it is effective against irritating gases (such as those in disinfectant solutions). irritating gases), the composition of the present invention has excellent absorption capacity. In addition, the composition of the present invention can absorb and neutralize irritating gases more effectively than vitamin C itself.
  • bioactive ingredients such as vitamin C, N-acetylcysteine, glycine, etc. Therefore, the above qualitative experiment can also confirm that it is effective against irritating gases (such as those in disinfectant solutions). irritating gases), the composition of the present invention has excellent absorption capacity. In addition, the composition of the present invention can absorb and neutralize irritating gases more effectively than vitamin C itself.
  • the mask A of the present invention into a 250 ml conical flask, and add 100 mL of water to the conical flask. Stir the water in the above-mentioned Erlenmeyer flask to fully dissolve the components of mask A in the water to obtain the mask extract. Take out 10mL of mask extract and perform a titration experiment according to the method in Table 1 to determine the content of active substances in the mask. The measurement results are magnified 10 times to obtain the content of active substances in the mask. The test results are shown in Table 2.
  • the above results can confirm that the mask of the present invention can effectively absorb and neutralize irritating gases in various disinfectants.
  • mask A adsorbs the composition of the present invention, so the above results can also confirm that the composition of the present invention has excellent absorption capacity for irritating gases (such as irritating gases in disinfectant solutions).
  • the composition of the present invention can absorb and neutralize irritating gases more effectively than vitamin C itself.
  • the mask turns yellow within a few hours after being exposed to the air. After the tester wears the above mask A, the tester can smell a slightly faint disinfectant smell, but the smell is not irritating.
  • test paper on the outside of the mask changes color, but the test paper on the inside of the mask does not change color.
  • the mask of the present invention still has the ability to absorb disinfectants and neutralize irritating gases, and the mask of the present invention has excellent stability.
  • mask A is adsorbed with the composition of the present invention, which contains bioactive ingredients such as vitamin C, N-acetylcysteine, glycine, etc., each of which has different reducing properties or reactivity. Even if it is left standing in the air for a long time, For a long time (such as 14 days), the composition can still absorb and neutralize irritating gases (such as irritating gases in the air or in disinfectants). Therefore, the above results can also confirm that the composition of the present invention has excellent stability. sex. In particular, the combination of the invention has significantly improved stability compared to vitamin C itself.
  • the above results can confirm that even if it is oxidized and discolored by air, the mask of the present invention still has the ability to absorb disinfectants and neutralize irritating gases, and the mask of the present invention has excellent stability.
  • mask A adsorbed the composition of the present invention, so the above results can also confirm that the composition of the present invention has excellent stability.
  • the combination of the invention has significantly improved stability compared to vitamin C itself.
  • the microbial limits of non-sterile masks are: bacteria ⁇ 100CFU/g, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, hemolysis Sexual streptococci and fungi shall not be detected.
  • mask A is unpacked in a class 100 ultra-clean bench, extracted with 0.9% sodium chloride injection, and the extract is added to agar culture medium.
  • mask A was placed in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for two weeks, then soaked in water to dilute the preservative, and then sampled and operated in an open environment to observe The impact of environmental bacteria on masks.
  • the test results are shown in Table 4.
  • the microbial index of the mask not only meets the requirements of industry standards, but also inhibits environmental microorganisms.
  • the cultured environmental colony microorganisms are mainly Paenibacillus urinae, which can produce spores and is resistant to harsh environments (such as preservatives), so it grows in low-concentration preservative environments.
  • this bacterium is a non-pathogenic background microorganism, mostly coming from animal urine.
  • reaction end point of glycine (or other amino acids) neutralizing glutaraldehyde disinfectant is determined by the following method:
  • step (4) Use sodium hydroxide aqueous solution to titrate the mixed solution in step (4) until the pH is 8.2;
  • step (7) Cool the mixed liquid in step (6) and measure the pH value of the mixed liquid;
  • step (9) Dilute the mixed solution of step (8), and titrate the mixed solution of step (8) using sodium hydroxide aqueous solution to a pH of 8.2;
  • step (10) Use sodium hydroxide aqueous solution to titrate the mixed solution in step (10) to pH 9.2, and record the volume V 2 (mL) of the titrant;
  • V 1 represents the volume of sodium hydroxide standard titration solution consumed after formaldehyde is added to the sample diluent for measurement, in milliliters (mL);
  • V 2 represents the volume of sodium hydroxide standard titration solution consumed after adding formaldehyde in the reagent blank test, in milliliters (mL);
  • C NaOH represents the concentration of sodium hydroxide standard titration solution, in moles per liter (mol/L);
  • MW amino acid represents the molar mass (molecular weight) of the amino acid, in grams per mole (g/mol);
  • the amino acid used in the embodiment of the present invention is glycine, and its molar molecular weight is 75.07g/mol.
  • Table 5 shows the end-point test results of the reaction between glutaraldehyde disinfectant and glycine.
  • the analysis method of the present invention can accurately obtain the stoichiometric point of the material consumption ratio of the neutralization reaction between glutaraldehyde and amino acid substances, that is, accurately obtain the end point of the neutralization reaction and obtain the amount of consumed amino acids.
  • the protective limit performance and color rendering performance of the mask of the present invention were tested by the following methods.
  • the color rendering performance of the mask is similar to the mask protective limit performance experiment. The difference is:
  • 3M TM occupational exposure protective mask was used as a comparative example.
  • Paste a piece of glutaraldehyde test paper on the inner surface of mask D, and wrap the test paper with waterproof and breathable material (such as the blue waterproof layer of a medical mask) to prevent it from being contaminated by the active ingredients of mask D.
  • Set the water bath to about 95°C and place a 100ml evaporating dish on the water bath to fully preheat.
  • Use a pipette to measure 25 ml of 2 wt% glutaraldehyde disinfectant solution and add it to the preheated evaporating dish.
  • the comparative example uses 3M TM 8247 organic vapor and particle protective mask, which conducts the above experiments under the same conditions.
  • the mask was placed in a drying dish and vacuum dried for more than 24 hours before the test.
  • the experimental method for the protective performance of hypochlorous acid chlorine-containing disinfectant is similar to the protective performance test of glutaraldehyde disinfectant. The difference is that a chlorine-containing disinfectant with an effective chlorine concentration of 30,000 ppm is used, and the test paper used is a chlorine test paper. Set the water bath at about 45°C and heat and fumigate for 4 hours. For the comparison example, 3M TM 8246 acid gas and particle protective mask was used.
  • the experimental method for the protective performance of peracetic acid disinfectant is similar to the test for the protective performance of chlorine-containing disinfectant. The difference is that 15000 ppm peracetic acid disinfectant is used, and the test paper is peracetic acid test paper. Set the water bath at about 45°C, heat and fumigate for 6 hours, then close the water bath and use the residual heat to leave it for 17.5 hours. For the comparison example, 3M TM 8246 acid gas and particle protective mask was used.
  • the experimental method for the protective performance of hydrogen peroxide disinfectant is similar to the protective performance test of chlorine-containing disinfectant. The difference is that 30,000 ppm hydrogen peroxide disinfectant is used, and the test paper is a hydrogen peroxide test paper. Set the water bath at about 45°C, heat and fumigate for 6 hours and then close the water bath. For the comparison example, 3M TM 8246 acid gas and particle protective mask was used.
  • test method for the protective performance of chlorine dioxide disinfectant
  • the test method is similar to the protective performance test of chlorine-containing disinfectant. The difference is that 20,000 ppm chlorine dioxide disinfectant is used, and the test paper is hydrogen peroxide test paper. Set the water bath at about 45°C, heat and fumigate for 6 hours, then close the water bath and use the residual heat to leave it for 18 hours.
  • 3M TM 8246 acid gas and particle protective mask was used.
  • the liquid used for fumigation in the evaporating dish can also be added by gradual titration until the test paper changes color, so as to simulate the situation of mask D after repeated use. Compared with the comparative example Compare.
  • 3M TM masks are used as a comparative example.
  • the specific masks used include 3M TM 8246 type masks and 3M TM 8247 type masks.
  • the above examples can confirm that the mask D of the present invention is significantly better than the comparative example in protecting the volatile gases of trichloroisocyanuric acid, chlorine dioxide, and glutaraldehyde disinfectant.
  • the mask D of the present invention is equivalent to the comparative example.
  • the protection against hydrogen peroxide the mask D of the present invention has a relatively long-lasting effect.
  • the test paper on the mask D did not change color until 6 hours after the experiment was carried out.
  • the above results show that in the environment of the above-mentioned high concentration of irritating gas, the mask of the present invention has strong protective ability.
  • the inventor unexpectedly discovered that due to the use of amino acids in the formula of the mask composition, the mask of the present invention will produce a specific discoloration reaction under the irritating gas environment of high concentrations of disinfectants, that is, under the irritating gas environment of different disinfectants, After repeated use in the environment, the floor mask of the present invention will produce different discoloration reactions.
  • the mask of the present invention will turn red after repeated use.
  • the mask of the present invention will turn dark yellow after repeated use.
  • glutaraldehyde disinfectant the mask of the present invention will turn dark brown after repeated use.
  • the active ingredients in the mask will oxidize and the mask will turn yellow.
  • the degree of color change mentioned above is related to the concentration of volatile gases in the disinfectant and the use time of the mask. Among them, the degree of color change can also reflect the time that the mask of the present invention can continue to be used. For example, the deeper the color change of the mask, the shorter the time the mask of the present invention can continue to be used.
  • the mask of the present invention can not only efficiently absorb and neutralize irritating gases in various disinfectants, but can also perform a discoloration reaction according to the state of the active ingredients in the mask, and timely reflect how long the mask can continue to be used.
  • the mask of the present invention can not only effectively absorb and neutralize irritating gases in disinfectants, but also has additional heat dissipation properties. Among them, the heat dissipation performance is specifically achieved through the following methods.
  • the tester wears a mask and takes a thermal image temperature measurement
  • the tester takes off the mask and takes a thermal image temperature measurement.
  • the heat is blocked by the mask and transferred to the facial skin, so the facial skin in contact with the mask has higher humidity and temperature.
  • the above steps reflect the impact of different masks on the tester's facial temperature by measuring the temperature of the tester's face when wearing and taking off the mask.
  • the mask A of the present invention is used as an example, and the disposable medical non-woven nursing mask and cotton mask are used as a comparative example to detect the above temperatures respectively.
  • Figure 5-a shows the thermal image when wearing a disposable medical non-woven nursing mask
  • Figure 5-b shows the thermal image of the facial skin taken at the moment when the above mask is taken off
  • Figure 6-a shows the thermal image when wearing a cotton mask.
  • Thermal image Figure 6-b shows the thermal image of facial skin taken at the moment when the above mask is taken off
  • Figure 7-a shows the thermal image when wearing the mask A of the present invention
  • Figure 7-b shows the thermal image taken at the moment when the above mask is taken off Thermal image of facial skin.
  • the skin surface temperature of the part of mask A that is in contact with the skin is significantly lower than that of the non-contact part.
  • the mask of the present invention not only has the above-mentioned ability to absorb and neutralize irritating gases, but also has obvious heat dissipation performance.
  • the maximum temperature of the tester's facial skin is 36.6°C.
  • the above-mentioned temperature is close to the body temperature of the human body, so the wearer will not feel stuffy when wearing the mask of the present invention.
  • the temperature of the facial skin will not increase. Therefore, the mask of the present invention has excellent heat dissipation performance.
  • the composition of the present invention can be stored in a vacuum spray bottle with a piston structure at the bottom, or in a traditional spray bottle with a straw as shown in Figure 8.
  • 1001 is a transparent plastic bottle with a wall thickness of 0.4-5mm
  • 1002 is a cock spray button
  • 1003 is a rotatable nozzle
  • 1004 is a suction tube
  • 1005 is a liquid sealing agent, with To isolate the composition solution and air
  • 1006 is the composition solution of the present invention.
  • Such a packaging structure can reduce the contact area between the composition and air.
  • the capacity of the spray bottle is 20 ml
  • the wall thickness is 1.2 mm
  • the liquid sealant uses 0.6 ml of liquid paraffin
  • the liquid sealant thickness is 1.5 mm.
  • approximately 0.094ml of liquid can be sprayed out each time the key is pressed.
  • a vacuum spray bottle with a piston AS at the bottom can also be used to store the composition solution of the present invention.
  • the composition solution is a 2.7% (W/V) vitamin C solution and a composition solution of mask E (see Example 2).
  • the storage environment is an indoor room with a north-facing window, no direct sunlight, but with natural light and fluorescent indoor lighting.
  • the half-life of an active ingredient such as a vitamin).
  • k represents the rate constant (d -1 )
  • C 0 represents the initial concentration
  • C represents the concentration at t
  • t-time is days (d)
  • t 1/2 represents the half-life.
  • the formulas of vitamin C solution or mask E were stored in different ways.
  • plastic bottles can be used to store vitamin C solution.
  • a plastic bottle can be used to store the vitamin C solution, and a liquid sealing agent can be added to the plastic bottle for further sealing.
  • an AS vacuum spray bottle can be used to store the formula of mask E; wherein the formula of mask E contains grape seed extract (proanthocyanidins).
  • test results of the above examples can confirm that using the container shown in Figure 8 to store the composition solution of the present invention, the composition of the present invention can be stored for a long time without deterioration, with a half-life of 443-3253 days, up to 3253 days. .
  • the inventor unexpectedly discovered that because the grape seed extract in the formula of Mask E has a maximum absorbance at 546nm, it can absorb blue-violet light, thus exhibiting the effect of a brown sunscreen.
  • This composition formula also greatly extends the shelf life of light-sensitive vitamin C, with a half-life of up to 3253 days. This makes the composition of the present invention have significant industrial applicability and commercial value.
  • the composition of the present invention obviously has significantly better stability.
  • Preserving the composition of the present invention in the above manner not only extends the storage time of the composition of the present invention, but also allows the composition of the present invention to be accessed at any time. It also provides a method for quickly preparing the mask of the present invention, which includes:
  • step (2) Spray the composition liquid of step (1) onto the inside and/or outside of the mask by spraying.
  • the mask used in step (2) can be a commercially available disposable mask or a cotton mask, etc.
  • the spray bottle body 1001 is tilted, and the rotatable nozzle 1003 is adjusted to a distance of about 5-10cm from the mask D, and the front and back sides of the cotton mask are Spray the composition liquid evenly, press the spray button 17 times each, a total of 34 times, approximately 3.2 ml of the composition liquid can be sprayed, thereby quickly completing the preparation of the occupational exposure protective mask D.
  • the spray bottle containing the composition solution of the present invention can be stored separately from the ordinary mask.
  • the composition of the present invention can be immediately sprayed on the inside and/or outside of the ordinary mask to obtain the mask of the present invention.
  • the mask can be stored in a dry environment and sprayed with the solution only when used. Since the middle layer of existing masks is mostly made of polypropylene melt-blown cloth and electret electrostatic process, such masks must be stored in an extremely dry environment to avoid loss of static charge.
  • the above method can not only quickly obtain the mask of the present invention, but also store the composition and the mask separately under different conditions to further extend the storage time of the composition and the mask.
  • Example 13 Disinfection effect of the composition of the present invention and its compatibility with alcohol-based disinfectants
  • the present invention designs relevant tests to detect the performance of the composition and alcohol-based disinfectants. compatibility. Among them, the disinfection effect of the composition and its compatibility with alcohol-based disinfectants were tested by the following methods.
  • step (3) Shake the container in step (3) for 5 minutes, and then observe the protein denaturation and precipitation effect.
  • compositions 1 and 2 were controlled to be about 5.5-6.2.
  • composition 1 has good protein protection effect.
  • Composition 1 is mixed with disinfectant alcohol (Experiment B)
  • the effect of protein denaturation and precipitation can still be achieved, so Composition 1 will not reduce the effect of disinfectant alcohol.
  • composition 2 water-propylene glycol solvent, containing protein coagulant and plant extract
  • egg white egg white
  • composition 2 can be used to slowly inhibit the biological activity of microbial surface proteins.
  • disinfectant alcohol experiment D
  • protein coagulant and plant extract are added to the composition, the protein denaturation and precipitation effect can still be achieved.
  • composition 2 when Composition 2 is used in combination with disinfectant alcohol, the addition of protein coagulants and plant extracts will not only not affect the effect of disinfectant alcohol, but can also work synergistically with disinfectant alcohol to quickly inhibit protein activity while also sustaining the effect. Inhibit protein activity, thereby achieving stronger disinfection effect and achieving long-term disinfection.
  • the composition of the present invention propylene glycol can be used as a moisture absorbing agent, and the moisture absorbing agent can make the composition form a solution state after absorbing moisture in the air.
  • the water-propylene glycol system in this embodiment corresponds to the aqueous composition solution system of the present invention. Therefore, by adding protein coagulants and plant extracts, the composition of the present invention will not only not affect the disinfection effect of disinfectant alcohol, but can also perform collaborative disinfection, quickly inhibit protein activity and achieve long-term disinfection, achieving stronger and lasting disinfection. Effect.
  • moisture-absorbing agents such as propylene glycol
  • plant extracts such as grape seed extract
  • Adding the above-mentioned plant extracts and moisture attractants can reduce the use of alcohol-based disinfectants, thereby reducing their irritation to the skin.

Abstract

A composition, comprising, on the basis of the total weight of the composition: (A) about 0.1-99 wt% of a bio-adsorbent, and (B) about 0.0001-99 wt% of a hygroscopic agent. The present invention also relates to a substrate, which comprises the composition. The present invention further relates to a multilayer material A and a multilayer material B, which comprise the substrate. The present invention also relates to a mask, which comprises the substrate or the multilayer materials.

Description

组合物、其用途和包含其的材料Compositions, their uses and materials containing them 技术领域Technical field
本发明涉及材料技术领域,具体涉及一种吸附并中和消毒剂挥发性气体的组合物、其用途,以及包含其的材料。The present invention relates to the field of material technology, and in particular to a composition that adsorbs and neutralizes volatile gases of disinfectants, its use, and materials containing the same.
背景技术Background technique
在新型冠状病毒肺炎(COVID-19)的防疫过程中会使用大量高效消毒剂。高效消毒剂指的是可以杀灭各种微生物(包括细菌芽孢)的消毒剂,目前广泛使用的消毒剂包括含氯消毒剂(例如氯异氰尿酸消毒片、84消毒液、漂白粉、次氯酸钠、次氯酸空气消毒液、液氯、以及新型的二氧化氯等)、过氧化物消毒剂(例如过氧乙酸、过氧化氢)、醛类消毒剂、环氧乙烷等。其中含氯消毒剂和过氧化物消毒剂为氧化性消毒剂,亦称高氧化还原电位消毒剂,具有广谱和高效杀灭微生物的作用。然而这类高效消毒剂对皮肤、呼吸道、眼睛等黏膜组织的氧化性、腐蚀性、刺激性、致过敏性远大于碘伏、苯扎溴铵、氯己定等常规医用皮肤、黏膜消毒剂。目前已有防疫人员暴露于含氯消毒剂环境后出现不良反应和身体损害的报道,过氧乙酸引起相关的职业性哮喘的报道,以及人们误服过氧乙酸消毒液、二氧化氯消毒片引起中毒事件的报道。因此,高效消毒剂的职业暴露伤害以及意外中毒的解救是一个涉及全球防疫化学用品安全的问题。A large number of highly effective disinfectants will be used in the prevention and control of the novel coronavirus pneumonia (COVID-19). High-efficiency disinfectants refer to disinfectants that can kill various microorganisms (including bacterial spores). Currently widely used disinfectants include chlorine-containing disinfectants (such as chloroisocyanuric acid disinfectant tablets, 84 disinfectant, bleaching powder, sodium hypochlorite, Chloric acid air disinfectant, liquid chlorine, and new chlorine dioxide, etc.), peroxide disinfectants (such as peracetic acid, hydrogen peroxide), aldehyde disinfectants, ethylene oxide, etc. Among them, chlorine-containing disinfectants and peroxide disinfectants are oxidizing disinfectants, also known as high redox potential disinfectants, which have broad-spectrum and efficient killing of microorganisms. However, this type of high-efficiency disinfectant is much more oxidative, corrosive, irritating, and allergenic to mucous membrane tissues such as skin, respiratory tract, and eyes than conventional medical skin and mucous membrane disinfectants such as iodine, benzalkonium bromide, and chlorhexidine. There have been reports of adverse reactions and physical damage to epidemic prevention personnel after being exposed to chlorine-containing disinfectants, reports of occupational asthma caused by peracetic acid, and reports of people accidentally taking peracetic acid disinfectant and chlorine dioxide disinfectant tablets. Reports of poisonings. Therefore, the occupational exposure injuries of high-efficiency disinfectants and the rescue of accidental poisoning are issues involving the safety of global anti-epidemic chemicals.
现有技术条件下,常规的一次性医用外科口罩、N95、三折信封式活性炭口罩无法有效滤除含氯消毒剂中低浓度的挥发性氯气。目前能够有效滤除氯气的个人呼吸道防护用品只有橡胶防毒面具和酸性气体滤毒罐(主要为活性炭、碱石灰、钠石灰成分)这样的专业护具,以及3M TM 8246等少数具有酸性气体防护能力的口罩,但由于价格昂贵,普及度不高。 Under the current technical conditions, conventional disposable medical surgical masks, N95, and three-fold envelope-type activated carbon masks cannot effectively filter out low-concentration volatile chlorine in chlorine-containing disinfectants. Currently, the only personal respiratory protective equipment that can effectively filter out chlorine is professional protective equipment such as rubber gas masks and acid gas canisters (mainly composed of activated carbon, soda lime, and soda lime), as well as a few such as 3M TM 8246 that have acid gas protection capabilities. masks, but due to their high price, their popularity is not high.
CN 2109208U公开了一种包含较强吸附力的防毒防菌活性炭纤维,使得其对苯、二氧化硫、氯气、氨气等有害气体以及细菌具有高效的吸附能力与防毒作用。然而,在水处理领域,活性炭通常需要与自来水接触2分钟以上才能充分吸附自来水中的余氯,除了简单的物理吸附外还存在2Cl 2+2H 2O+C→4HCl+CO 2缓慢的氧化还原反应。事实上,挥发性氯气经过口罩的时间只有数毫秒,较薄的活性炭纤维层来不及捕捉氯气这样的无机小分子气体,只有专业的滤毒罐或滤毒盒才能滤除。因此,活性炭口罩主要用于吸附分子体积较大的有机蒸汽及颗粒物。 CN 2109208U discloses an anti-virus and anti-bacteria activated carbon fiber with strong adsorption force, which enables it to have efficient adsorption capacity and anti-toxic effect on harmful gases such as benzene, sulfur dioxide, chlorine, ammonia and bacteria, as well as bacteria. However, in the field of water treatment, activated carbon usually needs to be in contact with tap water for more than 2 minutes to fully adsorb residual chlorine in tap water. In addition to simple physical adsorption, there is also a slow oxidation reduction of 2Cl 2 + 2H 2 O + C → 4HCl + CO 2 reaction. In fact, the time it takes for volatile chlorine to pass through the mask is only a few milliseconds. The thin activated carbon fiber layer does not have time to capture inorganic small molecule gases such as chlorine. Only professional canisters or cartridges can filter them out. Therefore, activated carbon masks are mainly used to adsorb organic vapor and particulate matter with larger molecular volumes.
CN 111394728A公开了一种酸性蚀刻铜回收系统中氯气的进一步处理方法,氯气和蚀刻液进行气液混合,再被送入第一级铁吸收罐内与金属铁反应产生三氯化铁。其中主要涉及用金属铁作为还原剂来吸收氯气。然而,由于还原性铁粉很可能被吸入肺部,从而引起类似肺含铁血黄素沉着症的疾病,因此该技术不宜用在口罩上。CN 111394728A discloses a further treatment method for chlorine gas in an acid etching copper recovery system. The chlorine gas and the etching liquid are mixed with gas and liquid, and then sent into the first-stage iron absorption tank to react with metallic iron to produce ferric chloride. This mainly involves using metallic iron as a reducing agent to absorb chlorine. However, this technology is not suitable for use on masks because reduced iron powder is likely to be inhaled into the lungs, causing diseases similar to pulmonary hemosiderosis.
CN 111330419A公开了一种用水和氢氧化钠(液碱)联合吸收氯气的方法。然而,该技术也不宜用在口罩上,碱性物质可能对面部皮肤以及呼吸道造成严重的损害。CN 111330419A discloses a method for jointly absorbing chlorine gas using water and sodium hydroxide (liquid alkali). However, this technology is not suitable for use on masks. Alkaline substances may cause serious damage to facial skin and respiratory tract.
《消毒剂技术规范》中公开了使用硫代硫酸钠中和含氯消毒剂和过氧化物消毒剂的技术方案。硫代硫酸钠为弱碱性、强还原性物质,口服基本不吸收,可以中和氧化性消毒剂的酸性和氧化性。但该物质对呼吸道黏膜的刺激性未知,尚无气道吸入该强还原性 无机物的安全性研究。另一方面,硫代硫酸钠在弱氧化剂作用下可能产生单质硫颗粒,如Cl 2+Na 2S 2O 3+H 2O→2NaCl+S↓+H 2SO 4。这种新生单质硫颗粒微小,属于可吸入颗粒物,可能对肺组织产生不良影响,因此也不宜用在涉及呼吸道防护的口罩上。《突发群体性氯气泄漏事故现场卫生应急救援处置与临床救治专家共识(2017)》进一步指出目前尚无氯气中毒的特效解毒剂。 The "Technical Specifications for Disinfectants" discloses a technical solution for using sodium thiosulfate to neutralize chlorine-containing disinfectants and peroxide disinfectants. Sodium thiosulfate is a weakly alkaline and strongly reducing substance that is basically not absorbed when taken orally and can neutralize the acidity and oxidation of oxidizing disinfectants. However, the irritation of this substance to the respiratory mucosa is unknown, and there is no safety study on airway inhalation of this strongly reducing inorganic substance. On the other hand, sodium thiosulfate may produce elemental sulfur particles under the action of weak oxidants, such as Cl 2 +Na 2 S 2 O 3 +H 2 O→2NaCl+S↓+H 2 SO 4 . This kind of new elemental sulfur particles are tiny and are inhalable particles. They may have adverse effects on lung tissue, so they are not suitable for use in masks involving respiratory protection. The "Expert Consensus on Health Emergency Rescue and Clinical Treatment at the Site of Sudden Mass Chlorine Gas Leak Accident (2017)" further pointed out that there is currently no specific antidote for chlorine gas poisoning.
发明内容Contents of the invention
在一方面,本发明涉及一种组合物,其特征在于,基于组合物的总重量,所述组合物包含:(A)约0.1-99重量%的生物吸附剂和(B)约0.0001-99重量%的引湿剂。In one aspect, the present invention relates to a composition characterized by comprising, based on the total weight of the composition,: (A) about 0.1-99% by weight of biosorbent and (B) about 0.0001-99% % by weight of moisture attractant.
在一个实施方案中,所述生物吸附剂选自以下的一种或多种:(a)含烯醇结构的化合物;(b)含巯基的化合物;(c)氨基酸;(d)生物酶。In one embodiment, the biosorbent is selected from one or more of the following: (a) compounds containing enol structures; (b) compounds containing sulfhydryl groups; (c) amino acids; (d) biological enzymes.
在一个实施方案中,所述引湿剂选自二甘醇、聚乙二醇、丙二醇、双丙甘醇、甘油、甘油聚醚、木糖醇、山梨(糖)醇、丙二醇葡糖苷、乳酸钠及其组合。In one embodiment, the moisture-absorbing agent is selected from the group consisting of diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyether, xylitol, sorbitol, propylene glycol glucoside, and sodium lactate. and combinations thereof.
在一个实施方案中,基于组合物的总重量,所述组合物还包含一下成分中的至少一种:(e)约0.00000001-1重量%的防腐剂;(f)约0.00001-90重量%的酸碱缓冲剂;(g)约0.000001-5重量%的抗氧化剂;(h)约0-1重量%的乳化剂;(i)约0-20重量%的液封剂;(j)约0-20重量%的蛋白质凝固剂;(k)约0-20重量%的植物提取物;(l)约0.0001-2重量%的气味掩盖剂。In one embodiment, the composition further includes at least one of the following ingredients, based on the total weight of the composition: (e) about 0.00000001-1% by weight of a preservative; (f) about 0.00001-90% by weight of a preservative Acid-base buffer; (g) about 0.000001-5 wt% antioxidant; (h) about 0-1 wt% emulsifier; (i) about 0-20 wt% liquid sealant; (j) about 0 - 20% by weight of protein coagulant; (k) about 0-20% by weight of plant extract; (l) about 0.0001-2% by weight of odor masking agent.
在另一方面,本发明涉及一种水溶液,其特征在于,其包含本发明的组合物。In another aspect, the invention relates to an aqueous solution, characterized in that it contains the composition of the invention.
在一个实施方案中,基于所述水溶液的总重量,所述组合物的含量为约30-80重量%。In one embodiment, the composition is present in an amount of about 30-80% by weight, based on the total weight of the aqueous solution.
在另一方面,本发明涉及一种基材,其特征在于,所述基材含有本发明的组合物,所述基材选自无纺布料、金属网格、玻璃纤维、棉布、亚麻布和过滤棉,优选为无纺布料。In another aspect, the invention relates to a substrate, characterized in that the substrate contains the composition of the invention, and the substrate is selected from the group consisting of non-woven cloth, metal mesh, glass fiber, cotton cloth, and linen cloth. and filter cotton, preferably non-woven fabric.
在又一方面,本发明涉及一种多层材料A,其特征在于,所述多层材料包含本发明的基材作为基层材料;活性炭层作为第一过滤层。在一个优选的实施方案中,在基层材料和第一过滤层之间还包含第二过滤层。In yet another aspect, the present invention relates to a multi-layer material A, characterized in that the multi-layer material includes the base material of the present invention as a base material; and an activated carbon layer as the first filter layer. In a preferred embodiment, a second filter layer is further included between the base material and the first filter layer.
在还一方面,本发明涉及一种多层材料B,其特征在于,所述多层材料包含本发明的基材作为第一基层材料;中间隔离层,其包含不被水浸润的多孔透气材料;第二基层材料,其包含生物酶、引湿剂、防腐剂和酸碱缓冲剂。In yet another aspect, the present invention relates to a multi-layer material B, characterized in that the multi-layer material includes the base material of the present invention as a first base material; an intermediate isolation layer including a porous breathable material that is not wetted by water. ; The second base material includes biological enzymes, moisture absorbing agents, preservatives and acid-base buffers.
在另一方面,本发明涉及一种口罩,其特征在于,所述口罩包含本发明的基材或多层材料。In another aspect, the invention relates to a mask, characterized in that the mask contains the base material or multi-layer material of the invention.
在另一方方面,本发明涉及一种制备本发明的口罩的方法,其包括:(1)提供本发明的组合物溶液;(2)通过喷洒的方式将步骤(1)的组合物液体喷涂到口罩的内侧和/或外侧。In another aspect, the present invention relates to a method for preparing a mask of the present invention, which includes: (1) providing a composition solution of the present invention; (2) spraying the composition liquid of step (1) onto The inside and/or outside of the mask.
附图说明Description of the drawings
图1表示本发明的口罩A的结构图;Figure 1 shows the structural diagram of the mask A of the present invention;
图2表示本发明的口罩B的结构图;Figure 2 shows the structural diagram of the mask B of the present invention;
图3表示本发明的口罩C的结构图;Figure 3 shows the structural diagram of the mask C of the present invention;
图4表示本发明的口罩D的结构图;Figure 4 shows the structural diagram of the mask D of the present invention;
图5表示佩戴一次性医用无纺布护理口罩或摘除上述口罩时的热像测温图;Figure 5 shows the thermal imaging thermometer when wearing a disposable medical non-woven nursing mask or removing the above mask;
图6表示佩戴棉布或摘除上述口罩时的热像测温图;Figure 6 shows the thermal image temperature measurement chart when wearing cotton or removing the above mask;
图7表示佩戴本发明的口罩A或摘除上述口罩时的热像测温图;Figure 7 shows the thermal image thermometry when wearing the mask A of the present invention or taking off the above mask;
图8表示为储存本发明的组合物溶液的喷雾瓶;Figure 8 shows a spray bottle storing a solution of the composition of the present invention;
图9表示为使用喷雾瓶制备本发明的口罩的示意图。Figure 9 shows a schematic diagram of using a spray bottle to prepare the mask of the present invention.
图中:101表示为基层材料;102表示为耳挂绳;201表示为活性炭层;302表示为中间隔离层;301表示为第二基层材料;401表示为基层材料;1001表示透明塑料瓶;1002表示喷雾瓶按键;1003表示喷嘴;1004表示吸液管;1005表示液封剂;1006表示组合物溶液。In the figure: 101 represents the base material; 102 represents the ear hanging rope; 201 represents the activated carbon layer; 302 represents the middle isolation layer; 301 represents the second base material; 401 represents the base material; 1001 represents a transparent plastic bottle; 1002 Indicates the spray bottle button; 1003 indicates the nozzle; 1004 indicates the pipette; 1005 indicates the liquid sealant; 1006 indicates the composition solution.
具体实施方式Detailed ways
以下将对本发明进一步详细说明。这样的描述为说明目的,而非限制本发明。本领域技术人员可由本说明书公开的内容容易地了解本发明的其它优点与功效。本发明也可以通过其它不同的具体实施例加以施行或应用。本领域技术人员在不背离本发明的精神前提下,进行各种修饰与变更。The present invention will be described in further detail below. Such description is for illustrative purposes and does not limit the invention. Those skilled in the art can easily understand other advantages and effects of the present invention from the content disclosed in this specification. The present invention may also be implemented or applied through other different specific embodiments. Those skilled in the art can make various modifications and changes without departing from the spirit of the present invention.
一般定义和术语General definitions and terminology
如果没有另行指出,在此所提及的所有出版物、专利申请、专利和其它参考文献通过援引以其全部并入本文。If not otherwise indicated, all publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety.
除非另有定义,本文使用的所有技术和科学术语具有与本发明所属领域技术人员通常理解的相同的含义。若存在矛盾,则以本文提供的定义为准。Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In the event of a conflict, the definitions provided herein shall control.
除非另有说明,所有的百分比、份数、比例等都是按重量计的。Unless otherwise stated, all percentages, parts, ratios, etc. are by weight.
当给出数量、浓度或其它值或参数作为范围、优选范围或优选的上限值和下限值或者具体的值时,应将其理解为特定公开了从任意上限范围或优选值与任意下限范围或优选值的成对数值所形成的所有范围,而无论范围是否单独地被公开。除非另有说明,当本文引用数值范围时,所述的范围是指包括其端点、以及所有该范围内的整数和分数。本发明的范围并不限制于当定义范围时所引用的特定数值。例如“1-8”涵盖1、2、3、4、5、6、7、8以及由其中任何两个值组成的任何亚范围,例如2-6、3-5。When an amount, concentration or other value or parameter is given as a range, preferred range or preferred upper and lower limit or as a specific value, it is to be understood that a specific disclosure is made from any upper range or preferred value to any lower limit. All ranges are formed by pairs of ranges or preferred values, regardless of whether the ranges are individually disclosed. Unless otherwise indicated, when a numerical range is cited herein, the stated range is intended to include the endpoints thereof and all integers and fractions within the range. The scope of the invention is not limited to the specific numerical values cited in defining the range. For example "1-8" encompasses 1, 2, 3, 4, 5, 6, 7, 8 and any sub-range consisting of any two of these values, such as 2-6, 3-5.
术语“约”、“大约”当与数值变量并用时,通常指该变量的数值和该变量的所有数值在实验误差内(例如对于平均值95%的置信区间内)或在指定数值的±10%内,或更宽范围内。The terms "about" and "approximately" when used with numerical variables generally mean that the value of the variable and all values of the variable are within experimental error (for example, within a 95% confidence interval for the mean) or within ±10 of the specified value. %, or within a wider range.
术语“包括”、“包含”、“具有”、“含有”或“涉及”及其在本文中的其它变体形式为包含性的或开放式的,且不排除其它未列举的元素或方法步骤。本领域技术人员应当理解,上述术语如“包括”涵盖“由…组成”的含义。表述“由…组成”排除未指明的任何元素、步骤或成分。表述“基本上由…组成”指范围限制在指定的元素、步骤或成分,加上任选存在的不会实质上影响所要求保护的主题的基本和新的特征的元素、步骤或成分。应当理解,表述“包含”涵盖表述“基本上由…组成”和“由…组成”。The terms "includes," "includes," "has," "contains," or "involves" and their other variations herein are inclusive or open-ended and do not exclude other unrecited elements or method steps. . Those skilled in the art will understand that the above terms such as "comprising" encompass the meaning of "consisting of." The expression "consisting of" excludes any element, step or ingredient not specified. The expression "consisting essentially of" means that the scope is limited to the specified element, step or ingredient plus the optional presence of such elements, steps or ingredients that do not materially affect the basic and novel characteristics of the claimed subject matter. It will be understood that the expression "comprising" encompasses the expressions "consisting essentially of" and "consisting of".
术语“选自…”是指在后面所列的组中的一个或多个元素,独立地加以选择,并且可以包括两个或更多个元素的组合。The term "selected from" refers to one or more elements from the group listed thereafter, selected independently, and may include combinations of two or more elements.
当在本文中描述数值或范围端值时,应理解所公开的内容包括所引用的特定值或端值。When numerical values or range endpoints are described herein, it is to be understood that the disclosure includes the specific value or endpoint recited.
本文所使用的术语“一种或多种”或“至少一种”指一种、两种、三种、四种、五种、六种、七种、八种、九种或更多种。The term "one or more" or "at least one" as used herein means one, two, three, four, five, six, seven, eight, nine or more.
除非另有说明,术语“其组合”及“其混合物”,表示所述各元素的多组分混合物,例如两种、三种、四种以及直到最大可能的多组分混合物。Unless stated otherwise, the terms "combinations thereof" and "mixtures thereof" mean multi-component mixtures of the respective elements, for example two, three, four and up to the maximum possible multi-component mixtures.
此外,本发明的部件或组分之前未标明个数的,表示对于部件或组分的出现(或存在)数是没有限制的。因此,应当解读为包括一个或至少一个,并且部件或组分的单数词形式也包括复数,除非该数值明显地表示单数。In addition, if the number of parts or components of the present invention is not specified before, it means that there is no limit to the number of occurrence (or existence) of the parts or components. Therefore, it should be read to include one or at least one, and the singular form of part or component also includes the plural unless the value clearly indicates the singular.
本文所使用的术语“任选”或“任选地”是指随后描述的事件或情况可能发生或可能不发生,该描述包括发生所述事件或情况和不发生所述事件或情况。As used herein, the terms "optionally" or "optionally" mean that the subsequently described event or circumstance may or may not occur, and that the description includes both the occurrence and absence of the stated event or circumstance.
术语“烷基”是指由碳原子和氢原子组成的直链或支链的饱和的脂肪烃基团,其通过单键与分子的其余部分连接。“烷基”可以具有1-10个碳原子,即“C 1-C 10烷基”,例如C 1-C 4烷基、C 1-C 3烷基、C 1-C 2烷基、C 3烷基、C 4烷基、C 3-C 6烷基。烷基的非限制性实例包括但不限于甲基、乙基、丙基、丁基、戊基、己基、异丙基、异丁基、仲丁基、叔丁基、异戊基、2-甲基丁基、1-甲基丁基、1-乙基丙基、1,2-二甲基丙基、新戊基、1,1-二甲基丙基、4-甲基戊基、3-甲基戊基、2-甲基戊基、1-甲基戊基、2-乙基丁基、1-乙基丁基、3,3-二甲基丁基、2,2-二甲基丁基、1,1-二甲基丁基、2,3-二甲基丁基、1,3-二甲基丁基或1,2-二甲基丁基,或者它们的异构体。 The term "alkyl" refers to a straight or branched saturated aliphatic hydrocarbon group consisting of carbon atoms and hydrogen atoms connected to the rest of the molecule by a single bond. "Alkyl" may have 1-10 carbon atoms, that is, "C 1 -C 10 alkyl", such as C 1 -C 4 alkyl, C 1 -C 3 alkyl, C 1 -C 2 alkyl, C 3 alkyl, C 4 alkyl, C 3 -C 6 alkyl. Non-limiting examples of alkyl groups include, but are not limited to, methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, 2- Methylbutyl, 1-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, neopentyl, 1,1-dimethylpropyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 2-ethylbutyl, 1-ethylbutyl, 3,3-dimethylbutyl, 2,2-di Methylbutyl, 1,1-dimethylbutyl, 2,3-dimethylbutyl, 1,3-dimethylbutyl or 1,2-dimethylbutyl, or their isomers body.
术语“环烷基”,在本文中单独或与其它基团组合使用时,指饱和的非芳族单环或多环(诸如双环)烃环(例如单环,如环丙基、环丁基、环戊基、环己基、环庚基、环辛基、环壬基;或双环,包括螺环、稠合或桥连系统(诸如双环[1.1.1]戊基、双环[2.2.1]庚基、双环[3.2.1]辛基或双环[5.2.0]壬基、十氢化萘基等)。例如,术语“C 3-10环烷基”指具有3-10个环碳原子(如3、4、5、6、7、8、9或10个)的环烷基。 The term "cycloalkyl", when used herein alone or in combination with other groups, refers to a saturated, non-aromatic monocyclic or polycyclic (such as bicyclic) hydrocarbon ring (e.g., monocyclic, such as cyclopropyl, cyclobutyl , cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl; or bicyclic, including spiro, fused or bridged systems (such as bicyclo[1.1.1]pentyl, bicyclo[2.2.1] Heptyl, bicyclo[3.2.1]octyl or bicyclo[5.2.0]nonyl, decahydronaphthyl, etc.). For example, the term "C 3-10 cycloalkyl" refers to having 3-10 ring carbon atoms ( Such as 3, 4, 5, 6, 7, 8, 9 or 10) cycloalkyl groups.
术语“3-18元环”,在本文中单独或与其它基团组合使用时,指包含3-12个原子的环。这样的环可以是饱和或不饱和的(即包含一个或多个双键或三键)。“3-12元环”可以涵盖例如3-6元、6-9、9-12、12-15元和15-18元元环,例如3、4、5、6、7、8、9、10、11、12、13、14、15、16、17或18元环。除了碳原子之外,该碳环中可以任选地包含0、1或2个额外的杂原子。杂原子的实例有氧、硫、氮。本领域技术人员应当理解,“3-18元环”中的3-18元仅指其中的碳原子数目,当包含额外的杂原子时,杂原子的数目不计算在环原子的数目中。例如当包含1个杂原子时,“3-18元环”则包含4-19个环原子,其中1个环原子为杂原子,其余的为碳原子。The term "3-18 membered ring", when used herein alone or in combination with other groups, refers to a ring containing 3-12 atoms. Such rings may be saturated or unsaturated (ie, contain one or more double or triple bonds). "3-12-membered ring" can cover, for example, 3-6-membered, 6-9, 9-12, 12-15-membered and 15-18-membered rings, such as 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 or 18 membered rings. In addition to the carbon atoms, 0, 1 or 2 additional heteroatoms may optionally be included in the carbocyclic ring. Examples of heteroatoms are oxygen, sulfur, and nitrogen. Those skilled in the art should understand that the 3-18 members in "3-18 membered ring" only refer to the number of carbon atoms therein. When additional heteroatoms are included, the number of heteroatoms is not counted in the number of ring atoms. For example, when it contains 1 heteroatom, a "3-18-membered ring" contains 4-19 ring atoms, of which 1 ring atom is a heteroatom and the rest are carbon atoms.
术语“卤”或“卤素”或“卤代”应理解为表示氟(F)、氯(Cl)、溴(Br)或碘(I)原子,优选氟、氯、溴原子。The term "halo" or "halogen" or "halo" is understood to mean a fluorine (F), chlorine (Cl), bromine (Br) or iodine (I) atom, preferably a fluorine, chlorine, bromine atom.
术语“芳基”是指具有共轭的π电子体系的全碳单环或稠合多环(如双环)的芳香环基团。例如,芳基可以具有6-14个碳原子,适合地具有6-10个,更适合地具有6个或10个。芳基的实例包括但不限于苯基、萘基和蒽基等。The term "aryl" refers to an all-carbon monocyclic or fused polycyclic (eg, bicyclic) aromatic ring group having a conjugated π electron system. For example, an aryl group may have 6-14 carbon atoms, suitably 6-10, more suitably 6 or 10. Examples of aryl groups include, but are not limited to, phenyl, naphthyl, anthracenyl, and the like.
术语“氨基酸”是指由氨基和羧基的官能团以及连接的侧链构成的有机化合物或部分,例如具有如下化学式的氨基酸及其立体异构体:H 2N-(CR aR b) tCO 2H;其中,R a和R b 各自独立地为氢或任意的取代基,t为大于或等于1的整数,例如1、2、3、4或5。取代基可以是直链或支链结构。例如R a和/或R b各自独立地对应于,但不限于天然存在的氨基酸上的氢或侧链,例如甲基、苄基、羟甲基、硫代甲基、羧基、羧甲基、胍基丙基等以及其衍生物和保护性衍生物。氨基酸包括天然存在的氨基酸、非天然氨基酸、诸如脯氨酸等亚氨基酸、氨基酸类似物以及以类似于天然存在的氨基酸的方式发挥功能的氨基酸模拟物,还包括它们的D和L立体异构体形式。天然编码的氨基酸是本领域技术人员已知的蛋白氨基酸,包括20种常见的氨基酸,即丙氨酸(Ala)、精氨酸(Arg)、天冬酰胺(Asn)、天冬氨酸(Asp)、半胱氨酸(Cys)、谷氨酰胺(Gln)、谷氨酸(Glu)、甘氨酸(Gly)、组氨酸(His)、异亮氨酸(Ile)、亮氨酸(Leu)、赖氨酸(Lys)、甲硫氨酸(Met)、苯丙氨酸(Phe)、脯氨酸(Pro)、丝氨酸(Ser)、苏氨酸(Thr)、色氨酸(Trp)、酪氨酸(Tyr)和缬氨酸(Val)。 The term "amino acid" refers to an organic compound or moiety consisting of amino and carboxyl functional groups and attached side chains, such as amino acids and their stereoisomers with the following chemical formula: H 2 N-(CR a R b ) t CO 2 H; wherein, R a and R b are each independently hydrogen or any substituent, and t is an integer greater than or equal to 1, such as 1, 2, 3, 4 or 5. Substituents may be linear or branched structures. For example, R a and/or R b each independently correspond to, but are not limited to, hydrogen or side chains on naturally occurring amino acids, such as methyl, benzyl, hydroxymethyl, thiomethyl, carboxyl, carboxymethyl, Guanidinopropyl, etc. and their derivatives and protective derivatives. Amino acids include naturally occurring amino acids, unnatural amino acids, imino acids such as proline, amino acid analogs, and amino acid mimetics that function in a manner similar to naturally occurring amino acids, and also include their D and L stereoisomers form. Naturally encoded amino acids are protein amino acids known to those skilled in the art, including 20 common amino acids, namely alanine (Ala), arginine (Arg), asparagine (Asn), aspartic acid (Asp) ), cysteine (Cys), glutamine (Gln), glutamic acid (Glu), glycine (Gly), histidine (His), isoleucine (Ile), leucine (Leu) , Lysine (Lys), methionine (Met), phenylalanine (Phe), proline (Pro), serine (Ser), threonine (Thr), tryptophan (Trp), Tyrosine (Tyr) and valine (Val).
本文所使用的术语“引湿剂”是指用于吸收水分的试剂。示例性的引湿剂包括但不限于二甘醇、聚乙二醇、丙二醇、双丙甘醇、甘油、甘油聚醚、木糖醇、山梨(糖)醇、丙二醇葡糖苷、乳酸钠。The term "moisture attractant" as used herein refers to an agent used to absorb moisture. Exemplary moisture attractants include, but are not limited to, diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyethers, xylitol, sorbitol, propylene glycol glucoside, and sodium lactate.
本文所使用的术语“酸碱缓冲剂”是指用于控制溶液pH,使pH保持在某一范围内不变的溶液。示例性的酸碱缓冲剂包括但不限于橼酸盐缓冲液、铵盐缓冲液、醋酸盐缓冲液、磷酸盐缓冲液、碳酸氢盐缓冲液。The term "acid-base buffer" used herein refers to a solution used to control the pH of a solution to keep the pH within a certain range. Exemplary acid-base buffers include, but are not limited to, citrate buffer, ammonium buffer, acetate buffer, phosphate buffer, and bicarbonate buffer.
本文所使用的术语“多孔透气材料”是指包含内部孔隙度的材料,其内部的小孔相互连通以便允许气流通过材料。示例性的多孔透气材料包括但不限于聚酯过滤棉、玻璃棉、岩棉、空气过滤棉、泡沫海绵。As used herein, the term "porous breathable material" refers to a material that contains internal porosity with interconnected pores to allow airflow through the material. Exemplary porous breathable materials include, but are not limited to, polyester filter wool, glass wool, rock wool, air filter cotton, and foam sponge.
本文所使用的术语“氧化型消毒剂”是指包含氧化性活性物质的消毒剂,其中示例性的氧化性活性物质包括但不限于氯气、过氧化氢、醛类化合物、过氧乙酸等。The term "oxidizing disinfectant" used herein refers to a disinfectant containing oxidizing active substances, wherein exemplary oxidizing active substances include but are not limited to chlorine, hydrogen peroxide, aldehydes, peracetic acid, etc.
本文所使用的术语“刺激性气体”是指对眼和呼吸道粘膜有刺激作用的气体,通常为化学工业常遇到的有毒气体。在本文中,所述刺激性气体是指包含在氧化性消毒剂的气体,其包括但不限于氯气、二氧化氯、过氧化氢、醛类化合物、过氧乙酸等。The term "irritant gas" used herein refers to gases that are irritating to the eyes and respiratory mucosa, and are usually toxic gases commonly encountered in the chemical industry. In this article, the irritating gas refers to the gas contained in the oxidative disinfectant, which includes but is not limited to chlorine, chlorine dioxide, hydrogen peroxide, aldehydes, peracetic acid, etc.
本文所使用的术语“多层材料A”和“多层材料B”仅用于区分上述两种包含不同结构的多层材料,并非在性质、使用或顺序等方面加以区分。The terms "multilayer material A" and "multilayer material B" used herein are only used to distinguish the above two multilayer materials containing different structures, but not in terms of nature, use or order.
本文使用的术语“第一基层材料”、“第二基层材料”、“第一过滤层”和“第二过滤层”等仅用于与多层材料中的其他层区分,并非在性质、使用或顺序等方面加以区分。The terms "first base layer material", "second base layer material", "first filter layer" and "second filter layer" used herein are only used to distinguish them from other layers in the multi-layer material, and do not indicate the nature or use of the materials. or order, etc.
组合物combination
在一方面,本发明涉及一种组合物,其用于吸附并中和氧化性消毒剂中的刺激性气体,基于组合物的总重量,所述组合物其包含:(A)约0.1-99重量%的生物吸附剂和(B)约0.0001-99重量%的引湿剂。In one aspect, the present invention relates to a composition for adsorbing and neutralizing irritating gases in an oxidative disinfectant, the composition comprising: (A) about 0.1-99 based on the total weight of the composition % by weight of biosorbent and (B) about 0.0001 to 99% by weight of moisture attractant.
在一个实施方案中,基于组合物的总重量,所述组合物包含:(A)约26-46重量%的生物吸附剂和(B)约44-64重量%的引湿剂。在一个优选的实施方案中,基于组合物的总重量,所述组合物包含:(A)约36重量%的生物吸附剂和(B)约54重量%的引湿剂。In one embodiment, the composition includes: (A) about 26-46 wt% biosorbent and (B) about 44-64 wt% moisture attractant, based on the total weight of the composition. In a preferred embodiment, the composition contains: (A) about 36 wt% biosorbent and (B) about 54 wt% moisture attractant, based on the total weight of the composition.
(A)生物吸附剂(A)Biosorbent
在本文中,生物吸附剂是能够吸附并中和刺激性气体的生物材料,示例性的生物吸附剂例如包括但不限于小分子化合物、高分子聚合物、氨基酸、蛋白质和酶等。In this article, a biosorbent is a biological material capable of adsorbing and neutralizing irritating gases. Exemplary biosorbents include, but are not limited to, small molecule compounds, high molecular polymers, amino acids, proteins, enzymes, etc.
在本文中,中和刺激性气体是指生物吸附剂与刺激性气体发生化学反应生成环境友好的物质,或者生物吸附剂将刺激性气体分解为环境友好的物质。In this article, neutralizing irritating gases means that the biosorbent chemically reacts with the irritating gas to form environmentally friendly substances, or the biosorbent decomposes the irritating gas into environmentally friendly substances.
在一个实施方案中,所述生物吸附剂选自以下的一种或多种:In one embodiment, the biosorbent is selected from one or more of the following:
(a)含烯醇结构的化合物;(a) Compounds containing enol structure;
(b)含巯基的化合物;(b) Compounds containing sulfhydryl groups;
(c)氨基酸;(c)Amino acids;
(d)生物酶。(d) Biological enzymes.
(a)含烯醇结构的化合物(a) Compounds containing enol structure
烯醇结构是指具有烯烃的化学部分,其具有连接至烯烃双键一端的羟基,可以用如下化学式表示。The enol structure refers to a chemical moiety with an alkene, which has a hydroxyl group attached to one end of the alkene double bond, and can be represented by the following chemical formula.
Figure PCTCN2022092725-appb-000001
Figure PCTCN2022092725-appb-000001
其中,取代基R 1和R 2为相同或不同的取代基,或者两者连接形成具有烯醇结构的环状化合物。示例性的含烯醇结构的化合物包括但不限于维生素C、维生素B6、维生素B9、邻苯二酚、乙烯醇、丙酮醇、豆甾烯醇、生育三烯酚、大戟二烯醇、异抗坏血酸、抗坏血酸棕榈酸酯、抗坏血酸葡糖苷等。 Among them, the substituents R 1 and R 2 are the same or different substituents, or they are connected to form a cyclic compound with an enol structure. Exemplary enol structure-containing compounds include, but are not limited to, vitamin C, vitamin B6, vitamin B9, catechol, vinyl alcohol, acetol, stigmastenol, tocotrienol, euphorbienol, isoenol, Ascorbic acid, ascorbyl palmitate, ascorbic acid glucoside, etc.
在一个实施方案中,所述含烯醇结构的化合物具有还原性,其能够吸附空气中的氧化性刺激性气体,并与之发生氧化还原反应,进而形成环境友好的产物。既能够清除环境中的氧化性刺激性气体,又不会对环境及人体健康产生影响。In one embodiment, the compound containing an enol structure has reducing properties and can adsorb oxidative and irritating gases in the air and undergo redox reactions with them to form environmentally friendly products. It can remove oxidative and irritating gases in the environment without affecting the environment and human health.
在另一个实施方案中,一些含烯醇结构的化合物(例如维生素C)被氧化后会变色,例如变为黄色。因此,含有烯醇结构的化合物可以起到指示剂的作用,例如含有烯醇结构的化合物变为黄色时,可知其中的有效成分的含量(未被氧化的含烯醇结构的化合物)较低,有助于提醒人们及时更新所使用的含烯醇结构的化合物。In another embodiment, some enol-containing compounds (eg, vitamin C) will change color, for example, yellow, after being oxidized. Therefore, compounds containing an enol structure can act as indicators. For example, when a compound containing an enol structure turns yellow, it can be known that the content of the active ingredient (the unoxidized compound containing an enol structure) is low. It helps to remind people to timely update the compounds containing enol structure used.
在一个实施方案中,所述含烯醇结构的化合物为含有0、1或2个额外的独立选自氧、硫、氮和磷的杂原子的3-18元环状烯醇化合物及其衍生物,该环可任选地被一个或多个选自如下的取代基所取代,C 1-10烷基、C 3-10环烷基、芳基、芳基-C 1-4烷基,其中每个烷基、环烷基、芳基是未被取代的或被至少一个独立选自羟基、CN、氨基、酰基、羧基、卤素、C 1-10烷基、C 3-10环烷基、C 1-10烷氧基的取代基取代。在一个优选的实施方案中,所述含烯醇结构的化合物为含有0、1或2个额外的独立选自氧、硫和氮的杂原子的3-18元环状烯醇化合物及其衍生物,该环可任选地被一个或多个选自如下的取代基所取代,C 1-10烷基、芳基,其中每个烷基、芳基是未被取代的或被至少一个独立选自羟基、氨基、酰基、羧基、卤素、C 1-10烷基的取代基取代;乙烯醇;丙酮醇。在一个更优选的实施方案中,所述含烯醇结构的化合物选自以下的一种或多种,维生素C、维生素B6、维生素B9、邻苯二酚、乙烯醇、丙酮醇、豆甾烯醇、生育三烯酚、大戟二烯醇、异抗坏血酸、抗坏血酸棕榈酸酯、抗坏血酸葡糖苷及其衍生物。在一个更优选的实施方案中,所述含烯醇结构的化合物选自以下的一种或多种,维生素C、维生素B6、维生素 B9。在一个特别优选的实施方案中,所述含烯醇结构的化合物为维生素C。 In one embodiment, the compound containing an enol structure is a 3-18 membered cyclic enol compound containing 0, 1 or 2 additional heteroatoms independently selected from oxygen, sulfur, nitrogen and phosphorus and derivatives thereof substance, the ring may be optionally substituted by one or more substituents selected from the following, C 1-10 alkyl, C 3-10 cycloalkyl, aryl, aryl-C 1-4 alkyl, Wherein each alkyl, cycloalkyl, aryl group is unsubstituted or is independently selected from at least one group consisting of hydroxyl, CN, amino, acyl, carboxyl, halogen, C 1-10 alkyl, C 3-10 cycloalkyl , C 1-10 alkoxy substituent substituted. In a preferred embodiment, the compound containing an enol structure is a 3-18 membered cyclic enol compound containing 0, 1 or 2 additional heteroatoms independently selected from oxygen, sulfur and nitrogen, and derivatives thereof substance, the ring may be optionally substituted by one or more substituents selected from the following, C 1-10 alkyl, aryl, wherein each alkyl, aryl is unsubstituted or is independently substituted by at least one Substituted with a substituent selected from hydroxyl, amino, acyl, carboxyl, halogen, C 1-10 alkyl; vinyl alcohol; acetol. In a more preferred embodiment, the compound containing an enol structure is selected from one or more of the following: vitamin C, vitamin B6, vitamin B9, catechol, vinyl alcohol, acetol, stigmasterene Alcohol, tocotrienol, euphorbienol, isoascorbic acid, ascorbyl palmitate, ascorbyl glucoside and its derivatives. In a more preferred embodiment, the compound containing an enol structure is selected from one or more of the following: vitamin C, vitamin B6, and vitamin B9. In a particularly preferred embodiment, the compound containing an enol structure is vitamin C.
在一个实施方案中,基于组合物的总重量,含烯醇结构的化合物的含量为约0.01-95重量%。在一个优选的实施方案中,基于组合物的总重量,含烯醇结构的化合物的含量为约1-50重量%。在一个更优选的实施方案中,基于组合物的总重量,含烯醇结构的化合物的含量为约13.2-14.8重量%。例如约13.2重量%、约13.3重量%、约13.4重量%、约13.5重量%、约13.6重量%、约13.7重量%、约13.8重量%、约14重量%、约14.2重量%、约14.4重量%、约14.6重量%、约14.8重量%。In one embodiment, the content of the enol structure-containing compound is about 0.01-95% by weight based on the total weight of the composition. In a preferred embodiment, the content of the enol structure-containing compound is about 1 to 50% by weight based on the total weight of the composition. In a more preferred embodiment, the content of the enol structure-containing compound is about 13.2-14.8% by weight based on the total weight of the composition. For example, about 13.2% by weight, about 13.3% by weight, about 13.4% by weight, about 13.5% by weight, about 13.6% by weight, about 13.7% by weight, about 13.8% by weight, about 14% by weight, about 14.2% by weight, about 14.4% by weight. , about 14.6% by weight, about 14.8% by weight.
含烯醇结构的化合物的含量过高会使得组合物在进行氧化还原反应后,产生大量酮类、有机酸类化合物,使组合物体系的pH值变化幅度加大,低温时容易析出结晶。含烯醇结构的化合物的含量过低则不能完全中和氧化性刺激性气体,而且口罩的变色不明显,无法起到指示剂的作用。If the content of compounds containing enol structures is too high, the composition will produce a large amount of ketones and organic acid compounds after the redox reaction, which will increase the pH value of the composition system and make it easy to precipitate and crystallize at low temperatures. If the content of compounds containing an enol structure is too low, the oxidative irritating gases cannot be completely neutralized, and the discoloration of the mask is not obvious and it cannot function as an indicator.
(b)含巯基的化合物(b) Compounds containing thiol groups
巯基是指-SH基团。巯基具有还原性,所以含有巯基的化合物可以被氧化。因此,含巯基的化合物可被用于吸附空气中的氧化性刺激性气体,并与之发生氧化还原反应,进而形成环境友好的产物。既能够清除环境中的氧化性刺激性气体,又不会对染环境及人体健康产生影响。另外,巯基化合物对重金属离子(例如Cu 2+、Pb 2+、Ag +等)具有较强的亲和力(其亲和力远远高于乙二胺四乙酸EDTA),使其能够与上述重金属离子结合形成金属硫化物沉淀,从而除去环境中的重金属离子。已知Cu 2+会加速维生素C的氧化,因此含巯基的化合物还可以除去环境中的重金属离子,显著提高含烯醇结构的化合物的稳定性。 Thiol refers to the -SH group. The sulfhydryl group is reducing, so compounds containing sulfhydryl groups can be oxidized. Therefore, thiol-containing compounds can be used to adsorb oxidative and irritating gases in the air and undergo redox reactions with them to form environmentally friendly products. It can remove oxidative and irritating gases in the environment without affecting the polluted environment and human health. In addition, mercapto compounds have a strong affinity for heavy metal ions (such as Cu 2+ , Pb 2+ , Ag +, etc.) (its affinity is much higher than that of ethylenediaminetetraacetic acid EDTA), allowing it to combine with the above heavy metal ions to form Metal sulfides precipitate, thereby removing heavy metal ions from the environment. Cu 2+ is known to accelerate the oxidation of vitamin C, so compounds containing thiol groups can also remove heavy metal ions in the environment and significantly improve the stability of compounds containing enol structures.
在一个实施方案中,所述含巯基的化合物选自半胱氨酸、巯基乙酸、二巯基丙醇、二巯丙磺钠、硫普罗宁、二巯丁二钠、半胱胺、青霉胺、硫辛酸、甲巯丙脯酸、谷胱甘肽、α-硫辛酸、二硫苏糖醇及其组合。在一个优选的实施方案中,所述含巯基的化合物选自N-酰基-半胱氨酸、N-烷基-半胱氨酸、二巯基丙醇、二巯丁二钠、二硫苏糖醇及其组合。在一个更优选的实施方案中,所述含巯基的化合物选自N-乙酰-L-半胱氨酸、N-甲基-L-半胱氨酸、N-乙基-L-半胱氨酸、二巯基丙醇、二巯丁二钠、二硫苏糖醇及其组合。在一个特别优选的实施方案中,所述含巯基的化合物为N-乙酰-L-半胱氨酸。In one embodiment, the thiol-containing compound is selected from the group consisting of cysteine, thioglycolic acid, dimercaprol, sodium dimercaprol, tiopronin, disodium dimercaptosulfate, cysteamine, penicillamine , lipoic acid, captopril, glutathione, alpha-lipoic acid, dithiothreitol and combinations thereof. In a preferred embodiment, the thiol-containing compound is selected from the group consisting of N-acyl-cysteine, N-alkyl-cysteine, dimercaprol, disodium dimercapto, and dithiothreose Alcohols and their combinations. In a more preferred embodiment, the thiol-containing compound is selected from the group consisting of N-acetyl-L-cysteine, N-methyl-L-cysteine, N-ethyl-L-cysteine Acid, dimercaprol, disodium dimercapto, dithiothreitol and combinations thereof. In a particularly preferred embodiment, the thiol-containing compound is N-acetyl-L-cysteine.
在一个实施方案中,基于组合物的总重量,含巯基的化合物的含量为约0.0001-99重量%。在一个优选的实施方案中,基于组合物的总重量,含巯基的化合物的含量为约0.1-20重量%。在一个更优选的实施方案中,基于组合物的总重量,含巯基的化合物的含量为约3.0-3.4重量%。例如约3.0重量%、约3.02重量%、约3.06重量%、约3.1重量%、约3.12重量%、约3.16重量%、约3.20重量%、约3.23重量%、约3.26重量%、约3.28重量%、约3.3重量%、约3.32重量%、约3.34重量%、约3.38重量%、约3.4重量%。例如约1重量%、约1.125重量%、约2.28重量%。In one embodiment, the thiol-containing compound is present in an amount of about 0.0001 to 99% by weight, based on the total weight of the composition. In a preferred embodiment, the thiol-containing compound is present in an amount of about 0.1 to 20% by weight, based on the total weight of the composition. In a more preferred embodiment, the thiol-containing compound is present in an amount of about 3.0 to 3.4% by weight, based on the total weight of the composition. For example, about 3.0% by weight, about 3.02% by weight, about 3.06% by weight, about 3.1% by weight, about 3.12% by weight, about 3.16% by weight, about 3.20% by weight, about 3.23% by weight, about 3.26% by weight, about 3.28% by weight. , about 3.3% by weight, about 3.32% by weight, about 3.34% by weight, about 3.38% by weight, about 3.4% by weight. For example, about 1% by weight, about 1.125% by weight, and about 2.28% by weight.
由于含巯基化合物本身含有特殊的气味,例如类似大蒜的硫化物臭味,过高的含巯基化合物含量容易刺激眼和呼吸道粘膜,不宜在生产实践中使用,例如用于日常生活用品。过低的含巯基化合物含量使得本发明组合物的还原性不足,不能够吸附并中和足够的氧化性刺激性气体,不能降低蛋白质的活性,同时也不利于含烯醇结构的化合物的稳 定性。Since sulfhydryl-containing compounds themselves have a special odor, such as a garlic-like sulfide odor, too high a content of sulfhydryl-containing compounds can easily irritate the eyes and respiratory mucosa and should not be used in production practice, such as in daily necessities. An excessively low content of thiol-containing compounds makes the composition of the present invention insufficiently reducible, unable to adsorb and neutralize sufficient oxidative irritating gases, unable to reduce the activity of proteins, and is also unfavorable to the stability of compounds containing enol structures. .
(c)氨基酸(c)Amino acids
在碱性条件下,氨基酸中的伯氨基可以与醛类化合物反应,得到席夫碱化合物。因此,在本发明的组合物中加入氨基酸,可以有效地吸附并中和空气中的醛基化合物,以降低醛类化合物对人体产生的伤害。Under alkaline conditions, the primary amino groups in amino acids can react with aldehydes to obtain Schiff base compounds. Therefore, adding amino acids to the composition of the present invention can effectively adsorb and neutralize aldehyde-based compounds in the air, thereby reducing the damage caused by aldehyde compounds to the human body.
在一个实施方案中,所述氨基酸选自丙氨酸、缬氨酸、亮氨酸、异亮氨酸、甲硫氨酸、脯氨酸、色氨酸、丝氨酸、酪氨酸、半胱氨酸、苯丙氨酸、天冬酰胺、谷氨酰胺、苏氨酸、天冬氨酸、谷氨酸、赖氨酸、精氨酸、组氨酸、甘氨酸及其组合。在一个优选的实施方案中,所述氨基酸选自甘氨酸、谷氨酸及其组合。在一个更优选的实施方案中,所述氨基酸为甘氨酸。In one embodiment, the amino acid is selected from the group consisting of alanine, valine, leucine, isoleucine, methionine, proline, tryptophan, serine, tyrosine, cysteine Acid, phenylalanine, asparagine, glutamine, threonine, aspartic acid, glutamic acid, lysine, arginine, histidine, glycine and combinations thereof. In a preferred embodiment, the amino acid is selected from the group consisting of glycine, glutamic acid and combinations thereof. In a more preferred embodiment, the amino acid is glycine.
在一个实施方案中,基于组合物的总重量,氨基酸的含量为约0.0001-95重量%。在一个优选的实施方案中,基于组合物的总重量,氨基酸的含量为约0.0001-85重量%。在一个更优选的实施方案中,基于组合物的总重量,氨基酸的含量为约20-25重量%。例如约20重量%、约20.5重量%、约21重量%、约21.1重量%约21.4重量%、约21.8重量%、约22重量%、约22.3重量%、约22.6重量%、约23重量%、约23.5重量%、约24重量%、约24.1重量%、约24.5重量%、约25重量%。In one embodiment, the amino acid is present in an amount of about 0.0001-95% by weight, based on the total weight of the composition. In a preferred embodiment, the amino acid is present in an amount of about 0.0001 to 85% by weight, based on the total weight of the composition. In a more preferred embodiment, the amino acid is present in an amount of about 20-25% by weight, based on the total weight of the composition. For example, about 20% by weight, about 20.5% by weight, about 21% by weight, about 21.1% by weight, about 21.4% by weight, about 21.8% by weight, about 22% by weight, about 22.3% by weight, about 22.6% by weight, about 23% by weight, About 23.5% by weight, about 24% by weight, about 24.1% by weight, about 24.5% by weight, about 25% by weight.
过高的氨基酸含量会在低温时结晶并析出,过低的氨基酸含量则不足以中和醛类消毒剂挥发产生的刺激性气体。An amino acid content that is too high will crystallize and precipitate at low temperatures, while an amino acid content that is too low is not enough to neutralize the irritating gases produced by the volatilization of aldehyde disinfectants.
(d)生物酶(d) Biological enzymes
生物酶是指由活细胞产生的具有催化作用的有机物,其能够特异性地催化物质的转化。根据实际生产或工作目的需要,可以选择并使用不同种类的生物酶。例如,为了吸收并分解过氧化氢,可在实际工作过程中使用过氧化氢酶。Biological enzymes refer to catalytic organic substances produced by living cells, which can specifically catalyze the transformation of substances. Different types of biological enzymes can be selected and used according to actual production or work purposes. For example, in order to absorb and break down hydrogen peroxide, catalase is used in the actual work process.
在一个实施方案中,所述生物酶选自过氧化氢酶和辣根过氧化物酶。在一个优选的实施方案中,所述生物酶为过氧化氢酶。示例性的过氧化氢酶可以为食品级过氧化氢酶,规格50000U/g。In one embodiment, the biological enzyme is selected from the group consisting of catalase and horseradish peroxidase. In a preferred embodiment, the biological enzyme is catalase. An exemplary catalase may be food-grade catalase with a specification of 50,000 U/g.
在一个实施方案中,基于组合物的总重量,生物酶的含量为约0.0000001-20重量%。在一个优选的实施方案中,基于组合物的总重量,生物酶的含量为约0.02-0.2重量%。In one embodiment, the biological enzyme is present in an amount of about 0.0000001-20% by weight based on the total weight of the composition. In a preferred embodiment, the biological enzyme is present in an amount of about 0.02-0.2% by weight based on the total weight of the composition.
过高或过低的生物酶含量都会降低过氧化氢催化分解的速度。Too high or too low biological enzyme content will reduce the speed of hydrogen peroxide catalytic decomposition.
(B)引湿剂(B) Moisture attractant
引湿剂是指用于吸收水分的试剂。示例性的引湿剂包括但不限于二甘醇、聚乙二醇、丙二醇、双丙甘醇、甘油、甘油聚醚、木糖醇、山梨(糖)醇、丙二醇葡糖苷、乳酸钠等。Hygroscopic agents are agents used to absorb moisture. Exemplary moisture attractants include, but are not limited to, diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyether, xylitol, sorbitol, propylene glycol glucoside, sodium lactate, and the like.
在本文中,本发明的组合物中的引湿剂能够吸收空气中或额外添加的水分,使组合物变为润湿或溶液状态,从而使生物吸附剂溶解于水分中,进而增加生物吸附剂与被吸附气体(例如氯气、过氧化氢、过氧乙酸、醛类化合物等)的接触面积,提高气体吸附的效率。In this article, the hygroscopic agent in the composition of the present invention can absorb moisture in the air or additional added moisture, so that the composition becomes a moist or solution state, thereby dissolving the biosorbent in the moisture, thereby increasing the biosorbent The contact area with the adsorbed gas (such as chlorine, hydrogen peroxide, peracetic acid, aldehyde compounds, etc.) improves the efficiency of gas adsorption.
在一个实施方案中,所述引湿剂选自二甘醇、聚乙二醇、丙二醇、双丙甘醇、甘油、 甘油聚醚、木糖醇、山梨(糖)醇、丙二醇葡糖苷、乳酸钠及其组合。在一个优选的实施方案中,所述引湿剂选自甘油、丙二醇及其组合。在一个更优选的实施方案中,所述引湿剂为甘油。In one embodiment, the moisture attracting agent is selected from the group consisting of diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyether, xylitol, sorbitol, propylene glycol glucoside, and sodium lactate. and combinations thereof. In a preferred embodiment, the moisture attractant is selected from the group consisting of glycerin, propylene glycol and combinations thereof. In a more preferred embodiment, the moisture attracting agent is glycerol.
在一个实施方案中,引湿剂的含量为约0.0001-99重量%。在一个优选的实施方案中,引湿剂的含量为约44-64重量%。在一个更优选的实施方案中,引湿剂的含量为约50-54重量%,例如约51重量%、约51.3重量%、约51.8重量%、约52重量%、约52.2重量%、约52.6重量%、约53重量%、约53.5重量%、约53.8重量%、约54重量%。In one embodiment, the moisture attractant is present in an amount of about 0.0001-99% by weight. In a preferred embodiment, the moisture attractant is present in an amount of about 44 to 64% by weight. In a more preferred embodiment, the content of the moisture attractant is about 50-54% by weight, such as about 51% by weight, about 51.3% by weight, about 51.8% by weight, about 52% by weight, about 52.2% by weight, about 52.6% by weight. % by weight, about 53% by weight, about 53.5% by weight, about 53.8% by weight, about 54% by weight.
过高的引湿剂含量会使组合物吸附大量水分,造成液体量骤增,降低组合物的透气性能,从而提高组合物的透气阻力。例如当引湿剂用于防护面罩时,过高的引湿剂含量会导致组合物透气性能的降低,从而降低防护面罩的舒适性。另外,过高的引湿剂含量还会增加组合物黏度,造成组合物溶液难以进行雾化喷洒的问题。过低的引湿剂含量无法形成足够的含水层,进而无法有效地吸收水溶性刺激性气体。Excessively high moisture attractant content will cause the composition to absorb a large amount of water, causing a sudden increase in liquid volume, reducing the breathability of the composition, thereby increasing the breathability resistance of the composition. For example, when a moisture absorbing agent is used in a protective mask, an excessively high moisture absorbing agent content will lead to a reduction in the breathability of the composition, thereby reducing the comfort of the protective mask. In addition, an excessively high moisture-drawing agent content will increase the viscosity of the composition, making it difficult to atomize and spray the composition solution. Too low a moisture attractant content cannot form a sufficient aquifer to effectively absorb water-soluble irritating gases.
(C)其他成分(C)Other ingredients
根据实际情况的需求以及生物吸附剂所需的最佳工作环境,本发明的组合物还包含其他组分。例如,为提高组合物的保存时间,本发明的组合物可以包含防腐剂。又例如,为了使生物吸附剂(例如氨基酸)更易于吸附醛基化合物,本发明的组合物可以包含酸碱缓冲剂,其中所述酸碱缓冲剂可以将组合物的工作环境调整为碱性或酸性。The composition of the present invention also contains other components according to the needs of the actual situation and the optimal working environment required by the biosorbent. For example, to increase the shelf life of the composition, the compositions of the present invention may include a preservative. For another example, in order to make the biosorbent (such as amino acid) more susceptible to adsorbing aldehyde-based compounds, the composition of the present invention can include an acid-base buffer, wherein the acid-base buffer can adjust the working environment of the composition to be alkaline or alkaline. acidic.
在一个实施方案中,基于组合物的总重量,所述组合物还包含以下成分中的至少一种:In one embodiment, the composition further includes at least one of the following ingredients, based on the total weight of the composition:
(e)约0.00000001-1重量%的防腐剂;(e) about 0.00000001-1% by weight of preservative;
(f)约0.00001-90重量%的酸碱缓冲剂;(f) About 0.00001-90% by weight of acid-base buffer;
(g)约0.000001-5重量%的抗氧化剂;(g) about 0.000001-5% by weight antioxidant;
(h)约0-1重量%的乳化剂;(h) about 0-1% by weight of emulsifier;
(i)约0-20重量%的液封剂;(i) About 0-20% by weight liquid sealant;
(j)约0-20重量%的蛋白质凝固剂;(j) about 0-20% by weight of protein coagulant;
(k)约0-20重量%的植物提取物;(k) about 0-20% by weight of plant extracts;
(l)约0.0001-2重量%的气味掩盖剂。(l) About 0.0001-2% by weight of odor masking agent.
(e)防腐剂(e) Preservatives
防腐剂是指可以提高本发明的组合物稳定性的组分。Preservatives refer to components that increase the stability of the compositions of the present invention.
在一个实施方案中,所述防腐剂选自对羟基苯甲酸类防腐剂(尼泊金酯类)、苯甲酸类防腐剂、山梨酸类防腐剂、苯扎溴铵、醋酸氯己定、邻苯基苯酚类、六亚甲基胍盐酸盐防腐剂、脱氢乙酸、双乙酸钠、聚赖氨酸、乳酸钠、纳他霉素。在一个优选的实施方案中,所述防腐剂选自对羟基苯甲酸酯类防腐剂、山梨酸类防腐剂。在一个更优选的实施方案中,所述防腐剂为对羟基苯甲酸酯类催化剂。在一个具体的实施方案中,所述防腐剂为羟苯乙酯(亦称尼泊金乙酯)。In one embodiment, the preservative is selected from the group consisting of parahydroxybenzoic acid preservatives (parabens), benzoic acid preservatives, sorbic acid preservatives, benzalkonium bromide, chlorhexidine acetate, ortho Phenylphenols, hexamethyleneguanidine hydrochloride preservative, dehydroacetic acid, sodium diacetate, polylysine, sodium lactate, natamycin. In a preferred embodiment, the preservative is selected from paraben-based preservatives and sorbic acid-based preservatives. In a more preferred embodiment, the preservative is a paraben catalyst. In a specific embodiment, the preservative is ethylparaben (also known as ethylparaben).
在一个实施方案中,在本发明的组合物中加入防腐剂,可以提高组合物的稳定性,抑制微生物的生长。可以抑制生长的微生物例如可以为细菌和真菌等。所述细菌例如可 以为大肠杆菌、绿脓杆菌、金黄色葡萄球菌、溶血性链球菌等。In one embodiment, adding a preservative to the composition of the present invention can improve the stability of the composition and inhibit the growth of microorganisms. Examples of microorganisms that can inhibit growth include bacteria and fungi. The bacteria may be, for example, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, hemolytic Streptococcus, etc.
在一个实施方案中,基于组合物的总重量,防腐剂的含量为约0.00000001-1重量%。在一个优选的实施方案中,基于组合物的总重量,防腐剂的含量为约0.001-0.5重量%。在一个更优选的实施方案中,基于组合物的总重量,防腐剂的含量为约0.05-0.3重量%。例如约0.05重量%、约0.1重量%、约0.15重量%、约0.2重量%、0.25重量%、约0.3重量%。In one embodiment, the preservative is present in an amount of about 0.00000001-1% by weight, based on the total weight of the composition. In a preferred embodiment, the preservative is present in an amount of about 0.001 to 0.5% by weight, based on the total weight of the composition. In a more preferred embodiment, the preservative is present in an amount of about 0.05 to 0.3% by weight, based on the total weight of the composition. For example, about 0.05% by weight, about 0.1% by weight, about 0.15% by weight, about 0.2% by weight, 0.25% by weight, and about 0.3% by weight.
过高的防腐剂含量会提高组合物的毒性,容易对人体产生危害,使得本发明的组合物难以用于日用品。过低的防腐剂含量不能显著提高组合物的稳定性,组合物易受到微生物污染,不宜长期保存。Excessive preservative content will increase the toxicity of the composition and easily cause harm to the human body, making it difficult for the composition of the present invention to be used in daily necessities. Too low a preservative content cannot significantly improve the stability of the composition, and the composition is susceptible to microbial contamination and is not suitable for long-term storage.
(f)酸碱缓冲剂(f)Acid-base buffer
酸碱缓冲剂是指由弱酸及其盐或弱碱及其盐组成的混合溶液,其能在一定程度上抵消、减轻外加强酸或强碱对溶液酸碱度的影响,从而保持溶液的pH值相对稳定。Acid-base buffer refers to a mixed solution composed of weak acid and its salts or weak base and its salts. It can offset and reduce the influence of external strong acid or strong base on the pH of the solution to a certain extent, thereby maintaining the pH value of the solution relatively Stablize.
在本发明中,根据生物吸附剂及其他组分对于工作环境的需求,选择不同的酸碱缓冲剂,以为生物吸附剂及其他组分提供合适的工作环境,提高生物吸附剂吸附并中和刺激性气体的效率。In the present invention, according to the needs of the biosorbent and other components for the working environment, different acid-base buffers are selected to provide a suitable working environment for the biosorbent and other components, improve the adsorption of the biosorbent and neutralize stimulation. Efficiency of sexual gas.
在一个实施方案中,所述酸碱缓冲剂选自碳酸氢钠缓冲液、磷酸盐缓冲液、醋酸钠以及橼酸钠缓冲液。在一个优选的实施方案中,所述酸碱缓冲剂选自磷酸盐缓冲液。在一个更优选的实施方案中,所述酸碱缓冲剂选自磷酸二氢钠-磷酸氢二钠缓冲液。在另一个优选的实施方案中,所述酸碱缓冲剂为碳酸氢钠缓冲液。In one embodiment, the acid-base buffer is selected from the group consisting of sodium bicarbonate buffer, phosphate buffer, sodium acetate, and sodium citrate buffer. In a preferred embodiment, the acid-base buffer is selected from phosphate buffer. In a more preferred embodiment, the acid-base buffer is selected from sodium dihydrogen phosphate-disodium hydrogen phosphate buffer. In another preferred embodiment, the acid-base buffer is sodium bicarbonate buffer.
在一个实施方案中,本发明所使用的酸碱缓冲剂可以将组合物体系的pH调整为约3-10。在一个优选的实施方案中,本发明所使用的酸碱缓冲剂可以将组合物体系的pH调整为约5.0-6.2。在一个更优选的实施方案中,本发明所使用的酸碱缓冲剂可以将组合物体系的pH调整为约5.8(皮肤的平均pH)。pH值过低不利于氨基酸中和醛类化合物的席夫碱反应,pH值过高会造成含烯醇结构的化合物(如维生素C)稳定性降低。In one embodiment, the acid-base buffer used in the present invention can adjust the pH of the composition system to about 3-10. In a preferred embodiment, the acid-base buffer used in the present invention can adjust the pH of the composition system to about 5.0-6.2. In a more preferred embodiment, the acid-base buffer used in the present invention can adjust the pH of the composition system to about 5.8 (the average pH of the skin). A pH value that is too low is not conducive to the Schiff base reaction of amino acids and aldehyde compounds, and a pH value that is too high will cause the stability of compounds containing enol structures (such as vitamin C) to decrease.
在一个实施方案中,基于组合物的总重量,酸碱缓冲剂的含量为约0.00001-90重量%。在一个优选的实施方案中,基于组合物的总重量,酸碱缓冲剂的含量为约0.01-5重量%。在一个更优选的实施方案中,基于组合物的总重量,酸碱缓冲剂的含量为约1.0-2.5重量%。例如约1.0重量%、约1.3重量%、约1.5重量%、约1.8重量%、约2.0重量%、约2.2重量%、约2.5重量%。In one embodiment, the acid-base buffering agent is present in an amount of about 0.00001-90% by weight, based on the total weight of the composition. In a preferred embodiment, the acid-base buffering agent is present in an amount of about 0.01 to 5% by weight, based on the total weight of the composition. In a more preferred embodiment, the acid-base buffering agent is present in an amount of about 1.0-2.5% by weight, based on the total weight of the composition. For example, about 1.0% by weight, about 1.3% by weight, about 1.5% by weight, about 1.8% by weight, about 2.0% by weight, about 2.2% by weight, about 2.5% by weight.
过高的酸碱缓冲剂含量会使组合物的渗透压升高,离子强度增强,不利于酶促反应(例如过氧化氢酶的酶促反应)的进行。过低的酸碱缓冲剂含量则不利于实现酶促反应(如过氧化氢酶)所需的条件,也不利于本发明的组合物的稳定保存。Excessively high acid-base buffer content will increase the osmotic pressure of the composition and enhance the ionic strength, which is not conducive to the enzymatic reaction (such as the enzymatic reaction of catalase). Too low an acid-base buffer content is not conducive to the conditions required for enzymatic reactions (such as catalase) and is not conducive to the stable storage of the composition of the present invention.
(g)抗氧化剂(g)Antioxidants
抗氧化剂是指能够延缓、降低、抑制或防止可氧化物氧化的物质。Antioxidants are substances that can delay, reduce, inhibit or prevent the oxidation of oxidizable substances.
在本发明中,生物吸附剂可以为具有还原性的含烯醇结构的化合物或含巯基的化合物。因此,为了延长组合物的保存时间,可以向组合物中加入抗氧化剂,以提高组合物的耐久性能。In the present invention, the biosorbent may be an enol structure-containing compound or a sulfhydryl group-containing compound with reducing properties. Therefore, in order to extend the storage time of the composition, antioxidants can be added to the composition to improve the durability of the composition.
在一个实施方案中,所述抗氧化剂选自焦亚硫酸钠、亚硫酸氢钠、硫代硫酸钠、维生素E、L-抗坏血酸棕榈酸酯、没食子酸烷酯、丁羟基茴香醚和丁羟基甲苯。在一个优选的实施方案中,所述抗氧化剂为焦亚硫酸钠。In one embodiment, the antioxidant is selected from the group consisting of sodium metabisulfite, sodium bisulfite, sodium thiosulfate, vitamin E, L-ascorbyl palmitate, alkyl gallate, butylated hydroxyanisole, and butylated hydroxytoluene. In a preferred embodiment, the antioxidant is sodium metabisulfite.
在一个实施方案中,基于组合物的总重量,抗氧化剂的含量为约0.000001-5重量%。在一个优选的实施方案中,基于组合物的总重量,抗氧化剂的含量为约0.001-0.04重量%。在一个更优选的实施方案中,基于组合物的总重量,酸碱缓冲剂的含量为约0.01-0.03重量%。例如约0.01重量%、约0.013重量%、约0.015重量%、约0.017重量%、约0.02重量%、约0.023重量%、约0.025重量%、约0.027重量%、约0.029重量%、约0.03重量%。In one embodiment, the antioxidant is present in an amount of about 0.000001-5% by weight, based on the total weight of the composition. In a preferred embodiment, the antioxidant is present in an amount of about 0.001 to 0.04% by weight, based on the total weight of the composition. In a more preferred embodiment, the acid-base buffering agent is present in an amount of about 0.01 to 0.03% by weight, based on the total weight of the composition. For example, about 0.01% by weight, about 0.013% by weight, about 0.015% by weight, about 0.017% by weight, about 0.02% by weight, about 0.023% by weight, about 0.025% by weight, about 0.027% by weight, about 0.029% by weight, about 0.03% by weight. .
过高的抗氧化剂含量会超过食品添加剂使用量的上限,不利于本发明的组合物应用于日用品。过低的抗氧化剂含量则不足以防止烯醇化合物被氧化。Excessively high antioxidant content will exceed the upper limit of the amount of food additives, which is not conducive to the application of the composition of the present invention in daily necessities. Antioxidant content that is too low is insufficient to prevent enol compounds from being oxidized.
(h)乳化剂(h) Emulsifier
乳化剂是指能够使两种或两种以上互不相溶的组分混合,以形成稳定的乳状液的一类化合物。Emulsifier refers to a class of compounds that can mix two or more mutually immiscible components to form a stable emulsion.
在本发明中,当防腐剂选用有机化合物时(例如羟苯乙酯),其在水中的溶解性较差。因此,为了提高防腐剂在水中的溶解性,使得本发明的组合物能够具有较长时间的保质期,会向组合物中加入乳化剂。In the present invention, when an organic compound (such as ethyl hydroxyphenyl ester) is selected as the preservative, its solubility in water is poor. Therefore, in order to improve the solubility of the preservative in water so that the composition of the present invention can have a longer shelf life, an emulsifier is added to the composition.
在一个实施方案中,所述乳化剂选自聚山梨酸酯、三乙醇胺、油酸山梨坦(司盘)、烷基酚聚氧乙烯醚(OP)、硬脂酸甘油酯、十二烷基磺酸钠。在一个优选的实施方案中,所述乳化剂为聚山梨酸酯。在一个具体的实施方案中,所述乳化剂为聚山梨酸酯-80(吐温-80)。In one embodiment, the emulsifier is selected from polysorbate, triethanolamine, sorbitan oleate (Span), alkylphenol polyoxyethylene ether (OP), glyceryl stearate, lauryl Sodium sulfonate. In a preferred embodiment, the emulsifier is polysorbate. In a specific embodiment, the emulsifier is polysorbate-80 (Tween-80).
在一个实施方案中,基于组合物的总重量,乳化剂的含量为约0-1重量%。在一个优选的实施方案中,基于组合物的总重量,乳化剂的含量为约0.001-0.01重量%。例如约0.001重量%、约0.002重量%、约0.003重量%、约0.004重量%、约0.005重量%、约0.006重量%、约0.007重量%、约0.008重量%、约0.009重量%、约0.01重量%。In one embodiment, the emulsifier is present in an amount of from about 0 to 1% by weight, based on the total weight of the composition. In a preferred embodiment, the emulsifier is present in an amount of about 0.001 to 0.01% by weight, based on the total weight of the composition. For example, about 0.001% by weight, about 0.002% by weight, about 0.003% by weight, about 0.004% by weight, about 0.005% by weight, about 0.006% by weight, about 0.007% by weight, about 0.008% by weight, about 0.009% by weight, about 0.01% by weight. .
过高的乳化剂含量会影响防腐剂的防腐效果。过低的乳化剂含量不利于防腐剂的溶解。例如在低温条件下存储本发明的组合物时,防腐剂可能从组合物体系中析出,因而防腐剂不能有效地起到防腐的作用。Excessive emulsifier content will affect the preservative effect of the preservative. Too low emulsifier content is not conducive to the dissolution of preservatives. For example, when the composition of the present invention is stored under low temperature conditions, the preservative may precipitate from the composition system, so the preservative cannot effectively play a preservative role.
在一个实施方案中,使用的防腐剂为水溶性防腐剂时,可不向组合物中加入乳化剂。In one embodiment, when the preservative used is a water-soluble preservative, no emulsifier may be added to the composition.
(i)液封剂(i) Liquid sealant
在本发明中,本发明的组合物在存储和取用过程中容易与空气接触,形成水溶液,并且组合物中的含烯醇结构的化合物以及含巯基结构的化合物易被溶液上方的空气氧化。因此,为了降低上述原因给组合物带来的损失,增强本发明的组合物的稳定性,向组合物的溶液中加入液封剂,以隔离本发明的组合物和空气。In the present invention, the composition of the present invention is easily in contact with air during storage and retrieval, forming an aqueous solution, and the compounds containing an enol structure and the compounds containing a thiol structure in the composition are easily oxidized by the air above the solution. Therefore, in order to reduce the losses caused by the above reasons to the composition and enhance the stability of the composition of the present invention, a liquid sealing agent is added to the solution of the composition to isolate the composition of the present invention from air.
在一个实施方案中,所述液封剂选自食用油、矿物油、硅油、二甲基硅油和液状石蜡(石蜡油)。在一个优选的实施方案中,所述的液封剂为液状石蜡。In one embodiment, the liquid sealing agent is selected from edible oil, mineral oil, silicone oil, dimethicone and liquid paraffin (paraffin oil). In a preferred embodiment, the liquid sealing agent is liquid paraffin.
在一个实施方案中,基于组合物的总重量,液封剂的含量为约0-20重量%。在一个 优选的实施方案中,基于组合物的总重量,液封剂的含量为约1-10重量%。例如约1重量%、约2重量%、约3重量%、约4重量%、约5重量%、约6重量%、约7重量%、约8重量%、约9重量%、约10重量%。In one embodiment, the liquid sealant is present in an amount of about 0-20% by weight based on the total weight of the composition. In a preferred embodiment, the liquid sealant is present in an amount of about 1 to 10% by weight based on the total weight of the composition. For example, about 1% by weight, about 2% by weight, about 3% by weight, about 4% by weight, about 5% by weight, about 6% by weight, about 7% by weight, about 8% by weight, about 9% by weight, about 10% by weight. .
使用液封剂的目的在于,将组合物存贮在刚性容器(如不锈钢桶)中时,防止组合物在取用时被空气氧化。过高的液封剂含量会使组合物中的低极性物质(例如脂溶性防腐剂)溶于液封剂中,影响组合物的性能。过低的液封剂含量会使的液封剂无法完全覆盖组合物表面。当使用具有隔绝空气功能的包装材料(例如底部具有活塞AS塑料的真空瓶、安瓿)进行零售分装时,可以不填加液封剂。The purpose of using a liquid sealant is to prevent the composition from being oxidized by air when it is taken out when the composition is stored in a rigid container (such as a stainless steel barrel). Excessively high liquid sealing agent content will cause low-polarity substances in the composition (such as fat-soluble preservatives) to dissolve in the liquid sealing agent, affecting the performance of the composition. Too low a liquid sealant content will prevent the liquid sealant from completely covering the surface of the composition. When packaging materials with air-isolating functions (such as vacuum bottles and ampoules with a piston AS plastic at the bottom) are used for retail packaging, liquid sealing agent does not need to be added.
(j)蛋白质凝固剂(j)Protein coagulant
通常防腐剂仅对细菌、真菌这类具有细胞结构的微生物有效,而对病毒这样的由核酸与蛋白质外壳构成的微生物无效。因此,向本发明的组合物中添加蛋白质凝固剂可以起到破坏蛋白质的空间构象(Conformation)的作用,促使病毒的蛋白质外壳凝固而失去生物活性,从而有可能产生抗病毒的效果。Usually preservatives are only effective against microorganisms with cellular structures such as bacteria and fungi, but are not effective against microorganisms such as viruses that are composed of nucleic acid and protein shells. Therefore, adding a protein coagulant to the composition of the present invention can destroy the spatial conformation of the protein, prompting the protein shell of the virus to coagulate and lose biological activity, thereby possibly producing an antiviral effect.
在一个实施方案中,所述的蛋白质凝固剂选自硫酸钠、硫酸铵、苦味酸、磷钨酸、磷钼酸、鞣酸、三氯醋酸、磺基水杨酸、尿素、小檗碱、汉防己碱、盐酸胍、葡萄糖酸及其盐类、葡萄糖酸-δ-内酯及其组合。在一个优选的实施方案中,所述蛋白凝固剂为葡萄糖酸-δ-内酯。In one embodiment, the protein coagulant is selected from sodium sulfate, ammonium sulfate, picric acid, phosphotungstic acid, phosphomolybdic acid, tannic acid, trichloroacetic acid, sulfosalicylic acid, urea, berberine, Tetrandrine, guanidine hydrochloride, gluconic acid and its salts, glucono-delta-lactone and combinations thereof. In a preferred embodiment, the protein coagulant is glucono-delta-lactone.
在一个实施方案中,基于组合物的总重量,蛋白质凝固剂的含量为约0-20重量%。在一个优选的实施方案中,基于组合物的总重量,蛋白凝固剂的含量为约0.0001-20重量%。在一个更优选的实施方案中,基于组合物的总重量,蛋白质凝固剂的含量为约0.1-0.3重量%,例如约0.1重量、约0.13重量%、约0.15重量%、约0.18重量%、约0.2重量%、约0.25重量%、约0.3重量%。In one embodiment, the protein coagulant is present in an amount of about 0-20% by weight, based on the total weight of the composition. In a preferred embodiment, the protein coagulant is present in an amount of about 0.0001 to 20% by weight, based on the total weight of the composition. In a more preferred embodiment, the protein coagulant is present in an amount of about 0.1-0.3% by weight, such as about 0.1% by weight, about 0.13% by weight, about 0.15% by weight, about 0.18% by weight, about 0.18% by weight, based on the total weight of the composition. 0.2% by weight, about 0.25% by weight, about 0.3% by weight.
过高含量的蛋白质凝固剂会使组合物的皮肤黏膜刺激性增加,产生过度的收敛、涩味。过低含量的蛋白质凝固剂含量会使组合物的抗病毒蛋白质外壳生物活性能力减弱。另外,较低含量的蛋白质凝固剂具有较低的刺激性,其可用于呼吸道雾化吸入。An excessively high content of protein coagulant will increase the skin and mucous membrane irritation of the composition and produce excessive astringency and astringency. Protein coagulant levels that are too low can reduce the bioactive ability of the antiviral protein coat of the composition. In addition, lower-content protein coagulants are less irritating and can be used for respiratory aerosol inhalation.
(k)植物提取物(k)Plant extracts
通常食品防腐剂仅对细菌、真菌这类具有细胞结构的微生物有效,而对病毒无效。向本发明的组合物中添加潜在的、具有抗微生物(特别是抗病毒)活性的植物提取物可能增强组合物的整体抗微生物的效果。Usually food preservatives are only effective against microorganisms with cellular structures such as bacteria and fungi, but not against viruses. The addition of plant extracts with potential antimicrobial (especially antiviral) activity to the compositions of the present invention may enhance the overall antimicrobial effectiveness of the compositions.
在一个实施方案中,所述的植物提取物的主要成分分子至少含有4个羟基,其选自含有绿原酸、木犀草苷、木犀草素、木犀草素-7-O-β-D-葡萄糖醛酸苷、原花青素成分之一的植物提取物,所述原花青素成分例如可选自杜仲的叶、忍冬(金银花)、红腺忍冬、山银花或毛花柱忍冬的花、忍冬藤、英国山楂、千屈菜花、假败酱根、卷心菜茎、扁蓄、篷子菜、蒴翟、红薯的叶、小果咖啡、中果咖啡及大果咖啡的种子、牛蒡的叶和根、花生壳、木犀草、连钱草、北刘寄奴、青兰、锦灯笼、裸花紫珠、苦碟子,葡萄籽。在一个优选的实施方案中,所述植物提取物为葡萄籽提取物(其主要成分为原花青素)。In one embodiment, the main component molecules of the plant extract contain at least 4 hydroxyl groups, which are selected from the group consisting of chlorogenic acid, luteolin, luteolin, and luteolin-7-O-β-D- Glucuronide and a plant extract of one of the proanthocyanidin components. The proanthocyanidin component can be selected from, for example, the leaves of Eucommia ulmoides, Lonicera japonica (honeysuckle), Lonicera erythricum, flowers of Honeysuckle or Lonicera tomentosa, Lonicera vine, and English hawthorn. , cauliflower, cauliflower root, cabbage stems, fenugreek, cantaloupe, capsules, sweet potato leaves, small coffee, medium coffee and large coffee seeds, burdock leaves and roots, peanut shells, Mignonette, Lianqiancao, Beiliujinu, Qinglan, Brocade Lantern, Naked Flower Purple Pearl, Kudianzi, Grape Seed. In a preferred embodiment, the plant extract is grape seed extract (the main component of which is proanthocyanidins).
在一个实施方案中,基于组合物的总重量,植物提取物的含量为约0-20重量%。在 一个优选的实施方案中,基于组合物的总重量,植物提取物的含量为约0.0001-20重量%。在一个更优选的实施方案中,基于组合物的总重量,植物提取物的含量为约0.5-0.9重量%。例如约0.5重量%、约0.6重量%、约0.7重量%、约0.8重量%、约0.9重量%。In one embodiment, the plant extract is present in an amount of about 0-20% by weight, based on the total weight of the composition. In a preferred embodiment, the plant extract is present in an amount of about 0.0001 to 20% by weight, based on the total weight of the composition. In a more preferred embodiment, the plant extract is present in an amount of about 0.5-0.9% by weight, based on the total weight of the composition. For example, about 0.5% by weight, about 0.6% by weight, about 0.7% by weight, about 0.8% by weight, and about 0.9% by weight.
植物提取物通常是棕色,具有紫外线-蓝紫光吸收性的物质,可以起到遮光剂的效果。过高的植物提取物含量会使组合物颜色过深,从而影响美观性。过低的植物提取物含量会使组合物吸光性能降低,不利于对光线敏感的含烯醇结构的合物的稳定存储,并且会导致抗微生物活性能力减弱。不过降低植物提取物含量可降低刺激性,使其可用于呼吸道雾化吸入。Plant extracts are usually brown, ultraviolet-blue-violet light-absorbing substances that can act as sunscreens. Too high a content of plant extracts will make the composition too dark, thus affecting its aesthetics. Too low a content of plant extracts will reduce the light absorption properties of the composition, which is not conducive to the stable storage of compounds containing enol structures that are sensitive to light, and will result in weakened antimicrobial activity. However, reducing the content of plant extracts can reduce irritation, making it suitable for respiratory aerosol inhalation.
(l)气味掩盖剂(l) Odor masking agent
含巯基的化合物通常具有硫化物的臭味,可能易引起不愉快的嗅觉。使用具有清香气味的气味掩盖剂可以较好的掩盖其臭味。Compounds containing sulfhydryl groups often have a sulfide odor and may cause an unpleasant smell. Using an odor masking agent with a fresh scent can better cover up the odor.
在一个实施方案中,所述气味掩盖剂可以是果香味的食用香精。在一个实施方案中,所述气味掩盖剂选自芸香科桔属果皮的挥发油,例如柠檬油,其主要成份为柠檬烯,其中次要成分还包括蒎烯、月桂烯、松油烯等。其中,含柠檬油的植物药(如陈皮,中药饮片)以及桉柠蒎肠溶软胶囊(国药准字H20052401)具有改善气管粘膜纤毛运动,促进呼吸道腺体的分泌、化痰,促进呼吸道自净的药理作用,是经典的呼吸道疾病辅助用药。In one embodiment, the odor masking agent may be a fruity flavor. In one embodiment, the odor masking agent is selected from volatile oils from tangerine peels of the family Rutaceae, such as lemon oil, whose main component is limonene, and its minor components also include pinene, myrcene, terpinene, etc. Among them, lemon oil-containing botanicals (such as tangerine peel, traditional Chinese medicine pieces) and eucalyptus, lemon and pinole enteric-coated soft capsules (National Drug Approval No. H20052401) can improve the ciliary movement of tracheal mucosa, promote the secretion of respiratory glands, reduce phlegm, and promote self-purification of the respiratory tract. Pharmacological effects: It is a classic auxiliary medicine for respiratory diseases.
在一个实施方案中,基于组合物的总重量,气味掩盖剂的含量为约0.0001-2重量%。在一个优选的实施方案中,基于组合物的总重量,气味掩盖剂的含量为约0.01-0.9重量%。在一个更优选的实施方案中,基于组合物的总重量,气味掩盖剂的含量为约0.2-0.5重量%。例如约0.2重量%、约0.3重量%、约0.4重量%、约0.5重量%。In one embodiment, the odor masking agent is present in an amount of about 0.0001-2% by weight, based on the total weight of the composition. In a preferred embodiment, the odor masking agent is present in an amount of about 0.01 to 0.9% by weight, based on the total weight of the composition. In a more preferred embodiment, the odor masking agent is present in an amount of about 0.2 to 0.5% by weight, based on the total weight of the composition. For example, about 0.2% by weight, about 0.3% by weight, about 0.4% by weight, and about 0.5% by weight.
过高气味掩盖剂含量会影响其他成分的稳定性,有可能产生刺激性等不良反应。过低的含量可能不足以掩盖含巯基化合物的气味。Excessive odor masking agent content will affect the stability of other ingredients and may cause irritation and other adverse reactions. Levels that are too low may not be enough to mask the odor of sulfhydryl-containing compounds.
目前已有许多研究表明鞣酸、绿原酸、木犀草苷、柿子单宁具有抗病毒效果,但上述物质稳定性较差,从而限制了其商用价值。这主要是由于上述物质属于包含多羟基结构的多酚类物质,其容易被金属离子以及空气氧化、水解而失效。本发明的组合物中含有较高浓度的含烯醇结构的化合物、含巯基的化合物,这可以对上述多酚类物质起到良好的保护作用,因此本发明的组合物与上述物质的联用也有助于上述物质能够实现其商用价值。Many studies have shown that tannic acid, chlorogenic acid, luteolin, and persimmon tannin have antiviral effects. However, the stability of the above substances is poor, thus limiting their commercial value. This is mainly because the above-mentioned substances are polyphenols containing polyhydroxyl structures, which are easily oxidized and hydrolyzed by metal ions and air and become ineffective. The composition of the present invention contains a relatively high concentration of compounds containing enol structures and compounds containing sulfhydryl groups, which can have a good protective effect on the above-mentioned polyphenols. Therefore, the combination of the composition of the present invention and the above-mentioned substances It also helps the above-mentioned substances to realize their commercial value.
另外,目前已有报道通过蛋白质模型计算出2019-nCoV的S蛋白等电点为6.24,S1/S2/His等电点在4.41-5.87,hACE2/His关键结合蛋白的等电点为5.19-6.11(平均pH5.60)。设置本发明的组合物的pH值为5.6-6.0(优选pH为5.8),在使用的过程中,所述pH将逐渐升高(组合物暴露在空气中时,CO 2的含量会逐渐下降),组合物的pH将会缓慢地升至S蛋白的等电点附近,从而起到使蛋白质沉淀的效果。因而本申请的组合物有可能起到抑制病毒表面蛋白活性的效果。 In addition, it has been reported that the isoelectric point of the S protein of 2019-nCoV is 6.24, the isoelectric point of S1/S2/His is 4.41-5.87, and the isoelectric point of the key binding protein of hACE2/His is 5.19-6.11 through protein models. (average pH 5.60). The pH value of the composition of the present invention is set to 5.6-6.0 (preferably pH is 5.8). During use, the pH will gradually increase (when the composition is exposed to the air, the CO2 content will gradually decrease) , the pH of the composition will slowly rise to near the isoelectric point of the S protein, thereby precipitating the protein. Therefore, the composition of the present application may have the effect of inhibiting the activity of viral surface proteins.
此外,已知含巯基化合物中的巯基结构也能够作用于蛋白质的二硫键,从而破坏蛋白质构象,降低痰液粘性,N-乙酰半胱氨酸雾化吸入剂已被欧洲以及中国药品监督管理局批准用于化痰治疗(如:吸入用乙酰半胱氨酸溶液,国药准H20150548,JX20020133,ZAMBON S.p.A.)。因此由于本发明的组合物包含巯基的化合物,其也能够实现持久的 蛋白质活性抑制的效果。In addition, it is known that the sulfhydryl structure in sulfhydryl-containing compounds can also act on the disulfide bonds of proteins, thereby destroying the protein conformation and reducing the viscosity of sputum. N-acetylcysteine aerosol inhalation has been regulated by European and Chinese drug regulators. Approved by the bureau for the treatment of phlegm (such as: acetylcysteine solution for inhalation, National Drug Approval H20150548, JX20020133, ZAMBON S.p.A.). Therefore, since the composition of the present invention contains a sulfhydryl compound, it can also achieve a long-lasting protein activity inhibition effect.
水溶液aqueous solution
在另一方面,本发明涉及一种水溶液,其特征在于,其包含本发明的组合物。In another aspect, the invention relates to an aqueous solution, characterized in that it contains the composition of the invention.
在一个实施方案中,基于所述水溶液的总重量,所述组合物的含量为约30-80重量%。在一个优选的实施方案中,基于所述水溶液的总重量,所述组合物的含量为约56-76重量%。在一个更优选的实施方案中,基于所述水溶液的总重量,所述组合物的含量为约66重量%。例如约30重量%、约35重量%、约40重量%、约43重量%、约45重量%、约50重量%、约55重量%、约60重量%、约63重量%、约65重量%、约66重量%、约67重量%、约70重量%、约76重量%、约75重量%。In one embodiment, the composition is present in an amount of about 30-80% by weight, based on the total weight of the aqueous solution. In a preferred embodiment, the composition is present in an amount of about 56-76% by weight, based on the total weight of the aqueous solution. In a more preferred embodiment, the composition is present in an amount of about 66% by weight, based on the total weight of the aqueous solution. For example, about 30% by weight, about 35% by weight, about 40% by weight, about 43% by weight, about 45% by weight, about 50% by weight, about 55% by weight, about 60% by weight, about 63% by weight, about 65% by weight. , about 66% by weight, about 67% by weight, about 70% by weight, about 76% by weight, about 75% by weight.
在本发明的水溶液中,合适的水含量有利于本发明的组合物实现其技术效果,例如吸附并中和氧化性消毒剂中的刺激性气体、净化空气、抑制生物蛋白质活性等。过高的水含量使得组合物的含量较低,不足以实现本发明的技术效果。过低的水含量不利于组分的充分溶解,从而无法使组合物各组分与被吸附气体充分接触,因而无法有效地吸附并中和氧化性消毒剂中的刺激性气体,也不利于其他技术效果的实现。In the aqueous solution of the present invention, an appropriate water content is conducive to the composition of the present invention achieving its technical effects, such as adsorbing and neutralizing irritating gases in oxidizing disinfectants, purifying the air, inhibiting biological protein activity, etc. Excessively high water content results in a low content of the composition, which is insufficient to achieve the technical effects of the present invention. Too low water content is not conducive to the full dissolution of the components, so that each component of the composition cannot be fully contacted with the adsorbed gas, so it cannot effectively adsorb and neutralize the irritating gases in the oxidizing disinfectant, and is not conducive to other Realization of technical effects.
相比维生素C水溶液,本发明的组合物水溶液可以更有效地吸收并中和刺激性气体(例如氧化性消毒剂中的刺激性气体),吸附效率可以获得明显的改善。Compared with the vitamin C aqueous solution, the composition aqueous solution of the present invention can absorb and neutralize irritating gases (such as irritating gases in oxidative disinfectants) more effectively, and the adsorption efficiency can be significantly improved.
基材base material
在另一方面,本发明涉及一种基材,其特征在于,所述基材含有本发明的组合物。In another aspect, the invention relates to a substrate, characterized in that it contains a composition of the invention.
在一个实施方案中,所述基材用于吸附并中和氧化性消毒剂中的刺激性气体。In one embodiment, the substrate is used to adsorb and neutralize irritating gases in oxidative disinfectants.
在一个实施方案中,本发明的组合物吸附在所述基材上。In one embodiment, the composition of the invention is adsorbed onto the substrate.
本发明的基材是指一种材料制品,例如片材、金属板材、无纺布材、玻璃纤维等。根据工作环境的需求,基材的表面可以附着有不同的材料。例如,为了吸附空气中的细小颗粒,例如花粉、粉尘等,基材表面可以附着有活性炭。又例如,为了吸附空气中的酸性气体,基材表面可以附着有弱碱性的化合物,例如碳酸氢钠等。又例如,为了吸附空气中的氧化性气体,例如氯气等,基材表面可以附着有还原性化合物,例如含烯醇结构的化合物或含巯基的化合物等。The base material of the present invention refers to a material product, such as sheet, metal plate, non-woven fabric, glass fiber, etc. Depending on the needs of the working environment, different materials can be attached to the surface of the substrate. For example, in order to absorb fine particles in the air, such as pollen, dust, etc., activated carbon can be attached to the surface of the substrate. For another example, in order to adsorb acidic gases in the air, a weakly alkaline compound, such as sodium bicarbonate, can be attached to the surface of the substrate. For another example, in order to adsorb oxidizing gases in the air, such as chlorine, reducing compounds, such as compounds containing enol structures or compounds containing thiol groups, may be attached to the surface of the substrate.
另外,根据基材的用途,可以使用不同类型的材料作为基材。例如,若用于空气净化器,所述基材可以为金属网格。又例如,若用于口腔防护用具,所述基材可以为口罩中的无纺布或防毒面具中的过滤膜。In addition, different types of materials can be used as the substrate depending on the purpose of the substrate. For example, if used in an air purifier, the substrate may be a metal mesh. For another example, if used for oral protective equipment, the base material can be a non-woven fabric in a mask or a filter membrane in a gas mask.
在一个实施方案中,所述基材选自无纺布料、金属网格、玻璃纤维、棉布、亚麻布、过滤棉。在一个优选的实施方案中,所述基材为无纺布料。In one embodiment, the substrate is selected from the group consisting of non-woven cloth, metal mesh, fiberglass, cotton cloth, linen cloth, and filter cotton. In a preferred embodiment, the substrate is non-woven fabric.
多层材料AMulti-layer material A
在又一方面,本发明涉及一种多层材料A,其特征在于,所述多层材料A包含:本发明所述的基材作为基层材料;活性炭层作为第一过滤层。In another aspect, the present invention relates to a multi-layer material A, characterized in that the multi-layer material A includes: the base material of the present invention as the base material; and the activated carbon layer as the first filter layer.
基层材料base material
在本发明中,在一个实施方案中,所述作为基层材料的基材选无纺布料、金属网格、 玻璃纤维、棉布、亚麻布、过滤棉。在一个优选的实施方案中,所述基材为无纺布料。所述基层材料附着有本发明的组合物,可用于吸附并中和刺激性气体,所述刺激性气体例如可以是氧化性消毒剂中的挥发性气体,如含氯消毒剂中的氯气、含过氧化氢消毒剂中挥发的过氧化氢或含过氧乙酸消毒剂中挥发的过氧乙酸。又例如,所述刺激性气体可以是含醛基化合物的消毒剂中挥发的醛基化合物。In the present invention, in one embodiment, the base material as the base material is selected from non-woven cloth, metal mesh, glass fiber, cotton cloth, linen cloth, and filter cotton. In a preferred embodiment, the substrate is non-woven fabric. The base material is attached with the composition of the present invention and can be used to adsorb and neutralize irritating gases. The irritating gases can be, for example, volatile gases in oxidizing disinfectants, such as chlorine in chlorine-containing disinfectants, The volatilized hydrogen peroxide in hydrogen peroxide disinfectants or the volatilized peracetic acid in peracetic acid-containing disinfectants. For another example, the irritating gas may be an aldehyde-based compound volatilized in a disinfectant containing an aldehyde-based compound.
活性炭层activated carbon layer
在本发明中,多层材料A还包含活性炭层作为第一过滤层,其中活性炭层用于吸附空气中的挥发性气体过氧乙酸,但不具有中和过氧乙酸的作用。In the present invention, the multi-layer material A also includes an activated carbon layer as the first filter layer, where the activated carbon layer is used to adsorb peracetic acid, a volatile gas in the air, but does not have the effect of neutralizing peracetic acid.
第二过滤层Second filter layer
在一个优选的实施方案中,本发明的多层材料A中,在基层材料和第一过滤层之间还包含第二过滤层。In a preferred embodiment, the multi-layer material A of the present invention further includes a second filter layer between the base material and the first filter layer.
根据实际工作需求,除了吸附并中和刺激性气体外,为了同时吸附空气中的粉尘或细小颗粒,在本发明的多层材料A的基层材料和第一过滤层之间,还包含第二过滤层。According to actual work requirements, in addition to adsorbing and neutralizing irritating gases, in order to simultaneously adsorb dust or fine particles in the air, a second filter is also included between the base material of the multi-layer material A of the present invention and the first filter layer. layer.
根据第二过滤层的用途,可以使用不同类型的材料作为第二过滤层。例如,若用于空气净化器,所述基材可以为金属网格。又例如,若用于口腔防护用具,所述基材可以为口罩中的无纺布或防毒面具中的过滤膜。Depending on the purpose of the second filter layer, different types of materials can be used as the second filter layer. For example, if used in an air purifier, the substrate may be a metal mesh. For another example, if used for oral protective equipment, the base material can be a non-woven fabric in a mask or a filter membrane in a gas mask.
在一个优选的实施方案中,所述第二过滤层选自无纺布料、金属网格、玻璃纤维、棉布、亚麻布、过滤棉。在一个优选的实施方案中,所述第二过滤层为无纺布料。在一个更优选的实施方案中,所述第二过滤层为熔喷无纺布料。In a preferred embodiment, the second filter layer is selected from the group consisting of non-woven cloth, metal mesh, glass fiber, cotton cloth, linen cloth, and filter cotton. In a preferred embodiment, the second filter layer is non-woven fabric. In a more preferred embodiment, the second filter layer is melt-blown non-woven fabric.
多层材料BMulti-layer material B
在还一方面,本发明涉及一种多层材料B,其特征在于,所述多层材料B包含:本发明的基材作为第一基层材料;中间隔离层;第二基层材料。In another aspect, the present invention relates to a multi-layer material B, characterized in that the multi-layer material B includes: the base material of the present invention as a first base material; an intermediate isolation layer; and a second base material.
第一基层材料first base material
在本发明中,第一基层材料为本发明的基材,其中所述基材如上述所定义。In the present invention, the first base material is the base material of the present invention, wherein the base material is as defined above.
中间隔离层middle isolation layer
在本发明中,中间隔离层为包含不被水浸润的多孔透气材料,其用于隔离第一基层材料和第二基层材料,以使两种基层材料可以在不同的环境下工作。In the present invention, the middle isolation layer is composed of a porous breathable material that is not wetted by water, and is used to isolate the first base material and the second base material so that the two base materials can work in different environments.
由于中间隔离层的存在,第一基层材料和第二基层材料具有不同的工作环境,例如两者的pH不同。又例如,两者的温度不同。又例如,两者的湿度不同。Due to the existence of the intermediate isolation layer, the first base layer material and the second base layer material have different working environments, for example, the pH of the two is different. For another example, the temperatures of the two are different. For another example, the humidity of the two is different.
在一个实施方案中,中间隔离层为包含不被水浸润的多孔透气材料,所述多孔透气材料选自聚酯过滤棉、玻璃棉、岩棉、空气过滤棉、泡沫海绵。在一个优选的实施方案中,所述多孔透气材料为聚酯过滤棉。在一个具体的实施方案中,所述多孔透气材料为乙烯-乙酸乙烯酯(EVA)透气海绵。In one embodiment, the middle isolation layer includes a porous breathable material that is not wetted by water. The porous breathable material is selected from the group consisting of polyester filter cotton, glass wool, rock wool, air filter cotton, and foam sponge. In a preferred embodiment, the porous breathable material is polyester filter cotton. In a specific embodiment, the porous breathable material is an ethylene vinyl acetate (EVA) breathable sponge.
在一个实施方案中,中间隔离层的厚度为约0.1-15mm。在一个优选的实施方案中,中间隔离层的厚度为约3mm。In one embodiment, the thickness of the intermediate isolation layer is about 0.1-15 mm. In a preferred embodiment, the thickness of the intermediate isolation layer is about 3 mm.
第二基层材料second base material
在本发明中,第二基层材料包含生物酶、引湿剂、防腐剂、和酸碱缓冲剂,其中生物酶、引湿剂、酸碱缓冲剂以及第二基层材料的类型如上述所定义。In the present invention, the second base material includes biological enzymes, moisture absorbing agents, preservatives, and acid-base buffers, wherein the types of biological enzymes, moisture absorbing agents, acid-base buffers, and second base materials are as defined above.
在一个优选的实施方案中,所述生物酶为过氧化氢酶。In a preferred embodiment, the biological enzyme is catalase.
在第二基层材料中,过氧化氢酶用于吸附并分解挥发性气体过氧化氢。In the second base material, catalase is used to adsorb and decompose the volatile gas hydrogen peroxide.
在一个优选的实施方案中,由于第一基层材料中的生物吸附剂与第二基层材料中的过氧化氢酶需要在不同的pH条件下工作,才可以充分发挥各自吸附并中和刺激性气体的作用,因此在第一基层材料和第二基层材料之间设置中间隔离层,可以有效地隔离两种材料中的组分。并且中间隔离层使用了不被水浸润的多孔透气材料,气体仍可以顺畅地通过中间隔离层,进一步被第二基层材料中的活性成分吸附并中和。In a preferred embodiment, since the biosorbent in the first base material and the catalase in the second base material need to work under different pH conditions, they can fully exert their respective adsorption and neutralization of irritating gases. Therefore, an intermediate isolation layer is provided between the first base material and the second base material, which can effectively isolate the components in the two materials. Moreover, the middle isolation layer uses a porous breathable material that is not wetted by water. Gas can still pass through the middle isolation layer smoothly and be further adsorbed and neutralized by the active ingredients in the second base material.
口罩Face mask
在又一方面,本发明涉及一种口罩,其包含本发明的基层材料、多层材料A或多层材料B,其中所述基层材料、多层材料A和多层材料B如上述所定义。In yet another aspect, the present invention relates to a mask comprising the base material, multi-layer material A or multi-layer material B of the present invention, wherein the base material, multi-layer material A and multi-layer material B are as defined above.
制备方法Preparation
本发明还涉及一种制备本发明的口罩的方法,其包括以下步骤:The present invention also relates to a method for preparing the mask of the present invention, which includes the following steps:
(1)制备本发明所述的组合物;(1) Preparing the composition of the present invention;
(2)将步骤(1)获得的组合物均匀浸润在第一基层材料的表面;(2) Evenly infiltrate the composition obtained in step (1) on the surface of the first base material;
(3)在保护性气体的气氛下干燥步骤(2)获得的基层材料;(3) Drying the base material obtained in step (2) under a protective gas atmosphere;
任选地,还包括以下步骤:Optionally, also include the following steps:
(4)将生物酶、引湿剂、防腐剂和酸碱指示剂均匀混合以得到组合物;(4) Evenly mix biological enzymes, moisture attractants, preservatives and acid-base indicators to obtain a composition;
(5)将步骤(4)获得的组合物均匀浸润在第二基层材料的表面;(5) Evenly infiltrate the composition obtained in step (4) on the surface of the second base material;
(6)在保护性气体的气氛下干燥步骤(5)获得的基层材料;(6) Drying the base material obtained in step (5) under a protective gas atmosphere;
(7)将第一基层材料与第一过滤层缝合,任选地与第二过滤层缝合;或(7) Sewing the first base material to the first filter layer, optionally to the second filter layer; or
(8)将第一基层材料、第二基层材料与中间隔离层缝合。(8) Sew the first base layer material, the second base layer material and the middle isolation layer.
第一基层材料、第二基层材料、第二过滤层、第一过滤层、中间隔离层中的活性成分或其他成分的种类及含量如上述所定义。The types and contents of the active ingredients or other ingredients in the first base layer material, the second base layer material, the second filter layer, the first filter layer, and the intermediate isolation layer are as defined above.
在一个实施方案中,步骤(3)和步骤(5)中使用的保护性气体选自氮气、氦气、氖气和二氧化碳。在一个优选的实施方案中,步骤(3)和步骤(5)中使用的保护性气体为氮气。步骤(3)和步骤(6)中使用的保护性气体可以相同,也可以不同。In one embodiment, the protective gas used in step (3) and step (5) is selected from nitrogen, helium, neon and carbon dioxide. In a preferred embodiment, the protective gas used in step (3) and step (5) is nitrogen. The protective gases used in step (3) and step (6) may be the same or different.
在一个实施方案中,步骤(3)和步骤(6)中的干燥温度为约50-80℃或室温。在一个优选的实施方案中,步骤(3)和步骤(6)中的干燥温度为约60℃。In one embodiment, the drying temperature in step (3) and step (6) is about 50-80°C or room temperature. In a preferred embodiment, the drying temperature in step (3) and step (6) is about 60°C.
在另一方面,本发明还涉及一种快速制备本发明的口罩的方法,其包括以下步骤:On the other hand, the present invention also relates to a method for quickly preparing the mask of the present invention, which includes the following steps:
(1)提供本发明的组合物溶液;(1) Provide the composition solution of the present invention;
(2)通过喷洒的方式将步骤(1)的组合物液体喷涂到口罩的内和/或外侧。(2) Spray the composition liquid of step (1) onto the inside and/or outside of the mask by spraying.
在一个实施方案中,步骤(1)的组合物溶液储存在如图8所述的喷雾瓶中。In one embodiment, the composition solution of step (1) is stored in a spray bottle as described in Figure 8.
在一个实施方案中,在步骤(2)中,通过如图8所述的喷雾瓶喷涂步骤(1)的组合物,喷涂过程参见图9。In one embodiment, in step (2), the composition of step (1) is sprayed via a spray bottle as shown in FIG. 8, see FIG. 9 for the spraying process.
在一个实施方案中,组合物喷涂位置为口罩上方约5-10cm处。例如约5cm、约6cm、约7cm、约8cm、约9cm、约10cm。In one embodiment, the composition spraying position is about 5-10 cm above the mask. For example, about 5cm, about 6cm, about 7cm, about 8cm, about 9cm, about 10cm.
在一个实施方案中,步骤(2)中喷涂的组合物溶液的体积为约3.2mL。In one embodiment, the volume of the composition solution sprayed in step (2) is about 3.2 mL.
在一个优选的实施方案中,对口罩的内外两侧各喷洒约15-20次,完成组合物溶液的喷涂。在一个更优选的实施方案中,对口罩的内外两侧各喷洒约17-19次,完成组合物溶液的喷涂。例如约15次、约16次、约17次、约18次、约19次、约20次。In a preferred embodiment, spray the inner and outer sides of the mask about 15-20 times to complete the spraying of the composition solution. In a more preferred embodiment, the inner and outer sides of the mask are sprayed about 17-19 times to complete the spraying of the composition solution. For example, about 15 times, about 16 times, about 17 times, about 18 times, about 19 times, and about 20 times.
本发明的组合物的稳定性及其对氧化性消毒液中刺激性气体的吸附中和能力The stability of the composition of the present invention and its ability to adsorb and neutralize irritating gases in oxidizing disinfectant solutions
本发明的组合物对氧化性消毒液中刺激性气体的吸附中和能力The ability of the composition of the present invention to adsorb and neutralize irritating gases in oxidizing disinfectant solutions
本发明的组合物对氧化性消毒液中刺激性气体的中和能力通过如下方法A进行检测。The ability of the composition of the present invention to neutralize irritating gases in the oxidizing disinfectant solution is tested by the following method A.
方法AMethod A
(1)配制消毒剂水溶液;(1) Prepare disinfectant aqueous solution;
(2)配制本发明的组合物的水溶液;(2) Prepare an aqueous solution of the composition of the present invention;
(3)使用步骤(1)的消毒剂水溶液滴定步骤(2)的组合物水溶液;(3) Titrate the aqueous composition solution of step (2) using the aqueous disinfectant solution of step (1);
(4)使用滴定指示剂,根据指示剂的变色确定滴定的终点,并根据滴定终点时,消耗的消毒剂水溶液的体积确定组合物的中和能力。(4) Use a titration indicator, determine the end point of the titration based on the color change of the indicator, and determine the neutralizing ability of the composition based on the volume of the disinfectant aqueous solution consumed at the end point of the titration.
在一个实施方案中,通过上述方法确定本发明的组合物对氧化性消毒剂中的刺激性气体的吸附中和能力。In one embodiment, the ability of the composition of the present invention to adsorb and neutralize irritating gases in oxidative disinfectants is determined by the method described above.
在一个优选地实施方案中,通过三氯异氰尿酸消毒剂、次氯酸钠消毒剂和二氧化氯消毒剂水溶液对本发明的组合物水溶液的滴定确定本发明的组合物对消毒剂中的氯气的吸附中和能力。在另一个优选的实施方案中,通过过氧化氢洗液对本发明的组合物水溶液的滴定确定本发明的组合物对消毒剂中过氧化氢的吸附中和能力。在还一个优选的实施方案中,通过氧乙酸消毒液对本发明的组合物水溶液的滴定确定本发明的组合物对消毒剂中过氧乙酸的吸附中和能力。In a preferred embodiment, the adsorption of chlorine gas in the disinfectant by the composition of the present invention is determined by titration of the aqueous solution of the composition of the present invention with trichloroisocyanuric acid disinfectant, sodium hypochlorite disinfectant and chlorine dioxide disinfectant aqueous solution. and ability. In another preferred embodiment, the ability of the composition of the present invention to adsorb and neutralize hydrogen peroxide in the disinfectant is determined by titration of an aqueous solution of the composition of the present invention with a hydrogen peroxide wash solution. In yet another preferred embodiment, the adsorption and neutralization ability of the composition of the present invention on the peracetic acid in the disinfectant is determined by titration of the aqueous solution of the composition of the present invention with an oxyacetic acid disinfectant solution.
根据待测刺激性气体的种类,相应地使用对应的滴定指示剂。例如滴定含氯消毒剂时,使用测氯试纸作为滴定指示剂。又例如,滴定过氧化氢消毒剂时,使用过氧化氢试纸作为滴定指示剂。又例如,滴定过氧乙酸消毒剂时,使用过氧乙酸试纸作为滴定指示剂。According to the type of irritating gas to be measured, use the corresponding titration indicator accordingly. For example, when titrating chlorine-containing disinfectants, use chlorine test paper as a titration indicator. For another example, when titrating hydrogen peroxide disinfectant, use hydrogen peroxide test paper as a titration indicator. For another example, when titrating peracetic acid disinfectant, use peracetic acid test paper as a titration indicator.
任选地,在确定滴定终点时,使用辅助指示剂。例如,以测氯试纸为辅助指示剂帮助确定过氧化氢和过氧乙酸消毒液的滴定终点。Optionally, a secondary indicator is used in determining the titration end point. For example, chlorine test paper is used as an auxiliary indicator to help determine the titration endpoint of hydrogen peroxide and peracetic acid disinfectants.
在一个具体的实施方案中,通过如下方法A1检测本发明的组合物对氧化性消毒液中刺激性气体的中和能力。In a specific embodiment, the ability of the composition of the present invention to neutralize irritating gases in the oxidative disinfectant solution is tested by the following method A1.
方法A1Method A1
(1)配制浓度为1000ppm(1000mg/L)的消毒液;(1) Prepare disinfectant solution with a concentration of 1000ppm (1000mg/L);
(2)配制本发明的组合物水溶液,其中组合物水溶液中的活性成分(含烯醇结构的化合物和/或含巯基结构的化合物和/或氨基酸)的含量为约2-8重量%;(2) Prepare an aqueous composition solution of the present invention, wherein the content of the active ingredient (enol structure-containing compound and/or thiol structure-containing compound and/or amino acid) in the composition aqueous solution is about 2-8% by weight;
(3)使用步骤(1)获得的消毒液对1mL步骤(2)的组合物水溶液进行滴定,记录滴定终点时消耗的消毒液的体积。(3) Use the disinfectant solution obtained in step (1) to titrate 1 mL of the composition aqueous solution in step (2), and record the volume of disinfectant solution consumed at the end point of the titration.
在一个实施方案中,通过上述方法配制三氯异氰尿酸水溶液进行滴定实验,在滴定终点,滴定消耗的三氯异氰尿酸水溶液的体积为约5-50mL。在一个优选的实施方案中,通过上述方法配制三氯异氰尿酸水溶液进行滴定实验,在滴定终点,滴定消耗的三氯异 氰尿酸水溶液的体积为约10-30mL。In one embodiment, the trichloroisocyanuric acid aqueous solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of the trichloroisocyanuric acid aqueous solution consumed by the titration is about 5-50 mL. In a preferred embodiment, the trichloroisocyanuric acid aqueous solution is prepared by the above method to perform a titration experiment. At the titration end point, the volume of the trichloroisocyanuric acid aqueous solution consumed by the titration is about 10-30 mL.
在一个实施方案中,通过上述方法配制次氯酸钠消毒剂水溶液进行滴定实验,在滴定终点,滴定消耗的次氯酸钠消毒剂水溶液的体积为约5-50mL。在一个优选的实施方案中,通过上述方法配制次氯酸钠消毒剂水溶液进行滴定实验,在滴定终点,滴定消耗的次氯酸钠消毒剂水溶液的体积为约10-30mL。In one embodiment, the sodium hypochlorite disinfectant aqueous solution is prepared by the above method to perform a titration experiment. At the titration end point, the volume of the sodium hypochlorite disinfectant aqueous solution consumed by the titration is about 5-50 mL. In a preferred embodiment, the sodium hypochlorite disinfectant aqueous solution is prepared by the above method for a titration experiment. At the end point of the titration, the volume of the sodium hypochlorite disinfectant aqueous solution consumed by the titration is about 10-30 mL.
在一个实施方案中,通过上述方法配制二氧化氯消毒剂水溶液进行滴定实验,在滴定终点,滴定消耗的二氧化氯消毒剂水溶液的体积为约50-150mL。在一个优选的实施方案中,通过上述方法配制次氯酸钠消毒剂水溶液进行滴定实验,在滴定终点,滴定消耗的次氯酸钠消毒剂水溶液的体积为约70-130mL。In one embodiment, a chlorine dioxide disinfectant aqueous solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of the chlorine dioxide disinfectant aqueous solution consumed by the titration is about 50-150 mL. In a preferred embodiment, the sodium hypochlorite disinfectant aqueous solution is prepared by the above method for a titration experiment. At the end point of the titration, the volume of the sodium hypochlorite disinfectant aqueous solution consumed by the titration is about 70-130 mL.
在一个实施方案中,通过上述方法配制过氧化氢洗液进行滴定实验,在滴定终点,滴定消耗的过氧化氢洗液的体积为约0.08-1mL。在一个优选的实施方案中,通过上述方法配制过氧化氢洗液进行滴定实验,在滴定终点,滴定消耗的过氧化氢洗液的体积为约0.08-0.5mL。In one embodiment, the hydrogen peroxide wash solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of hydrogen peroxide wash solution consumed by the titration is about 0.08-1 mL. In a preferred embodiment, the hydrogen peroxide wash solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of hydrogen peroxide wash solution consumed by the titration is about 0.08-0.5 mL.
在一个实施方案中,通过上述方法配制过氧乙酸消毒液进行滴定实验,在滴定终点,滴定消耗的过氧乙酸消毒液的体积为约0.4-2.5mL。在一个优选的实施方案中,通过上述方法配制过氧乙酸消毒液进行滴定实验,在滴定终点,滴定消耗的过氧乙酸消毒液的体积为约0.4-2.0mL。In one embodiment, the peracetic acid disinfectant solution is prepared by the above method for a titration experiment. At the end point of the titration, the volume of the peracetic acid disinfectant solution consumed by the titration is about 0.4-2.5 mL. In a preferred embodiment, the peracetic acid disinfectant solution is prepared by the above method for a titration experiment. At the end point of the titration, the volume of the peracetic acid disinfectant solution consumed by the titration is about 0.4-2.0 mL.
在一个实施方案中,通过上述方法配制戊二醛消毒液进行滴定实验,在滴定终点,滴定消耗的戊二醛消毒液的体积为约3-5mL。在一个优选的实施方案中,通过上述方法配制戊二醛消毒液进行滴定实验,在滴定终点,滴定消耗的过氧乙酸消毒液的体积为约3.5-4.5mL。In one embodiment, the glutaraldehyde disinfectant solution is prepared by the above method to perform a titration experiment. At the end point of the titration, the volume of the glutaraldehyde disinfectant solution consumed by the titration is about 3-5 mL. In a preferred embodiment, the glutaraldehyde disinfectant solution is prepared through the above method for a titration experiment. At the end point of the titration, the volume of peracetic acid disinfectant solution consumed by the titration is about 3.5-4.5 mL.
本发明的组合物的稳定性Stability of the composition of the invention
本发明的组合物的稳定性通过如下方法进行检测。The stability of the composition of the present invention is tested by the following method.
(1)配制消毒剂水溶液;(1) Prepare disinfectant aqueous solution;
(2)配制本发明的组合物的水溶液;(2) Prepare an aqueous solution of the composition of the present invention;
(3)使用步骤(1)的消毒剂水溶液滴定步骤(2)的组合物水溶液,记录滴定终点时消耗的消毒剂水溶液的体积C 0(3) Use the disinfectant aqueous solution of step (1) to titrate the composition aqueous solution of step (2), and record the volume C 0 of the disinfectant aqueous solution consumed at the end point of the titration;
(4)将步骤(1)的组合物水溶液恒温存放在密闭空间一段时间;(4) Store the aqueous composition solution of step (1) in a closed space at a constant temperature for a period of time;
(5)使用步骤(1)的消毒剂水溶液滴定步骤(4)的组合物水溶液,记录滴定终点时消耗的消毒剂水溶液的体积C;(5) Use the disinfectant aqueous solution of step (1) to titrate the composition aqueous solution of step (4), and record the volume C of the disinfectant aqueous solution consumed at the end point of the titration;
(6)以一级反应动力学估算活性物质的化学动力学参数,并进一步得到化合物的半衰期。(6) Use first-order reaction kinetics to estimate the chemical kinetic parameters of the active substance and further obtain the half-life of the compound.
lg C=-(kt/2.303)+lgC 0 lg C=-(kt/2.303)+lgC 0
t 1/2=0.693/k t 1/2 =0.693/k
其中,k表示速率常数(d -1),C 0表示初始浓度,C表示t时的浓度,t-时间为天(d),t 1/2表示半衰期。 Among them, k represents the rate constant (d -1 ), C 0 represents the initial concentration, C represents the concentration at t, t-time is days (d), and t 1/2 represents the half-life.
在一个具体的实施方案中,通过如下方法检测本发明的组合物的稳定性:In a specific embodiment, the stability of the composition of the invention is tested by the following method:
(1)配制浓度为1000ppm(1000mg/L)的消毒液;(1) Prepare disinfectant solution with a concentration of 1000ppm (1000mg/L);
(2)配制本发明的组合物水溶液,其中组合物水溶液中的活性成分(含烯醇结构的化合物和/或含巯基结构的化合物和/或氨基酸)的含量为约2-3重量%;(2) Prepare an aqueous composition solution of the present invention, wherein the content of the active ingredient (enol structure-containing compound and/or thiol structure-containing compound and/or amino acid) in the composition aqueous solution is about 2-3% by weight;
(3)使用步骤(1)获得的消毒液对1mL步骤(2)的组合物水溶液进行滴定,记录滴定终点时消耗的消毒液的体积C 0(3) Use the disinfectant solution obtained in step (1) to titrate 1 mL of the aqueous composition solution of step (2), and record the volume C 0 of the disinfectant solution consumed at the end point of the titration;
(4)将步骤(2)的组合物水溶液存放在室温空间(例如窗户朝北的室内房间,无直射阳光,但是有自然光以及荧光灯室内照明)约60-365天。(4) Store the aqueous composition solution of step (2) in a room temperature space (such as an indoor room with a north-facing window, no direct sunlight, but with natural light and fluorescent indoor lighting) for about 60-365 days.
(5)使用步骤(1)获得的消毒液对1mL步骤(4)的组合物水溶液进行滴定,记录滴定终点时消耗的消毒液的体积C;(5) Use the disinfectant solution obtained in step (1) to titrate 1 mL of the aqueous composition solution of step (4), and record the volume C of the disinfectant solution consumed at the end point of the titration;
(6)以一级反应动力学估算活性物质的化学动力学参数,并进一步得到化合物的半衰期。(6) Use first-order reaction kinetics to estimate the chemical kinetic parameters of the active substance and further obtain the half-life of the compound.
在一个实施方案中,通过上述方法配制三氯异氰尿酸水溶液进行滴定实验,经过计算获得本发明的组合物的半衰期为约360-3600天。在一个优选的实施方案中,通过上述方法配制三氯异氰尿酸水溶液进行滴定实验,经过计算获得本发明的组合物的半衰期为约361-3300天。例如365天、443天、443天、682天、1000天、2000天、3000天、3253天。In one embodiment, an aqueous solution of trichloroisocyanuric acid is prepared by the above method and subjected to a titration experiment. After calculation, the half-life of the composition of the present invention is approximately 360-3600 days. In a preferred embodiment, an aqueous solution of trichloroisocyanuric acid is prepared by the above method and subjected to a titration experiment. After calculation, the half-life of the composition of the present invention is approximately 361-3300 days. For example, 365 days, 443 days, 443 days, 682 days, 1000 days, 2000 days, 3000 days, 3253 days.
本发明的组合物的消毒效果及其与酒精类消毒剂的相容性Disinfection effect of the composition of the present invention and its compatibility with alcohol-based disinfectants
本发明的组合物用于够吸附并中和刺激性气体。目前WHO推荐含有乙醇或异丙醇为主要成分的消毒剂(即,酒精类限度及)用于皮肤消毒。为确认本发明的组合物不会对酒精类消毒剂的性能产生影响(即,确认使用本发明的组合物的口罩不会影响酒精类消毒剂对皮肤的消毒作用),同时为确定本发明的组合物的消毒效果,本发明设计相关试验测试组合物与酒精类消毒剂的相容性。The compositions of the present invention are used to adsorb and neutralize irritating gases. Currently, WHO recommends disinfectants containing ethanol or isopropyl alcohol as the main ingredient (i.e., alcohol-based disinfectants) for skin disinfection. In order to confirm that the composition of the present invention will not affect the performance of alcohol-based disinfectants (that is, to confirm that masks using the composition of the present invention will not affect the disinfection effect of alcohol-based disinfectants on the skin), at the same time, in order to determine the Regarding the disinfection effect of the composition, the present invention designs relevant tests to test the compatibility of the composition with alcohol-based disinfectants.
本发明的组合物的消毒效果及其与酒精类消毒剂的相容性通过如下方法进行测试。The disinfection effect of the composition of the present invention and its compatibility with alcohol-based disinfectants were tested by the following method.
(1)取50mL的锥形瓶或15mL的试管;(1) Take a 50mL Erlenmeyer flask or a 15mL test tube;
(2)向步骤(1)的容器中依次添加水和/或消毒酒精和/或丙二醇和/或组合物1(水-甘油溶剂,不含蛋白质凝固剂以及植物提取物)和/或组合物2(水-丙二醇溶剂,含有蛋白质凝固剂以及植物提取物);(2) Add water and/or sterilizing alcohol and/or propylene glycol and/or composition 1 (water-glycerin solvent, without protein coagulant and plant extract) and/or composition to the container in step (1). 2 (water-propylene glycol solvent, containing protein coagulant and plant extracts);
(3)向步骤(3)的混合液中加入鸡蛋清;(3) Add egg white to the mixture in step (3);
(4)振摇步骤(3)的容器5分钟,随后观察蛋白质变性沉淀效果。(4) Shake the container in step (3) for 5 minutes, and then observe the protein denaturation and precipitation effect.
在一个实施方案中,组合物1以及组合物2的pH为约5.5-6.2。In one embodiment, the pH of Composition 1 as well as Composition 2 is about 5.5-6.2.
在一个实施方案中,在步骤(2)中加入组合物2或组合物2与消毒酒精的组合,可以观察到蛋白质变性沉淀的效果。In one embodiment, when composition 2 or the combination of composition 2 and disinfecting alcohol is added in step (2), the effect of protein denaturation and precipitation can be observed.
本发明的口罩对氧化性消毒液中刺激性气体的吸附中和能力及其稳定性The ability and stability of the mask of the present invention to adsorb and neutralize irritating gases in oxidizing disinfectant solution
本发明的口罩对氧化性消毒液中刺激性气体的中和能力The ability of the mask of the present invention to neutralize irritating gases in oxidizing disinfectant solution
本发明的口罩对氧化性消毒液中刺激性气体的中和能力通过如下两种方法进行检测,即定性测试和定量测试。The ability of the mask of the present invention to neutralize irritating gases in the oxidative disinfectant solution is tested through the following two methods, namely qualitative testing and quantitative testing.
定性测试Qualitative testing
方法BMethod B
(1)提供本发明的口罩;(1) Provide the mask of the present invention;
(2)配制消毒剂水溶液;(2) Prepare disinfectant aqueous solution;
(3)将步骤(2)的消毒剂水溶液置于密闭容器中,震荡容器,以使易挥发的刺激性气体充满所述容器;(3) Place the disinfectant aqueous solution of step (2) in a closed container, and shake the container to fill the container with volatile irritating gas;
(4)打开步骤(3)的密闭容器,测试人员闻容器中的气体;(4) Open the sealed container in step (3), and the tester smells the gas in the container;
(5)打开步骤(3)的密闭容器,测试人员佩戴本发明的口罩前后闻容器中的气体。(5) Open the sealed container in step (3), and the tester smells the gas in the container before and after wearing the mask of the present invention.
方法CMethod C
(1)提供本发明的口罩;(1) Provide the mask of the present invention;
(2)在口罩中心区域的内、外表面粘贴检测试纸;(2) Paste test strips on the inner and outer surfaces of the central area of the mask;
(3)配制消毒剂水溶液;(3) Prepare disinfectant aqueous solution;
(4)加热消毒剂水溶液,并在消毒剂水溶液上方覆盖口罩;(4) Heat the disinfectant solution and cover the mask on top of the disinfectant solution;
(5)观察消毒剂中的挥发性气体是否穿透口罩。(5) Observe whether the volatile gases in the disinfectant penetrate the mask.
在一个实施方案中,方法B的步骤(2)和方法C的步骤(3)配置的消毒剂水溶液选自含氯消毒剂水溶液、过氧化氢洗液、过氧乙酸消毒液、二氧化氯消毒液和戊二醛消毒液。在一个进一步的实施方案中,所述含氯消毒剂水溶液选自三氯异腈尿酸消毒液和次氯酸钠消毒液。In one embodiment, the disinfectant aqueous solution configured in step (2) of method B and step (3) of method C is selected from the group consisting of chlorine-containing disinfectant aqueous solution, hydrogen peroxide wash solution, peracetic acid disinfectant solution, and chlorine dioxide disinfection and glutaraldehyde disinfectant. In a further embodiment, the chlorine-containing disinfectant aqueous solution is selected from the group consisting of trichloroisonitrile uric acid disinfectant solution and sodium hypochlorite disinfectant solution.
在一个实施方案中,方法B的步骤(2)和方法C的步骤(3)配置的消毒剂水溶液的浓度选自1000ppm、30000ppm、5000ppm、100ppm和20000ppm。In one embodiment, the concentration of the disinfectant aqueous solution configured in step (2) of method B and step (3) of method C is selected from the group consisting of 1000ppm, 30000ppm, 5000ppm, 100ppm and 20000ppm.
在一个具体的实施方案中,方法B的步骤(2)和方法C的步骤(3)配置的消毒剂水溶液包括1000ppm的含氯消毒液、30000ppm过氧化氢洗液、5000ppm过氧乙酸消毒液、100ppm二氧化氯消毒液和20000ppm戊二醛消毒液。In a specific embodiment, the disinfectant aqueous solution configured in step (2) of method B and step (3) of method C includes 1000 ppm chlorine-containing disinfectant solution, 30000 ppm hydrogen peroxide wash solution, 5000 ppm peracetic acid disinfectant solution, 100ppm chlorine dioxide disinfectant and 20000ppm glutaraldehyde disinfectant.
在一个实施方案中,方法B使用的密闭容器为100ml碘量瓶。In one embodiment, the closed container used in Method B is a 100 ml iodine flask.
在一个实施方案中,方法B的步骤(3),使用的消毒液的量为约5-10mL。例如约5mL、约6mL、约7mL、约8mL、约9mL、约10mL。In one embodiment, in step (3) of method B, the amount of disinfectant used is about 5-10 mL. For example, about 5 mL, about 6 mL, about 7 mL, about 8 mL, about 9 mL, and about 10 mL.
在一个实施方案中,方法C使用的检测试纸选自测氯试纸、二氧化氯试纸和戊二醛检测试纸。在一个具体的实施方案中,对于含氯消毒液、过氧化氢消毒液,方法B使用的检测试纸为测氯试纸;对于二氧化氯消毒液,方法C使用的检测试纸为二氧化氯试纸;对于戊二醛消毒液,方法C使用的检测试纸为戊二醛检测试纸。In one embodiment, the test paper used in Method C is selected from the group consisting of chlorine test paper, chlorine dioxide test paper and glutaraldehyde test paper. In a specific embodiment, for chlorine-containing disinfectant and hydrogen peroxide disinfectant, the test paper used in method B is chlorine test paper; for chlorine dioxide disinfectant, the test paper used in method C is chlorine dioxide test paper; For glutaraldehyde disinfectant, the test paper used in method C is glutaraldehyde test paper.
在一个实施方案中,在方法C的步骤(2)中,所述两片检测试纸的间隔为3-5mm,以便于气流通过。In one embodiment, in step (2) of method C, the distance between the two pieces of detection test paper is 3-5 mm to facilitate the passage of airflow.
在一个实施方案中,根据方法B的检测方法,在佩戴本发明的口罩前,测试人员可以闻到密闭容器内具有强烈的刺激性气味;在佩戴本发明的口罩后,测试人员在约2-5分钟内不能闻到密闭容器内的刺激性气味。In one embodiment, according to the detection method of method B, before wearing the mask of the present invention, the tester can smell a strong irritating smell in the closed container; after wearing the mask of the present invention, the tester can smell the smell in about 2- No pungent odor can be smelled in the closed container within 5 minutes.
在一个优选的实施方案中,使用二氧化氯消毒液和戊二醛消毒液进行定性测试时,仅通过方法C的方式进行检测。In a preferred embodiment, when using chlorine dioxide disinfectant and glutaraldehyde disinfectant for qualitative testing, the detection is only carried out by method C.
在一个实施方案中,根据方法C的检测方法,观察到在本发明的口罩外侧,试纸变色,但在本发明的口罩内侧,试纸未变色。In one embodiment, according to the detection method of Method C, it is observed that the test paper changes color on the outside of the mask of the present invention, but does not change color on the inside of the mask of the present invention.
定量测试Quantitative testing
通过如下方法D定量测试本发明的口罩对氧化性消毒液中刺激性气体的中和能力:The ability of the mask of the present invention to neutralize irritating gases in the oxidative disinfectant solution is quantitatively tested by the following method D:
方法DMethod D
(1)提供本发明的口罩;(1) Provide the mask of the present invention;
(2)将步骤(1)的口罩溶于水中,以获得口罩提取液;(2) Dissolve the mask in step (1) in water to obtain a mask extract;
(3)配制消毒剂水溶液;(3) Prepare disinfectant aqueous solution;
(4)使用步骤(3)的消毒剂水溶液滴定步骤(2)的口罩提取液,并记录滴定终点时消耗的消毒剂水溶液。(4) Use the disinfectant aqueous solution from step (3) to titrate the mask extract from step (2), and record the disinfectant aqueous solution consumed at the end point of the titration.
在一个具体的实施方案中,通过如下方法D1定量测试本发明的口罩对氧化性消毒液中刺激性气体的中和能力:In a specific embodiment, the ability of the mask of the present invention to neutralize irritating gases in the oxidative disinfectant solution is quantitatively tested by the following method D1:
(1)据本发明的方法制备本发明的口罩;(1) Prepare the mask of the present invention according to the method of the present invention;
(2)将步骤(1)的口罩溶于100mL水中,以获得口罩提取液;(2) Dissolve the mask in step (1) in 100 mL of water to obtain the mask extract;
(3)根据上述方法A分别配制不同浓度的消毒剂水溶液;(3) Prepare disinfectant aqueous solutions of different concentrations according to the above method A;
(4)取10mL步骤(2)的口罩提取液,使用步骤(3)的消毒剂水溶液滴定上述口罩提取液,并记录滴定终点时消耗的消毒剂水溶液;(4) Take 10 mL of the mask extract from step (2), titrate the mask extract with the disinfectant aqueous solution from step (3), and record the disinfectant aqueous solution consumed at the end point of the titration;
(5)将步骤(4)的滴定结果放大10倍,以获得口罩对氧化性消毒液中刺激性气体的中和能力。(5) Amplify the titration result of step (4) 10 times to obtain the mask's ability to neutralize irritating gases in the oxidizing disinfectant solution.
在一个实施方案中,滴定指示剂的选择如方法A所述。In one embodiment, the titration indicator is selected as described in Method A.
在一个实施方案中,本发明的口罩内可以含有液体的量为约3-4mL。例如约3mL、约3.2mL、约3.4mL、约3.6mL、约3.8mL、约4mL。In one embodiment, the mask of the present invention may contain liquid in an amount of about 3-4 mL. For example, about 3 mL, about 3.2 mL, about 3.4 mL, about 3.6 mL, about 3.8 mL, about 4 mL.
在一个实施方案中,通过上述方法滴定本发明的口罩提取液,在滴定终点,消耗的三氯异氰尿酸水溶液的体积为约90-100mL。In one embodiment, the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of the trichloroisocyanuric acid aqueous solution consumed is about 90-100 mL.
在一个实施方案中,通过上述方法滴定本发明的口罩提取液,在滴定终点,消耗的过氧化氢洗液的体积为约1-2mL。In one embodiment, the mask extract of the present invention is titrated by the above method, and at the end point of the titration, the volume of hydrogen peroxide wash solution consumed is about 1-2 mL.
在一个实施方案中,通过上述方法滴定本发明的口罩提取液,在滴定终点,消耗的过氧乙酸消毒液的体积为约8-10mL。In one embodiment, the mask extract of the present invention is titrated by the above method, and at the end point of the titration, the volume of peracetic acid disinfectant consumed is about 8-10 mL.
在一个实施方案中,通过上述方法滴定本发明的口罩提取液,在滴定终点,消耗的二氧化氯消毒剂水溶液的体积为约350-450mL。In one embodiment, the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of the consumed chlorine dioxide disinfectant aqueous solution is about 350-450 mL.
在一个实施方案中,通过上述方法滴定本发明的口罩提取液,在滴定终点,消耗的戊二醛消毒液的体积为约10-15mL。In one embodiment, the mask extract of the present invention is titrated by the above method, and at the end point of the titration, the volume of glutaraldehyde disinfectant solution consumed is about 10-15 mL.
本发明的口罩的稳定性Stability of the mask of the present invention
本发明的口罩的稳定性通过如下三种方法进行检测,包括定性测试、定量测试和微生物含量测定。The stability of the mask of the present invention is tested through the following three methods, including qualitative testing, quantitative testing and microbial content determination.
定性测试Qualitative testing
通过如下方法E和F定性测试本发明的口罩的稳定性。The stability of the mask of the present invention was qualitatively tested by the following methods E and F.
方法EMethod E
(1)提供本发明的口罩;(1) Provide the mask of the present invention;
(2)将步骤(1)的口罩置于相对湿度70-95%、温度25-35℃的环境下14天;(2) Place the mask in step (1) in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for 14 days;
(3)测试人员佩戴步骤(3)获得的口罩30分钟;(3) The tester wears the mask obtained in step (3) for 30 minutes;
(4)根据方法B测试本发明的口罩的稳定性。(4) Test the stability of the mask of the present invention according to method B.
方法FMethod F
(1)提供本发明的口罩;(1) Provide the mask of the present invention;
(2)将步骤(1)的口罩置于相对湿度70-95%、温度25-35℃的环境下14天;(2) Place the mask in step (1) in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for 14 days;
(3)测试人员佩戴步骤(3)获得的口罩30分钟;(3) The tester wears the mask obtained in step (3) for 30 minutes;
(4)根据方法C测试本发明的口罩的稳定性。(4) Test the stability of the mask of the present invention according to method C.
在一个实施方案中,方法E和方法F中使用的消毒液、消毒液的浓度和消毒液的用量如如上所述。In one embodiment, the disinfectant solution, the concentration of the disinfectant solution, and the amount of the disinfectant solution used in Methods E and F are as described above.
在一个实施方案中,根据方法E的检测方法,在佩戴本发明的口罩前,测试人员可以闻到密闭容器内具有强烈的刺激性气味;在佩戴本发明的口罩后,测试人员可以闻到微弱的消毒剂气味,并且上述气味不具有刺激性。In one embodiment, according to the detection method of method E, before wearing the mask of the present invention, the tester can smell a strong pungent odor in the closed container; after wearing the mask of the present invention, the tester can smell a weak smell The smell of disinfectant is non-irritating.
在一个实施方案中,根据方法F的检测方法,观察到在本发明的口罩外侧,试纸变色,但在本发明的口罩内侧,试纸未变色。In one embodiment, according to the detection method of Method F, it is observed that the test paper changes color on the outside of the mask of the present invention, but does not change color on the inside of the mask of the present invention.
定量测试Quantitative testing
通过如下方法G测试本发明的口罩的稳定性。The stability of the mask of the present invention is tested by the following method G.
方法GMethod G
(1)提供本发明的口罩;(1) Provide the mask of the present invention;
(2)将步骤(1)的口罩置于相对湿度70-95%、温度25-35℃的环境下14天;(2) Place the mask in step (1) in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for 14 days;
(3)根据方法D测试本发明的口罩的稳定性。(3) Test the stability of the mask of the present invention according to method D.
在一个实施方案中,滴定指示剂的选择如方法A所述。In one embodiment, the titration indicator is selected as described in Method A.
在一个实施方案中,通过上述方法滴定本发明的口罩提取液,在滴定终点,消耗的三氯异氰尿酸水溶液的体积为约30-40mL。In one embodiment, the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of the trichloroisocyanuric acid aqueous solution consumed is about 30-40 mL.
在一个实施方案中,通过上述方法滴定本发明的口罩提取液,在滴定终点,消耗的过氧化氢洗液的体积为约0.3-0.4mL。In one embodiment, the mask extract of the present invention is titrated by the above method, and at the end point of the titration, the volume of hydrogen peroxide wash solution consumed is about 0.3-0.4 mL.
在一个实施方案中,通过上述方法滴定本发明的口罩提取液,在滴定终点,消耗的过氧乙酸消毒液的体积为约3-4mL。In one embodiment, the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of peracetic acid disinfectant consumed is about 3-4 mL.
在一个实施方案中,通过上述方法滴定本发明的口罩提取液,在滴定终点,消耗的二氧化氯消毒剂水溶液的体积为约170-180mL。In one embodiment, the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of the consumed chlorine dioxide disinfectant aqueous solution is about 170-180 mL.
在一个实施方案中,通过上述方法滴定本发明的口罩提取液,在滴定终点,消耗的戊二醛消毒液的体积为约10-12mL。In one embodiment, the mask extract of the present invention is titrated by the above method. At the end point of the titration, the volume of glutaraldehyde disinfectant solution consumed is about 10-12 mL.
微生物含量测定Microbial content determination
参照《YY/T0969-2013一次性使用医用口罩》的检测方法测试本发明的口罩的稳定性。The stability of the mask of the present invention was tested with reference to the detection method of "YY/T0969-2013 Disposable Medical Masks".
在一个具体的实施方案中,通过以下方法H测试本发明的口罩的稳定性。In a specific embodiment, the stability of the mask of the present invention is tested by the following method H.
方法HMethod H
(1)提供本发明的口罩;(1) Provide the mask of the present invention;
(2)获得步骤(1)的口罩提取液;(2) Obtain the mask extraction solution of step (1);
(3)检测口罩培养液中的菌群数量;(3) Detect the number of bacterial colonies in the mask culture solution;
(4)将口罩培养液置于相对湿度70-95%、温度25-35℃的环境下14天;(4) Place the mask culture solution in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for 14 days;
(5)检测口罩培养液中的菌群数量。(5) Detect the number of bacteria in the mask culture fluid.
在一个实施方案中,检测的菌群种类包括细菌和真菌等,示例性的细菌例如可以为大肠菌群、绿脓杆菌、金黄色葡萄球菌、溶血性链球菌等。In one embodiment, the detected flora species include bacteria, fungi, and the like. Exemplary bacteria can be, for example, coliforms, Pseudomonas aeruginosa, Staphylococcus aureus, hemolytic Streptococcus, etc.
在一个实施方案中,通过上述方法检测本发明的口罩提取液,14天后,大肠菌的菌群数量为0。In one embodiment, the mask extract of the present invention is detected by the above method. After 14 days, the number of coliform bacteria is 0.
在另一个实施方案中,通过上述方法检测本发明的口罩提取液,14天后,绿脓杆菌的菌群数量为0。In another embodiment, the mask extract of the present invention is detected by the above method. After 14 days, the number of Pseudomonas aeruginosa bacterial colonies is 0.
在又一个实施方案中,通过上述方法检测本发明的口罩提取液,14天后,黄色葡萄球菌的菌群数量为0。In another embodiment, the mask extract of the present invention is detected by the above method. After 14 days, the number of Staphylococcus aureus colonies is 0.
在还一个实施方案中,通过上述方法检测本发明的口罩提取液,14天后,溶血性链球菌的菌群数量为0。In another embodiment, the mask extract of the present invention is detected by the above method. After 14 days, the number of hemolytic streptococci is 0.
在另一个实施方案中,通过上述方法检测本发明的口罩提取液,14天后,真菌的菌群数量为0。In another embodiment, the mask extract of the present invention is detected by the above method. After 14 days, the number of fungal colonies is 0.
在一个实施方案中,通过上述方法检测本发明的口罩提取液,14天后,细菌的菌落总数为250CFU/g,其中所述细菌为非致病性的尿类芽孢杆菌。In one embodiment, the mask extract of the present invention is tested by the above method. After 14 days, the total number of bacterial colonies is 250 CFU/g, wherein the bacteria are non-pathogenic Paenibacillus urinae.
本发明的口罩的显色能力Color rendering ability of the mask of the present invention
本发明的口罩的显色能力通过如下方法I进行检测。The color development ability of the mask of the present invention is tested by the following method I.
方法IMethod I
(1)提供本发明的口罩;(1) Provide the mask of the present invention;
(2)配制消毒剂水溶液;(2) Prepare disinfectant aqueous solution;
(3)加热消毒剂水溶液,并在消毒剂水溶液上方覆盖口罩;(3) Heat the disinfectant solution and cover the mask on top of the disinfectant solution;
(4)观察口罩的颜色变化。(4) Observe the color change of the mask.
在一个实施方案中,通过上述方法I模拟本发明的口罩经多次重复使用后的情景。In one embodiment, the above-mentioned method I is used to simulate the scenario of the mask of the present invention after repeated use.
在一个实施方案中,方法I加热口罩的方法为熏蒸,熏蒸温度为约40-94℃。In one embodiment, the method of heating the mask in Method 1 is fumigation, and the fumigation temperature is about 40-94°C.
在一个实施方案中,方法I加热口罩的方法为熏蒸,熏蒸时间为约2-6小时。在一个优选的实施方案中,加热熏蒸后,继续置于余热环境下约16-18小时。In one embodiment, the method of heating the mask in Method 1 is fumigation, and the fumigation time is about 2-6 hours. In a preferred embodiment, after heating and fumigation, it is continued to be placed in a residual heat environment for about 16-18 hours.
在一个具体的实施方案中,消毒液的类型及浓度如上述方法B和C所述。In a specific embodiment, the type and concentration of the disinfectant solution are as described in methods B and C above.
在一个实施方案中,根据方法I的检测方法,经过高浓度的含氯消毒液(例如次氯酸消毒液、二氧化氯消毒液)的气体环境后,本发明的口罩会变为红色。In one embodiment, according to the detection method of Method I, the mask of the present invention will turn red after passing through the gas environment of high-concentration chlorine-containing disinfectant (such as hypochlorous acid disinfectant, chlorine dioxide disinfectant).
在一个实施方案中,根据方法I的检测方法,经过高浓度的过氧化物消毒剂的气体环境后,本发明的口罩会变为深黄色。In one embodiment, according to the detection method of Method I, the mask of the present invention will turn into deep yellow after passing through the gas environment of high-concentration peroxide disinfectant.
在一个实施方案中,根据方法I的检测方法,经过高浓度的戊二醛消毒液的气体环境后,本发明的口罩会变为深褐色。In one embodiment, according to the detection method of Method I, after passing through the gas environment of high-concentration glutaraldehyde disinfectant solution, the mask of the present invention will turn into dark brown.
在另一个实施方案中,在方法I步骤(3)的加热前,还包括以下步骤:In another embodiment, before heating in step (3) of method 1, the following steps are also included:
(2.5)在口罩内表面粘贴检测试纸。(2.5) Paste the test paper on the inner surface of the mask.
在一个优选的实施方案中,检测试纸的选择如上述方法C所述。In a preferred embodiment, the detection test paper is selected as described in method C above.
在一个优选的实施方案中,根据方法I的检测方法,经过高浓度的三氯异氰尿酸消毒液的气体环境后,本发明口罩内侧的试纸未变色。In a preferred embodiment, according to the detection method of Method I, after passing through the gas environment of high-concentration trichloroisocyanuric acid disinfectant solution, the test paper on the inside of the mask of the present invention does not change color.
在另一个优选的实施方案中,根据方法I的检测方法,经过高浓度的过氧化氢洗液的气体环境后,本发明的口罩内侧的试纸稍有变色。In another preferred embodiment, according to the detection method of Method I, after passing through the gas environment of high-concentration hydrogen peroxide washing solution, the test paper on the inside of the mask of the present invention slightly changes color.
在又一个优选的实施方案中,根据方法I的检测方法,经过高浓度的过氧乙酸消毒液的气体环境后,本发明的口罩内侧的试纸部分变色。In yet another preferred embodiment, according to the detection method of Method I, after passing through the gas environment of high-concentration peracetic acid disinfectant solution, the test paper on the inner side of the mask of the present invention partially changes color.
在还一个实施方案中,根据方法I的检测方法,经过高浓度的二氧化氯消毒液的气体环境后,本发明的口罩内侧的试纸未变色。In yet another embodiment, according to the detection method of Method I, after passing through the gas environment of high-concentration chlorine dioxide disinfectant, the test paper on the inside of the mask of the present invention does not change color.
在另一个优选的实施方案中,根据方法I的检测方法,经过高浓度的戊二醛消毒液的气体环境后,本发明的口罩内侧的试纸未变色。In another preferred embodiment, according to the detection method of Method I, after passing through the gas environment of high-concentration glutaraldehyde disinfectant solution, the test paper on the inside of the mask of the present invention does not change color.
本发明的口罩的散热能力The heat dissipation ability of the mask of the present invention
本发明的口罩的散热能力通过如下方法J进行检测。The heat dissipation ability of the mask of the present invention is tested by the following method J.
方法JMethod J
(1)提供本发明的口罩;(1) Provide the mask of the present invention;
(2)测试者佩戴步骤(1)的口罩45分钟;(2) The tester wears the mask in step (1) for 45 minutes;
(3)测试者佩戴口罩并进行热像图测温;(3) The tester wears a mask and takes a thermal image temperature measurement;
(4)测试者摘下口罩并进行热像图测温。(4) The tester takes off the mask and takes a thermal image temperature measurement.
在一个实施方案中,根据方法J的检测方法,相比鼻孔下方未接触皮肤的区域,本发明的口罩接触皮肤的区域温度低约2-3℃。例如约2℃、约2.2℃、约2.4℃、约2.6℃、约2.8℃、约3℃。In one embodiment, according to the detection method of Method J, the temperature of the area of the mask of the present invention that contacts the skin is about 2-3°C lower than the area below the nostrils that does not contact the skin. For example, about 2°C, about 2.2°C, about 2.4°C, about 2.6°C, about 2.8°C, and about 3°C.
有益效果beneficial effects
本发明的组合物使用生物吸附剂和引湿剂,通过引湿剂对水的吸附作用,使组合物变为润湿或溶液的状态,增大活性成分生物吸附剂与刺激性气体的接触面,有效地提高对刺激性气体吸附并中和的效率,可以有效地降低空气中的某些刺激性气体的浓度,例如氯气、二氧化氯、过氧化氢、过氧乙酸和醛类化合物等。另外,由于本发明的组合物可以变为润湿或溶液状态,使活性成分与刺激性气体的接触面增大,因此相比维生素C本身,本发明的组合物可以更有效地吸收并中和刺激性气体。The composition of the present invention uses a biosorbent and a hygroscopic agent. Through the adsorption effect of the hygroscopic agent on water, the composition becomes a moist or solution state, thereby increasing the contact area between the active ingredient biosorbent and irritating gases. , effectively improve the efficiency of adsorbing and neutralizing irritating gases, and can effectively reduce the concentration of certain irritating gases in the air, such as chlorine, chlorine dioxide, hydrogen peroxide, peracetic acid and aldehyde compounds, etc. In addition, since the composition of the present invention can be changed into a moist or solution state, which increases the contact surface between the active ingredients and irritating gases, the composition of the present invention can absorb and neutralize it more effectively than vitamin C itself. Irritating gas.
另外,本发明的组合物水溶液也能够有效地吸收并中和刺激性气体,特别是氧化性消毒剂中的刺激性气体。相比维生素C的水溶液,本发明组合物水溶液对刺激性气体的吸收能力可以获得明显的改善。In addition, the aqueous composition solution of the present invention can also effectively absorb and neutralize irritating gases, especially irritating gases in oxidative disinfectants. Compared with the aqueous solution of vitamin C, the aqueous solution of the composition of the present invention can significantly improve the absorption capacity of irritating gases.
进一步地,含有本发明的组合物的基材也可以有效地吸附并中和空气中高效消毒剂挥发产生的刺激性异味气体,适用于医院感染控制、防疫等实施消毒作业人员。尤其在有害微生物以及高效消毒剂挥发性气味并存的职业暴露环境下的提供呼吸道、皮肤、黏膜防护效果;也可作为误服、误用高效消毒剂导致消毒剂中毒者的拮抗剂使用。含有本发明的组合物的基材也可以用于生活清洁类消毒用品、空气清新设备(如降低环境中的甲醛、戊二醛浓度)等多个技术领域,可能在某些特定领域的微生物防护或空气净化中发挥作用。Furthermore, the base material containing the composition of the present invention can also effectively absorb and neutralize the irritating odor gas generated by the volatilization of high-efficiency disinfectants in the air, and is suitable for disinfection workers such as hospital infection control and epidemic prevention. Especially in occupational exposure environments where harmful microorganisms and the volatile odor of high-efficiency disinfectants coexist, it provides protective effects on the respiratory tract, skin, and mucous membranes; it can also be used as an antagonist for those who accidentally ingest or misuse high-efficiency disinfectants, leading to disinfectant poisoning. The base material containing the composition of the present invention can also be used in many technical fields such as daily cleaning disinfection products and air freshening equipment (such as reducing the concentration of formaldehyde and glutaraldehyde in the environment), and may be used for microbial protection in certain specific fields. or play a role in air purification.
更进一步地,含有本发明的组合物的多层材料可以吸附并中和多种刺激性气体,因此可以适用于不同的场合,有效地吸附并中和氯气、过氧化氢、过氧乙酸、醛类化合物等气体。Furthermore, the multilayer material containing the composition of the present invention can adsorb and neutralize a variety of irritating gases, so it can be applied to different occasions and effectively adsorb and neutralize chlorine, hydrogen peroxide, peracetic acid, and aldehydes. Compounds and other gases.
另外,含有本发明的组合物的口罩在一些特定的领域有可能减少活性炭口罩的使用量,其中组合物中的组分多为可食用或对人类身体无害的物质。而且,含有本发明的组合物的口罩有可能减少传统活性碳口罩中的活性炭粉末被人体吸入或污染工作环境的风险。这是因为活性炭在生产过程需要较高能耗,且吸附过有毒有害物质的旧活性炭被一些国家现行法规视为危险固体废物。In addition, masks containing the composition of the present invention may reduce the use of activated carbon masks in some specific fields, and the components in the composition are mostly edible or harmless substances to the human body. Moreover, masks containing the composition of the present invention may reduce the risk of activated carbon powder in traditional activated carbon masks being inhaled by the human body or polluting the working environment. This is because activated carbon requires high energy consumption in the production process, and old activated carbon that has adsorbed toxic and hazardous substances is considered hazardous solid waste by current regulations in some countries.
此外,含有本发明的组合物的基材、多层材料或口罩可通过溶剂提取其中的活性成分,得到上述材料的提取液,因此在紧急情况下,还可以从本发明的材料中快速提取包含活性成分生物吸附剂的提取液,并通过口服、皮肤、黏膜冲洗、湿敷等途径用于消毒剂误服、误用者的现场解毒。In addition, the active ingredients in the base material, multi-layer material or mask containing the composition of the present invention can be extracted by solvent to obtain an extract of the above-mentioned materials. Therefore, in an emergency, it is also possible to quickly extract the active ingredients from the material of the present invention. The extract of the active ingredient biosorbent can be used for on-site detoxification of those who accidentally ingested or misused the disinfectant through oral administration, skin and mucous membrane rinses, wet compresses, etc.
另外,由于使用了引湿剂,含有本发明的组合物的多层材料能够在多层材料的中心与边缘位置之间实现引湿剂-水浓度梯度平衡,有利于水分的挥发,并带走热量,从而降低多层材料周围的温度。具体地,例如佩戴含有本发明的组合物的口罩,佩戴者面部温度较低,不会有闷热的感觉。特别地,面部皮肤温度低于鼻孔下方的皮肤温度。In addition, due to the use of a hygroscopic agent, the multi-layer material containing the composition of the present invention can achieve a hygroscopic agent-water concentration gradient balance between the center and edge positions of the multi-layer material, which is conducive to the volatilization of moisture and taking it away. heat, thereby lowering the temperature around the multilayer material. Specifically, for example, when wearing a mask containing the composition of the present invention, the wearer's facial temperature will be lower and the wearer will not feel stuffy. In particular, the facial skin temperature is lower than the skin temperature under the nostrils.
再有,本发明的组合物具有显色指示的性能,在空气中经过高强度使用后,组合物会变色。因此本发明的组合物用于口罩、多层材料等产品时,能够及时反馈有效成分的情况,方便对组合物进行更换。Furthermore, the composition of the present invention has the property of color development and indication, and the composition will change color after high-intensity use in the air. Therefore, when the composition of the present invention is used in products such as masks and multi-layer materials, it can provide timely feedback on the status of active ingredients and facilitate replacement of the composition.
再有,本发明的组合物具有优异的稳定性。首先,本发明的组合物包含含烯醇结构的化合物、含巯基的化合物和氨基酸等生物活性成分,即使在空气中静置较长时间,组合物依然能够吸收并中和空气中的刺激性气体,例如氯气、二氧化氯、过氧化氢、过氧乙酸和醛类化合物等。另外,向本发明的组合物中添加植物提取物后,可以起到遮光的效果,大幅提高活性成分的保质期,使其经过长时间储存后,仍能够吸收并中和空气中的刺激性气体。相比维生素C本身,本发明的组合物具有更加优异的稳定性。Furthermore, the composition of the present invention has excellent stability. First of all, the composition of the present invention contains bioactive ingredients such as enol-containing compounds, sulfhydryl-containing compounds, and amino acids. Even if it is left standing in the air for a long time, the composition can still absorb and neutralize irritating gases in the air. , such as chlorine, chlorine dioxide, hydrogen peroxide, peracetic acid and aldehyde compounds, etc. In addition, adding plant extracts to the composition of the present invention can have a light-shielding effect and greatly increase the shelf life of the active ingredients, allowing them to absorb and neutralize irritating gases in the air after long-term storage. Compared with vitamin C itself, the composition of the present invention has better stability.
此外,本发明组合物不会影响消毒酒精的性能。进一步地,所述组合物还含有蛋白质凝固剂及植物提取物成分,相应的组合物可能具有抑制细病毒、细菌、真菌等微生物表面蛋白的活性的效果,与消毒酒精配合使用时可能增强并延长酒精的消毒效果,同时减轻消毒酒精对皮肤的刺激性。Furthermore, the compositions of the present invention do not affect the performance of disinfecting alcohols. Furthermore, the composition also contains protein coagulant and plant extract components. The corresponding composition may have the effect of inhibiting the activity of surface proteins of microorganisms such as viruses, bacteria, fungi, etc., and may enhance and prolong the activity of surface proteins of microorganisms such as viruses, bacteria, and fungi when used in conjunction with disinfectant alcohol. The disinfection effect of alcohol also reduces the irritation of disinfectant alcohol to the skin.
实施例Example
下面结合具体实施例对本发明的方案做进一步详细的描述。The solution of the present invention will be described in further detail below with reference to specific embodiments.
需要说明的是,以下实施例仅仅是为清楚地说明本发明的技术方案所作的举例,而并非对本发明的限定。对于所属领域的普通技术人员来说,在上述说明的基础上还可以做出其它不同形式的变化或变动,这里无需也无法对所有的实施方式予以穷举,而由此所引伸出的显而易见的变化或变动仍处于本发明创造的保护范围之中。除非另外指明,本文所用的仪器设备和试剂材料都是可以商购的。It should be noted that the following examples are only examples to clearly illustrate the technical solutions of the present invention, and are not intended to limit the present invention. For those of ordinary skill in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to exhaustively enumerate all the implementation methods, and the obvious obvious consequences derived from this Changes or modifications are still within the protection scope of the invention. Unless otherwise specified, the instrumentation and reagent materials used in this article are commercially available.
仪器instrument
玻璃仪器:容量瓶、刻度移液管、碘量瓶、烧杯、锥形瓶(三角烧瓶)、量杯、蒸发皿(陶瓷,圆底,100ml)、真空干燥皿、玻璃棒(直径约2mm),四川蜀玻(集团)有限责任公司。Glass instruments: volumetric flask, graduated pipette, iodine flask, beaker, Erlenmeyer flask (Erlenmeyer flask), measuring cup, evaporating dish (ceramic, round bottom, 100ml), vacuum drying dish, glass rod (diameter about 2mm), Sichuan Shubo (Group) Co., Ltd.
分析天平:METTLER TOLEDO ME 204电子天平。MAX 220g:d=0.1mg。Analytical balance: METTLER TOLEDO ME 204 electronic balance. MAX 220g:d=0.1mg.
酸度计:Mettler Toledo FiveEasy Plus FE28-S pH分辨率0.01Acidometer: Mettler Toledo FiveEasy Plus FE28-S pH resolution 0.01
电热恒温水浴锅:1000W,±0.5℃,上海跃进医疗器械有限公司。Electric constant temperature water bath: 1000W, ±0.5℃, Shanghai Yuejin Medical Equipment Co., Ltd.
材料Material
氧化性消毒剂:Oxidizing disinfectants:
三氯异氰尿酸消毒片:杭州朗索医用消毒剂有限公司。有效氯含量500±50mg/片。Trichloroisocyanuric acid disinfectant tablets: Hangzhou Langso Medical Disinfectant Co., Ltd. Available chlorine content is 500±50mg/tablet.
次氯酸钠消毒液:杭州朗索医用消毒剂有限公司。浓度4.5-5.5重量%。Sodium hypochlorite disinfectant: Hangzhou Langso Medical Disinfectant Co., Ltd. Concentration 4.5-5.5% by weight.
二氧化氯消毒片:北京华龙星宇科技发展公司。二氧化氯含量100±10mg/片。Chlorine dioxide disinfectant tablets: Beijing Hualong Xingyu Technology Development Co., Ltd. Chlorine dioxide content is 100±10mg/tablet.
过氧化氢洗液:山东瑞泰奇洗涤消毒科技有限公司。浓度2.5-3.5重量%。Hydrogen peroxide lotion: Shandong Ruitaiqi Washing and Disinfection Technology Co., Ltd. Concentration 2.5-3.5% by weight.
过氧乙酸消毒液(二元包装):山东安捷高科消毒科技有限公司。浓度15-18重量%。Peracetic acid disinfectant (binary packaging): Shandong Anjie Hi-Tech Disinfection Technology Co., Ltd. Concentration 15-18% by weight.
戊二醛消毒液:上海利康消毒高科技有限公司。浓度2.1-2.6重量%。Glutaraldehyde disinfectant: Shanghai Likang Disinfection High-Tech Co., Ltd. Concentration 2.1-2.6% by weight.
测氯试纸:杭州朗索医用消毒剂有限公司。浓度为0-2000ppm。Chlorine test paper: Hangzhou Langso Medical Disinfectant Co., Ltd. The concentration is 0-2000ppm.
过氧化氢试纸:杭州陆恒生物科技有限公司。浓度为0-25ppm。Hydrogen peroxide test paper: Hangzhou Luheng Biotechnology Co., Ltd. The concentration is 0-25ppm.
过氧乙酸试纸:杭州陆恒生物科技有限公司。浓度为0-40ppm。Peracetic acid test paper: Hangzhou Luheng Biotechnology Co., Ltd. The concentration is 0-40ppm.
戊二醛试纸:杭州陆恒生物科技有限公司。浓度为0-3重量%。Glutaraldehyde test paper: Hangzhou Luheng Biotechnology Co., Ltd. The concentration is 0-3% by weight.
二氧化氯试纸:长沙尚清环保科技有限公司。浓度为0-20ppm。Chlorine dioxide test paper: Changsha Shangqing Environmental Protection Technology Co., Ltd. The concentration is 0-20ppm.
稀盐酸:国药集团化学试剂有限公司。分析纯,稀释到10重量%。Dilute hydrochloric acid: Sinopharm Chemical Reagent Co., Ltd. Analytically pure, diluted to 10% by weight.
甲醛溶液:国药集团化学试剂有限公司。分析纯(含甲醇阻聚剂)。含量37-40重量%。Formaldehyde solution: Sinopharm Chemical Reagent Co., Ltd. Analytically pure (contains methanol inhibitor). Content 37-40% by weight.
氢氧化钠标准滴定溶液:国家标准物质GBW(E)081029,上海化学试剂研究所有限公司,c(NaOH)=0.1030mol/L。Sodium hydroxide standard titration solution: National Standard Material GBW(E)081029, Shanghai Chemical Reagent Research Institute Co., Ltd., c(NaOH)=0.1030mol/L.
NaHCO 3(碳酸氢钠):天津市致远化学试剂有限公司。分析纯。 NaHCO 3 (sodium bicarbonate): Tianjin Zhiyuan Chemical Reagent Co., Ltd. Analytically pure.
维生素C(抗坏血酸):购自福晨(天津)化学试剂有限公司。分析纯。Vitamin C (ascorbic acid): purchased from Fuchen (Tianjin) Chemical Reagent Co., Ltd. Analytically pure.
乙酰半胱氨酸注射液(4g:20ml):含量分析用,杭州民生药业有限公司,国药准字H20051788。Acetylcysteine injection (4g: 20ml): for content analysis, Hangzhou Minsheng Pharmaceutical Co., Ltd., national drug approval number H20051788.
N-乙酰半胱氨酸:制备用,河南集美化工用品有限公司,食品添加剂。N-acetylcysteine: for preparation, Henan Jimei Chemical Products Co., Ltd., food additive.
EDTA Na 2(乙二胺四乙酸二钠):上海化学试剂有限公司。分析纯。 EDTA Na 2 (disodium ethylenediaminetetraacetate): Shanghai Chemical Reagent Co., Ltd. Analytically pure.
焦亚硫酸钠:湖南尔康制药股份有限公司。药用辅料。Sodium metabisulfite: Hunan Erkang Pharmaceutical Co., Ltd. medical supplements.
氢氧化钠:南京化学试剂有限公司。分析纯。Sodium hydroxide: Nanjing Chemical Reagent Co., Ltd. Analytically pure.
甘油:湖南尔康制药股份有限公司。药用辅料。Glycerin: Hunan Erkang Pharmaceutical Co., Ltd. medical supplements.
丙二醇(1,2丙二醇):湖南尔康制药股份有限公司。药用辅料。Propylene glycol (1,2 propylene glycol): Hunan Erkang Pharmaceutical Co., Ltd. medical supplements.
磷酸二氢钠-磷酸氢二钠缓冲液:南京化学试剂有限公司。分析纯,自配。Sodium hydrogen phosphate-disodium hydrogen phosphate buffer: Nanjing Chemical Reagent Co., Ltd. Analytically pure, self-prepared.
羟苯乙酯:湖南尔康制药股份有限公司。药用辅料。Ethylparaben: Hunan Erkang Pharmaceutical Co., Ltd. medical supplements.
活性炭层布料(夹碳无纺布):昆山绿创电子科技有限公司。Activated carbon layer fabric (carbon sandwiched non-woven fabric): Kunshan Green Chuang Electronic Technology Co., Ltd.
聚酯过滤棉:初效空气过滤棉,厚度0.3-1mm。Polyester filter cotton: primary air filter cotton, thickness 0.3-1mm.
过氧化氢酶:河南仰韶生化工程有限公司。食品配料。Catalase: Henan Yangshao Biochemical Engineering Co., Ltd. food ingredients.
甘氨酸:国药集团化学试剂有限公司。分析纯。Glycine: Sinopharm Chemical Reagent Co., Ltd. Analytically pure.
L-丙氨酸:河南嘉致化工产品有限公司。食品级添加剂。L-Alanine: Henan Jiazhi Chemical Products Co., Ltd. Food grade additives.
L-丝氨酸:河南嘉致化工产品有限公司。食品级添加剂。L-serine: Henan Jiazhi Chemical Products Co., Ltd. Food grade additives.
聚山梨酸酯-80(吐温80):太仓制药厂。药用辅料。Polysorbate-80 (Tween 80): Taicang Pharmaceutical Factory. medical supplements.
三乙醇胺:国药集团化学试剂有限公司。分析纯。Triethanolamine: Sinopharm Chemical Reagent Co., Ltd. Analytically pure.
(轻质)液状石蜡:湖南尔康制药股份有限公司。药用辅料。(Light) liquid paraffin: Hunan Erkang Pharmaceutical Co., Ltd. medical supplements.
消毒酒精:无水乙醇加水自配,或直接使用市售成品,乙醇含量70-75%(V/V)。常熟市杨园化工有限公司。分析纯。Disinfection alcohol: Prepare your own with absolute ethanol and water, or use commercially available finished products directly, with an ethanol content of 70-75% (V/V). Changshu Yangyuan Chemical Co., Ltd. Analytically pure.
鸡蛋清:市售生鸡蛋的蛋清部分,富含多种蛋白质,主要成份为卵清蛋白。Egg white: The egg white part of commercially available raw eggs is rich in a variety of proteins, with the main component being ovalbumin.
棉布口罩:
Figure PCTCN2022092725-appb-000002
重量约9.8g/个,双层纯棉针织布,主要用于装修、清洁、保暖用途的可清洗重复使用的日常用针织口罩,估测棉线规格为40S,每层布料密度约200g/m 2,过滤层面积约105.2cm 2,中性包装,售价约0.63RMB/个。
Cotton masks:
Figure PCTCN2022092725-appb-000002
The weight is about 9.8g/piece, double-layer pure cotton knitted fabric. It is a washable and reusable daily knitted mask mainly used for decoration, cleaning, and warmth. The estimated cotton thread specification is 40S, and the density of each layer of fabric is about 200g/ m2 . , filter layer area is about 105.2cm 2 , neutral packaging, selling price is about 0.63RMB/piece.
一次性无纺布口罩:稳健
Figure PCTCN2022092725-appb-000003
医用护理口罩。稳健医疗有限公司。售价约0.8RMB/个。
Disposable non-woven masks: robust
Figure PCTCN2022092725-appb-000003
Medical nursing masks. ROBUST MEDICAL LIMITED. The price is about 0.8RMB/piece.
葡萄糖酸-δ-内酯:安徽省兴宙医药食品有限公司,食品添加剂。Glucono-delta-lactone: Anhui Xingzhou Pharmaceutical Food Co., Ltd., food additive.
葡萄籽提取物(原花青素):西安荣甄生物科技有限公司,原花青素含量95%OPC(UV),[CAS No]:84929-27-1。Grape seed extract (proanthocyanidins): Xi'an Rongzhen Biotechnology Co., Ltd., proanthocyanidin content 95% OPC (UV), [CAS No]: 84929-27-1.
食用青苹果香精,菠萝香精:河南统亚生物科技有限公司。Edible green apple flavor, pineapple flavor: Henan Tongya Biotechnology Co., Ltd.
柠檬油:广州惠馨生物科技有限公司,[CAS No]:8008-56-8,主要成分为柠檬烯。Lemon oil: Guangzhou Huixin Biotechnology Co., Ltd., [CAS No]: 8008-56-8, the main component is limonene.
3M TM 8246职业防护口罩:R95活性炭防颗粒物口罩,用于酸性气体以及油性/非油性颗粒物防护,Minnesota Mining and Manufacturing。零售价约28RMB/个。 3M TM 8246 Occupational Protective Mask: R95 activated carbon anti-particle mask, used for acid gas and oily/non-oily particle protection, Minnesota Mining and Manufacturing. The retail price is about 28RMB/piece.
3M TM 8247职业防护口罩:R95活性炭防颗粒物口罩,用于有机蒸气异味及油性/非油性颗粒物防护,Minnesota Mining and Manufacturing。零售约28RMB/个。 3M TM 8247 Occupational Protective Mask: R95 activated carbon anti-particle mask, used for organic vapor odor and oily/non-oily particle protection, Minnesota Mining and Manufacturing. Retail price is about 28RMB/piece.
实施例1组合物水溶液的制备Example 1 Preparation of aqueous composition solution
组合物A水溶液Composition A aqueous solution
将27g维生素C、13g碳酸氢钠、0.027g EDTA Na 2、1.80g焦亚硫酸钠加入到1000mL纯化水中定容,搅拌上述溶液,使上述各组分均匀混合,得到浓度为2.7%(W/V)的维生素C溶液。 Add 27g vitamin C, 13g sodium bicarbonate, 0.027g EDTA Na 2 and 1.80g sodium metabisulfite to 1000mL purified water to adjust to volume, stir the above solution to evenly mix the above components, and obtain a concentration of 2.7% (W/V) of vitamin C solution.
组合物B水溶液Composition B aqueous solution
将2.4g N-乙酰半胱氨酸、0.4g氢氧化钠、0.06g EDTA Na 2加入到100mL纯化水中定容,搅拌上述溶液,使上述各组分均匀混合,得到浓度为2.4%(W/V)的N-乙酰半胱氨酸溶液。 Add 2.4g N-acetylcysteine, 0.4g sodium hydroxide, and 0.06g EDTA Na 2 to 100 mL purified water to adjust to volume, stir the above solution, and mix the above components evenly to obtain a concentration of 2.4% (W/ V) N-acetylcysteine solution.
组合物C水溶液Composition C aqueous solution
将6g甘氨酸,加入100mL纯化水中定容,搅拌上述溶液,使上述各组分均匀混合,得到浓度为6%(W/V)的甘氨酸溶液。Add 6 g of glycine to 100 mL of purified water to make it up to volume, stir the above solution, and mix the above components evenly to obtain a glycine solution with a concentration of 6% (W/V).
组合物D水溶液Composition D aqueous solution
将6g甘氨酸、4.5g L-丙氨酸和4.5g L-丝氨酸加入到100mL纯化水中定容,搅拌上述溶液,使上述各组分均匀混合,得到复合氨基酸溶液。Add 6g glycine, 4.5g L-alanine and 4.5g L-serine to 100mL purified water to adjust to volume, stir the above solution to evenly mix the above components to obtain a complex amino acid solution.
实施例2本发明口罩的制备Example 2 Preparation of the mask of the present invention
口罩AMask A
将4.5mL的组合物A水溶液、1.5mL的组合物B水溶液、128mg甘氨酸和1.6g的甘油混合,然后向溶液中加入磷酸二氢钠-磷酸氢二钠缓冲液(pH=6.0)和6mg的羟苯乙酯并均匀搅拌。将上述溶液均匀浸润口罩的基层材料后,在氮气的气氛下干燥,以获得口罩A。Mix 4.5 mL of composition A aqueous solution, 1.5 mL of composition B aqueous solution, 128 mg of glycine and 1.6 g of glycerin, and then add sodium dihydrogen phosphate-disodium hydrogen phosphate buffer (pH=6.0) and 6 mg of glycerin to the solution. Ethyl hydroxyphenyl ester and stir evenly. After the above solution is evenly infiltrated into the base material of the mask, it is dried in a nitrogen atmosphere to obtain mask A.
如图1所示,102表示为口罩的耳挂绳,101表示为口罩的基层材料,其吸附有上述组合物。As shown in Figure 1, 102 represents the ear strap of the mask, and 101 represents the base material of the mask, which has the above composition adsorbed thereon.
口罩BMask B
将12mL的组合物A水溶液、6mL的组合物B水溶液和1.75g的甘油混合,然后向溶液中加入磷酸二氢钠-磷酸氢二钠缓冲液(pH=6.0)和6mg的羟苯乙酯并均匀搅拌。将上述溶液均匀浸润口罩的基层材料后,在氮气的气氛下干燥,以获得口罩B的基层材料101。然后通过热熔的方法将活性炭层201固定在基层材料101的外侧,以获得口罩B。Mix 12 mL of composition A aqueous solution, 6 mL of composition B aqueous solution and 1.75 g of glycerin, and then add sodium dihydrogen phosphate-disodium hydrogen phosphate buffer (pH=6.0) and 6 mg of ethyl hydroxyphenyl ester to the solution. Stir evenly. After the above solution is uniformly infiltrated into the base material of the mask, it is dried in a nitrogen atmosphere to obtain the base material 101 of mask B. Then, the activated carbon layer 201 is fixed on the outside of the base material 101 by hot melting to obtain the mask B.
如图2所示,102表示为口罩的耳挂绳,101表示为口罩的基层材料,201表示为口罩的活性炭层。此外,根据工作环境的需要,在需要过滤细小颗粒(例如粉尘、花粉等)的场景,也可在活性炭层201与基层材料101之间插入熔喷布过滤层,用于阻挡细小颗粒。由于过氧乙酸属于有机蒸汽,因此在口罩B中加入活性炭层可以有效地加强口罩的物理吸附,从而实现物理吸附、与化学吸附中和相结合的联合过滤效果。As shown in Figure 2, 102 represents the ear strap of the mask, 101 represents the base material of the mask, and 201 represents the activated carbon layer of the mask. In addition, according to the needs of the working environment, in scenes where fine particles (such as dust, pollen, etc.) need to be filtered, a melt-blown cloth filter layer can also be inserted between the activated carbon layer 201 and the base material 101 to block fine particles. Since peracetic acid is an organic vapor, adding an activated carbon layer to mask B can effectively strengthen the physical adsorption of the mask, thereby achieving a combined filtration effect of physical adsorption and chemical adsorption neutralization.
口罩CMask C
将15mL的组合物A水溶液、3mL的组合物B水溶液和1.75g的甘油混合,然后向溶液中加入磷酸二氢钠-磷酸氢二钠缓冲液(pH=6.0)和6mg的羟苯乙酯并均匀搅拌。将上述溶液均匀浸润口罩的基层材料后,在氮气的气氛下干燥,以获得口罩C的第一基层材料101。将过氧化氢酶、1.75g的甘油、6mg的羟苯乙酯和磷酸二氢钠-磷酸氢二钠缓冲液(pH=7.4)混合并均匀搅拌。将上述溶液均匀浸润口罩的基层材料后,在氮气的气氛下干燥,以获得口罩C的第二基层材料301。使用厚度为3mm的聚酯过滤棉作为中间隔离层302。将第一基层材料101、中间隔离层201和第二基层材料301按顺序由外向内排列,通过热熔的方法制备得到多层口罩C。Mix 15 mL of composition A aqueous solution, 3 mL of composition B aqueous solution and 1.75 g of glycerin, and then add sodium dihydrogen phosphate-disodium hydrogen phosphate buffer (pH=6.0) and 6 mg of ethyl hydroxyphenyl ester to the solution. Stir evenly. After the above solution is evenly infiltrated into the base material of the mask, it is dried in a nitrogen atmosphere to obtain the first base material 101 of the mask C. Mix catalase, 1.75 g of glycerin, 6 mg of ethyl hydroxyphenyl ester and sodium dihydrogen phosphate-disodium hydrogen phosphate buffer (pH=7.4) and stir evenly. After the above solution is evenly infiltrated into the base material of the mask, it is dried in a nitrogen atmosphere to obtain the second base material 301 of the mask C. Polyester filter cotton with a thickness of 3 mm is used as the middle isolation layer 302. Arrange the first base material 101, the middle isolation layer 201 and the second base material 301 in order from the outside to the inside, and prepare a multi-layer mask C by hot melting.
如图3所示,102表示为口罩的耳挂绳,101表示为口罩的第一基层材料,302表示为第二基层材料,301表示为第二基层材料。由于第一基层材料101和第二基层材料302中的活性物质需要在不同的pH环境中工作,其中第一基层材料101中的活性物质在pH 5.0-6.2的弱酸环境下较为稳定,而过氧化氢酶在pH 7.0的环境下可以实现催化分解过氧化氢的最大化,因此,中间隔离层302可以有效地隔离两个基层材料的活性物质,并且选用聚酯过滤棉也不会影响空气的流通。另外,将第二基层材料301设置在靠近人脸的内侧,可以使得第二基层材料301具有相对较高的温度,更加利于过氧化氢酶分解过氧化氢。As shown in Figure 3, 102 represents the ear strap of the mask, 101 represents the first base material of the mask, 302 represents the second base material, and 301 represents the second base material. Since the active substances in the first base material 101 and the second base material 302 need to work in different pH environments, the active substances in the first base material 101 are relatively stable in a weakly acidic environment of pH 5.0-6.2, while peroxidation Hydrogenase can maximize the catalytic decomposition of hydrogen peroxide in a pH 7.0 environment. Therefore, the middle isolation layer 302 can effectively isolate the active substances of the two base materials, and the use of polyester filter cotton will not affect the air circulation. . In addition, arranging the second base material 301 on the inside close to the person's face can make the second base material 301 have a relatively high temperature, which is more conducive to the decomposition of hydrogen peroxide by catalase.
口罩DMask D
将2.7g维生素C、9.6g甘油、0.0375g羟苯乙酯、0.0006g EDTA-Na 2、0.005g焦亚硫酸钠、0.5625g N-乙酰半胱氨酸、1.8g甘氨酸、1.35g L-丙氨酸、1.35g L-丝氨酸、 1.3g碳酸氢钠加入到25mL纯水中定容。将上述组合物溶液置于喷雾瓶中,其中加入0.6ml液状石蜡作为液封层。提供一个棉布口罩,在口罩的内侧和外侧均匀喷洒上述组合物溶液,获得口罩D。 Combine 2.7g vitamin C, 9.6g glycerin, 0.0375g ethyl hydroxyphenyl ester, 0.0006g EDTA-Na 2 , 0.005g sodium metabisulfite, 0.5625g N-acetylcysteine, 1.8g glycine, 1.35g L-alanine , 1.35g L-serine and 1.3g sodium bicarbonate were added to 25mL pure water to adjust to volume. Place the above composition solution into a spray bottle, and add 0.6 ml of liquid paraffin as a liquid sealing layer. Provide a cotton mask, and spray the above composition solution evenly on the inside and outside of the mask to obtain mask D.
口罩D的喷涂过程如图9所示。The spraying process of mask D is shown in Figure 9.
口罩EMask E
将210g丙二醇、0.6g葡萄糖酸-δ-内酯、0.03g EDTA-Na 2、0.1g焦亚硫酸钠、36g甘氨酸、36g丙氨酸、18g丝氨酸、54g维生素C、13g N-乙酰半胱氨酸、30g碳酸氢钠、3.5g葡萄籽提取物(原花青素)、1.2g柠檬油、0.6g羟苯乙酯、200g水配制成500ml的组合物液体。将上述组合物溶液分装于20ml的喷雾瓶中,每瓶加入0.6ml液状石蜡作为液封层。提供一个棉布口罩,按图9所示的方法,向口罩的内侧和外侧均匀喷洒上述组合物溶液,获得口罩E。 Combine 210g propylene glycol, 0.6g glucono-delta-lactone, 0.03g EDTA-Na 2 , 0.1g sodium metabisulfite, 36g glycine, 36g alanine, 18g serine, 54g vitamin C, 13g N-acetylcysteine, 30g sodium bicarbonate, 3.5g grape seed extract (proanthocyanidins), 1.2g lemon oil, 0.6g ethyl hydroxyphenyl ester, and 200g water are prepared into a 500ml composition liquid. The above composition solution was dispensed into 20 ml spray bottles, and 0.6 ml of liquid paraffin was added to each bottle as a liquid sealing layer. Provide a cotton mask, and spray the above composition solution evenly on the inside and outside of the mask according to the method shown in Figure 9 to obtain Mask E.
实施例3维生素C、N-乙酰半胱氨酸和甘氨酸对高效消毒剂的中和能力Example 3 Neutralizing abilities of vitamin C, N-acetylcysteine and glycine against high-efficiency disinfectants
将2.7g维生素C溶于100mL纯化水中,以制备浓度为2.7%(W/V)的维生素C溶液。Dissolve 2.7g of vitamin C in 100 mL of purified water to prepare a vitamin C solution with a concentration of 2.7% (W/V).
将2.4g N-乙酰半胱氨酸溶于100mL纯化水中,以制备浓度为2.4%(W/V)的N-乙酰半胱氨酸溶液。Dissolve 2.4g N-acetylcysteine in 100mL purified water to prepare an N-acetylcysteine solution with a concentration of 2.4% (W/V).
将6.0g甘氨酸溶于100mL纯化水中,以制备浓度为6%(W/V)的甘氨酸溶液。Dissolve 6.0 g of glycine in 100 mL of purified water to prepare a glycine solution with a concentration of 6% (W/V).
根据表1,配置消毒剂的水溶液,并使用所述消毒剂滴定1mL的维生素C溶液、N-乙酰半胱氨酸和甘氨酸。使用滴定指示剂判断滴定终点,必要时,可使用辅助指示剂显色,帮助确定滴定终点。在滴定终点处,记录消耗的消毒剂溶液。According to Table 1, prepare an aqueous disinfectant solution, and use the disinfectant to titrate 1 mL of vitamin C solution, N-acetylcysteine, and glycine. Use a titration indicator to determine the titration end point. If necessary, use an auxiliary indicator to develop color to help determine the titration end point. At the end point of the titration, the disinfectant solution consumed is recorded.
表1Table 1
Figure PCTCN2022092725-appb-000004
Figure PCTCN2022092725-appb-000004
Figure PCTCN2022092725-appb-000005
Figure PCTCN2022092725-appb-000005
a.1000ppm次氯酸钠消毒液实测pH 11.32,具有强碱性,而测氯试纸在碱性环境下显色灵敏度降低,故传统次氯酸类的含氯消毒剂须在稀盐酸的酸性条件下滴定。稀盐酸只能加入中和剂,不能加入含氯消毒剂,以免Cl 2+H 2O→HCl+HClO的方程式逆转。 a. The measured pH of 1000ppm sodium hypochlorite disinfectant is 11.32, which is highly alkaline. However, the color sensitivity of chlorine test paper decreases in an alkaline environment. Therefore, traditional hypochlorous acid-based chlorine-containing disinfectants must be titrated under the acidic conditions of dilute hydrochloric acid. Only neutralizer can be added to dilute hydrochloric acid, and chlorine-containing disinfectant cannot be added to avoid reversal of the equation of Cl 2 +H 2 O → HCl + HClO.
b.5000ppm过氧乙酸消毒液实测pH 2.1,具有强酸性,超出了过氧化物试纸的显色条件,需酸碱中和后再用试纸检测过氧化物浓度。过氧乙酸与乙酰半胱氨酸的中和产物可使过氧化物检测试纸褪色,以试纸投入溶液中显色变化瞬间的最大值作为读数。b. The measured pH of 5000ppm peracetic acid disinfectant is 2.1, which is highly acidic and exceeds the color development conditions of peroxide test paper. It needs to be neutralized by acid and alkali before using test paper to detect the peroxide concentration. The neutralization product of peracetic acid and acetylcysteine can cause the peroxide detection test paper to fade, and the maximum value of the color change at the moment when the test paper is put into the solution is taken as the reading.
c.过氧化物消毒剂的氧化性比含氯消毒剂更强,可使测氯试纸变棕黄色后进一步氧化从而导致棕黄色产物褪色,因此不能把测氯试纸直接投入反应体系。c. Peroxide disinfectants are more oxidizing than chlorine-containing disinfectants and can cause the chlorine test paper to turn brown and then further oxidize, causing the brown product to fade. Therefore, the chlorine test paper cannot be directly put into the reaction system.
d.甘氨酸与戊二醛的反应可在室温下进行,反应条件pH>5.0,通常在5-10秒内生成黄色产物并逐渐变深,然而目前商品化的戊二醛检测试纸检测范围为0-3%,大多数也是甘氨酸显色法。由于试纸显色反应也是黄-橙色,试纸读数极易被干扰。目前也没有量程100ppm以内的高灵敏度试纸。d. The reaction between glycine and glutaraldehyde can be carried out at room temperature. The reaction condition is pH>5.0. A yellow product is usually generated within 5-10 seconds and gradually becomes darker. However, the detection range of currently commercialized glutaraldehyde test paper is 0 -3%, most are also glycine colorimetric methods. Since the color reaction of the test paper is also yellow-orange, the test paper reading is easily disturbed. Currently, there are no high-sensitivity test strips with a measurement range of less than 100 ppm.
e.将戊二醛与过量的甘氨酸加热充分反应,然后用酸度计、氢氧化钠标准滴定溶液和甲醛溶液,测量样品中氨基酸含量的变化从而推算出被戊二醛消耗的甘氨酸,详见实施例9。e. Heat glutaraldehyde and excess glycine to fully react, then use an acidometer, sodium hydroxide standard titration solution and formaldehyde solution to measure the changes in amino acid content in the sample to deduce the glycine consumed by glutaraldehyde. For details, see Implementation Example 9.
f.氨基酸的α-氨基与次氯酸结合后生成氯胺,其反应速率常数K 2为1.0×10 5M -1s -1,远低于半胱氨酸侧链K 2为3.0×10 7M -1s -1的反应速率常数,因此滴定实验中无法观察到这种缓慢的中和效果。 f. The α-amino group of amino acids combines with hypochlorous acid to form chloramine. Its reaction rate constant K 2 is 1.0×10 5 M -1 s -1 , which is much lower than the cysteine side chain K 2 of 3.0×10 The reaction rate constant is 7 M -1 s -1 , so this slow neutralization effect cannot be observed in titration experiments.
如表1所示,维生素C和N-乙酰半胱氨酸的水溶液均可以有效地中和含氯消毒剂中的次氯酸成分,而甘氨酸的水溶液可以有效地中和含戊二醛的消毒剂。而在本发明的组合物中,引湿剂具有吸收水分的作用,可以将组合物变为润湿状态或溶液状态,即对应表1中的维生素C水溶液、N-乙酰半胱氨酸水溶液和甘氨酸水溶液,同时引湿剂不会参与上述化合物与氯气的反应,不会影响其中和反应的效率。因此,上述结果证实,本发明的化合物可以有效地吸附并中和含氯消毒剂、含过氧化物消毒剂和含戊二醛消毒剂,并可以吸附并中和上述消毒剂挥发的刺激性气体。As shown in Table 1, aqueous solutions of vitamin C and N-acetylcysteine can effectively neutralize hypochlorous acid in chlorine-containing disinfectants, while aqueous solutions of glycine can effectively neutralize glutaraldehyde-containing disinfectants. agent. In the composition of the present invention, the moisture absorbing agent has the function of absorbing water and can change the composition into a moist state or a solution state, that is, corresponding to the vitamin C aqueous solution, N-acetylcysteine aqueous solution and Glycine aqueous solution, while the moisture attractant will not participate in the reaction between the above compounds and chlorine, and will not affect the efficiency of the neutralization reaction. Therefore, the above results confirm that the compounds of the present invention can effectively adsorb and neutralize chlorine-containing disinfectants, peroxide-containing disinfectants and glutaraldehyde-containing disinfectants, and can adsorb and neutralize the irritating gases volatilized by the above-mentioned disinfectants. .
实施例4口罩对消毒剂中刺激性气体的吸附中和能力的定性测试Example 4 Qualitative test of the mask's ability to adsorb and neutralize irritating gases in disinfectants
(I)按照表1中的医用消毒浓度配置消毒液,通过移液管移取5mL消毒液至100mL的碘量瓶中,并盖紧瓶塞,剧烈震荡约1min,使消毒液中挥发的刺激性气体充满密闭的碘量瓶。在佩戴本发明的口罩A前后,测试员打开瓶塞,靠近瓶口气闻气味2-5分钟,并记录试纸的显色情况。(1) Prepare the disinfectant according to the medical disinfection concentration in Table 1, transfer 5 mL of disinfectant into a 100 mL iodine bottle through a pipette, seal the bottle tightly, and shake vigorously for about 1 minute to remove the volatile irritation from the disinfectant. Sexual gas fills the sealed iodine bottle. Before and after wearing the mask A of the present invention, the tester opens the bottle stopper, smells the smell close to the mouth of the bottle for 2-5 minutes, and records the color development of the test paper.
其中,由于二氧化氯消毒液的挥发性和刺激性较强,戊二醛消毒液有致敏性,因此出于实验安全以及伦理学的考虑,建议不针对所述两种消毒液进行上述第(1)种定性实验。Among them, due to the strong volatility and irritation of chlorine dioxide disinfectant and the sensitization of glutaraldehyde disinfectant, it is recommended not to conduct the above-mentioned (()) on the two disinfectants due to experimental safety and ethical considerations. 1) A qualitative experiment.
(II)按照表1中的医用消毒浓度配置消毒液,通过移液管移取5mL消毒液至100mL的碘量瓶中,微加碘量瓶使消毒剂挥发。在上述碘量瓶的中心区域放置发明的口罩A,其中口罩中心区域的正反两面分别粘贴有长度约10mm的试纸,两张试纸相距3-5mm,以便于气流通过。对于含氯消毒剂(如三氯异氰尿酸消毒液、次氯酸钠消毒液)、过氧化氢和过氧乙酸消毒液,使用的试纸为测氯试纸;对于二氧化氯消毒液,使用的试纸为二氧化氯试纸;对于戊二醛消毒液,使用的试纸为戊二醛试纸。碘量瓶加热2-5分钟后可以观察到口罩外侧的试纸变色,而口罩内侧的试纸未变色。(II) Prepare the disinfectant according to the medical disinfection concentration in Table 1, transfer 5 mL of disinfectant into a 100 mL iodine bottle through a pipette, and slightly add iodine to the bottle to evaporate the disinfectant. The mask A of the invention is placed in the central area of the above-mentioned iodine bottle. The front and back sides of the central area of the mask are respectively pasted with test paper with a length of about 10mm. The two test papers are 3-5mm apart to facilitate the passage of airflow. For chlorine-containing disinfectants (such as trichloroisocyanuric acid disinfectant, sodium hypochlorite disinfectant), hydrogen peroxide and peracetic acid disinfectants, the test paper used is chlorine test paper; for chlorine dioxide disinfectant, the test paper used is chlorine test paper Chlorine oxide test paper; for glutaraldehyde disinfectant, the test paper used is glutaraldehyde test paper. After heating the iodine bottle for 2-5 minutes, you can observe that the test paper on the outside of the mask changes color, but the test paper on the inside of the mask does not change color.
通过上述定性实验可以证实,本发明的口罩可以有效地吸附并中和多种消毒剂中的刺激性气体。Through the above qualitative experiments, it can be confirmed that the mask of the present invention can effectively absorb and neutralize irritating gases in various disinfectants.
另外,口罩A中吸附有本发明的组合物,其包含维生素C、N-乙酰半胱氨酸、甘氨酸等生物活性成分,因此上述定性实验也可以证实,对于刺激性气体(例如消毒液中的刺激性气体),本发明的组合物具有优异的吸收能力。此外,相比维生素C本身,本发明的组合物可以更有效地吸收并中和刺激性气体。In addition, mask A is adsorbed with the composition of the present invention, which contains bioactive ingredients such as vitamin C, N-acetylcysteine, glycine, etc. Therefore, the above qualitative experiment can also confirm that it is effective against irritating gases (such as those in disinfectant solutions). irritating gases), the composition of the present invention has excellent absorption capacity. In addition, the composition of the present invention can absorb and neutralize irritating gases more effectively than vitamin C itself.
实施例5口罩对消毒剂中刺激性气体的吸附中和能力的定量测试Example 5 Quantitative test of the mask’s ability to adsorb and neutralize irritating gases in disinfectants
将本发明的口罩A放入250ml的锥形瓶中,向锥形瓶中加入100mL水。搅拌上述锥形瓶中的水,使口罩A的组分充分溶于水中,以获得口罩提取液。取出10mL口罩提取液,根据表1的方法进行滴定实验,以测定口罩中活性物质的含量。测定结果放大10倍即得到口罩内活性物质的含量。测试结果见表2。Put the mask A of the present invention into a 250 ml conical flask, and add 100 mL of water to the conical flask. Stir the water in the above-mentioned Erlenmeyer flask to fully dissolve the components of mask A in the water to obtain the mask extract. Take out 10mL of mask extract and perform a titration experiment according to the method in Table 1 to determine the content of active substances in the mask. The measurement results are magnified 10 times to obtain the content of active substances in the mask. The test results are shown in Table 2.
表2新制备的口罩内活性物质含量测试Table 2 Test of active substance content in newly prepared masks
Figure PCTCN2022092725-appb-000006
Figure PCTCN2022092725-appb-000006
上述结果可以证实,本发明的口罩可以有效地吸附并中和多种消毒剂中的刺激性气体。另外,口罩A吸附有本发明的组合物,因此上述结果也可以证实,对于刺激性气体(例如消毒液中的刺激性气体),本发明的组合物具有优异的吸收能力。此外,相比维生素C本身,本发明的组合物可以更有效地吸收并中和刺激性气体。The above results can confirm that the mask of the present invention can effectively absorb and neutralize irritating gases in various disinfectants. In addition, mask A adsorbs the composition of the present invention, so the above results can also confirm that the composition of the present invention has excellent absorption capacity for irritating gases (such as irritating gases in disinfectant solutions). In addition, the composition of the present invention can absorb and neutralize irritating gases more effectively than vitamin C itself.
实施例6口罩定性鲁棒性测试Example 6 Qualitative robustness test of masks
将口罩A置于相对湿度70-95%、温度25-35℃的环境中14天。14天后,测试员先佩戴口罩A约30分钟,使口罩A充分湿润达到水分的平衡状态,然后再按照实施例4的方法检测口罩A的稳定性。Place mask A in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for 14 days. After 14 days, the tester first wore mask A for about 30 minutes to fully moisten mask A and reach a moisture balance state, and then tested the stability of mask A according to the method of Example 4.
试验结果显示:The test results show:
根据实施例4的第(1)种方法,口罩暴露在空气后数小时内就为黄色。测试员佩戴上述口罩A后,测试员可以闻到稍淡淡的消毒气味,但该气味不具有刺激性。According to the method (1) of Embodiment 4, the mask turns yellow within a few hours after being exposed to the air. After the tester wears the above mask A, the tester can smell a slightly faint disinfectant smell, but the smell is not irritating.
根据实施例4的第(2)种方法,加热2-5分钟后,可以观察到口罩外侧的试纸变色,而口罩内侧的试纸未变色。According to the method (2) of Example 4, after heating for 2-5 minutes, it can be observed that the test paper on the outside of the mask changes color, but the test paper on the inside of the mask does not change color.
上述结果可以证实,即使被空气氧化并变色,本发明的口罩仍具有吸附消毒剂并中和刺激性气体的能力,本发明的口罩具有优异的稳定性。The above results can confirm that even if it is oxidized and discolored by air, the mask of the present invention still has the ability to absorb disinfectants and neutralize irritating gases, and the mask of the present invention has excellent stability.
另外,口罩A中吸附有本发明的组合物,其包含维生素C、N-乙酰半胱氨酸、甘氨酸等生物活性成分,其各自具有不同的还原性或反应活性,即使在空气中静置较长的时间(例如14天),组合物依然能够吸收并中和刺激性气体(例如空气中或消毒剂中的刺激性气体),因此上述结果也可以证实,本发明的组合物具有优异的稳定性。特别地,相比维生素C本身,本发明的组合具有明显改善的稳定性。In addition, mask A is adsorbed with the composition of the present invention, which contains bioactive ingredients such as vitamin C, N-acetylcysteine, glycine, etc., each of which has different reducing properties or reactivity. Even if it is left standing in the air for a long time, For a long time (such as 14 days), the composition can still absorb and neutralize irritating gases (such as irritating gases in the air or in disinfectants). Therefore, the above results can also confirm that the composition of the present invention has excellent stability. sex. In particular, the combination of the invention has significantly improved stability compared to vitamin C itself.
实施例7口罩定量鲁棒性测试Example 7 Mask Quantitative Robustness Test
将口罩A置于相对湿度70-95%、温度25-35℃的环境中14天。14天后,口罩A被空气氧化变为黄色,然后按照实施例5的方法检测口罩A的稳定性。测试结果见表3。Place mask A in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for 14 days. After 14 days, mask A was oxidized by air and turned yellow, and then the stability of mask A was tested according to the method of Example 5. The test results are shown in Table 3.
表3泛黄、被空气氧化的口罩A内残余活性物质的含量Table 3 Contents of residual active substances in mask A that turned yellow and was oxidized by air
Figure PCTCN2022092725-appb-000007
Figure PCTCN2022092725-appb-000007
上述结果可以证实,即使被空气氧化并变色,本发明的口罩仍具有吸附消毒剂并中和刺激性气体的能力,本发明的口罩具有优异的稳定性。另外,口罩A吸附有本发明的组合物,因此上述结果也可以证实,本发明的组合物具有优异的稳定性。特别地,相比维生素C本身,本发明的组合具有明显改善的稳定性。The above results can confirm that even if it is oxidized and discolored by air, the mask of the present invention still has the ability to absorb disinfectants and neutralize irritating gases, and the mask of the present invention has excellent stability. In addition, mask A adsorbed the composition of the present invention, so the above results can also confirm that the composition of the present invention has excellent stability. In particular, the combination of the invention has significantly improved stability compared to vitamin C itself.
实施例8口罩的微生物含量测定Example 8 Determination of microbial content of masks
参照《YY/T0969-2013一次性使用医用口罩》的检测方法,其微生物指标中,非灭菌口罩的微生物限度为:细菌≤100CFU/g,大肠杆菌,绿脓杆菌,金黄色葡萄球菌,溶血性链球菌,真菌不得检出。将口罩A按上述检查方法,在100级超净台中打开包装,用0.9%氯化钠注射液提取,将提取液加入琼脂培养基。Referring to the testing method of "YY/T0969-2013 Disposable Medical Masks", among the microbial indicators, the microbial limits of non-sterile masks are: bacteria ≤100CFU/g, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, hemolysis Sexual streptococci and fungi shall not be detected. According to the above inspection method, mask A is unpacked in a class 100 ultra-clean bench, extracted with 0.9% sodium chloride injection, and the extract is added to agar culture medium.
为了观察在真实世界中使用的情况,将口罩A放置在相对湿度70-95%、温度25-35℃的环境中暴露两周后,用水浸泡稀释防腐剂,然后在开放环境中取样操作,观察环境菌对口罩的影响。测试结果见表4。In order to observe the use in the real world, mask A was placed in an environment with a relative humidity of 70-95% and a temperature of 25-35°C for two weeks, then soaked in water to dilute the preservative, and then sampled and operated in an open environment to observe The impact of environmental bacteria on masks. The test results are shown in Table 4.
表4口罩的微生物指标检测结果Table 4 Microbial indicator test results of masks
Figure PCTCN2022092725-appb-000008
Figure PCTCN2022092725-appb-000008
从微生物指标检测结果来看,由于防腐剂(羟苯乙酯)的加入,使口罩的微生物指标不仅达到了行业标准的要求,而且还对环境微生物起到了抑制作用。经Bruker微生物鉴定质谱分析系统检测,培养出的环境菌落微生物主要为尿类类芽孢杆菌,该菌能够产生芽孢,对恶劣环境(如防腐剂)具有抵抗性,因而在低浓度防腐剂环境中生长,该菌属于非致病性的背景微生物,多来自于动物尿液。Judging from the microbial index test results, due to the addition of the preservative (ethyl hydroxyphenyl ester), the microbial index of the mask not only meets the requirements of industry standards, but also inhibits environmental microorganisms. As detected by the Bruker Microbial Identification Mass Spectrometry Analysis System, the cultured environmental colony microorganisms are mainly Paenibacillus urinae, which can produce spores and is resistant to harsh environments (such as preservatives), so it grows in low-concentration preservative environments. , this bacterium is a non-pathogenic background microorganism, mostly coming from animal urine.
实施例9戊二醛与氨基酸的反应终点的测定方法Example 9 Method for determination of reaction end point between glutaraldehyde and amino acids
表1中,甘氨酸(或其他氨基酸)中和戊二醛消毒剂的反应终点通过如下方法测定:In Table 1, the reaction end point of glycine (or other amino acids) neutralizing glutaraldehyde disinfectant is determined by the following method:
(1)提供氨基酸水溶液及戊二醛消毒液;(1) Provide amino acid aqueous solution and glutaraldehyde disinfectant;
(2)将步骤(1)的氨基酸和戊二醛消毒液混合后定容;(2) Mix the amino acid and glutaraldehyde disinfectant in step (1) and dilute to volume;
(3)加热步骤(2)的定容混合液并进一步定容;(3) Heating the constant volume mixture in step (2) and further diluting the volume;
(4)稀释步骤(3)的混合液并测量混合液的pH值;(4) Dilute the mixed solution in step (3) and measure the pH value of the mixed solution;
(5)使用氢氧化钠水溶液滴定步骤(4)的混合液至pH为8.2;(5) Use sodium hydroxide aqueous solution to titrate the mixed solution in step (4) until the pH is 8.2;
(6)将甲醛溶液加入步骤(5)的混合液;(6) Add the formaldehyde solution to the mixed solution of step (5);
(7)冷却步骤(6)的混合液并测量混合液的pH值;(7) Cool the mixed liquid in step (6) and measure the pH value of the mixed liquid;
(8)使用氢氧化钠水溶液滴定步骤(7)的混合液至pH为9.2,并记录滴定液的体积V 1(mL); (8) Use sodium hydroxide aqueous solution to titrate the mixed solution in step (7) to pH 9.2, and record the volume V 1 (mL) of the titrant solution;
(9)稀释步骤(8)的混合液,并使用氢氧化钠水溶液滴定步骤(8)的混合液至pH为8.2;(9) Dilute the mixed solution of step (8), and titrate the mixed solution of step (8) using sodium hydroxide aqueous solution to a pH of 8.2;
(10)将甲醛溶液加入步骤(9)的混合液;(10) Add the formaldehyde solution to the mixed solution of step (9);
(11)使用氢氧化钠水溶液滴定步骤(10)的混合液至pH为9.2,并记录滴定液的体积V 2(mL); (11) Use sodium hydroxide aqueous solution to titrate the mixed solution in step (10) to pH 9.2, and record the volume V 2 (mL) of the titrant;
(12)根据下述公式(II)获得1ml戊二醛消毒液中氨基酸物质浓度C amino acid(重量%): (12) Obtain the concentration of amino acid substance C amino acid (weight %) in 1ml of glutaraldehyde disinfectant according to the following formula (II):
C amino acid=[(V 1-V 2)×C NaOH×0.001×MW amino acid/(5×20/100)]*100%   (II) C amino acid = [(V 1 -V 2 ) × C NaOH × 0.001 × MW amino acid / (5 × 20/100)] * 100% (II)
其中,in,
V 1表示测定用试样稀释液加入甲醛后消耗氢氧化钠标准滴定溶液的体积,单位为毫升(mL); V 1 represents the volume of sodium hydroxide standard titration solution consumed after formaldehyde is added to the sample diluent for measurement, in milliliters (mL);
V 2表示试剂空白试验加入甲醛后消耗氢氧化钠标准滴定溶液的体积,单位为毫升(mL); V 2 represents the volume of sodium hydroxide standard titration solution consumed after adding formaldehyde in the reagent blank test, in milliliters (mL);
C NaOH表示氢氧化钠标准滴定溶液的浓度,单位为摩尔每升(mol/L); C NaOH represents the concentration of sodium hydroxide standard titration solution, in moles per liter (mol/L);
MW amino acid表示氨基酸的摩尔质量(分子量),单位为克每摩尔(g/mol); MW amino acid represents the molar mass (molecular weight) of the amino acid, in grams per mole (g/mol);
在本发明中,使用6重量%的甘氨酸与2重量%的戊二醛消毒液反应,并通过上述方法确定其反应终点,具体实验步骤为:In the present invention, 6 wt% glycine is used to react with 2 wt% glutaraldehyde disinfectant, and the reaction end point is determined by the above method. The specific experimental steps are:
(1)用移液管精密量取10ml浓度为6重量%甘氨酸水溶液,以及1ml浓度为2重量%戊二醛消毒液。将上述溶液加入25ml的容量瓶中混匀,容量瓶密闭后置于约50℃的水浴锅中加热反应20分钟。反应结束后,混合液冷却至室温并量取5ml深褐色反应液,上述反应液加入100ml容量瓶中,并加水混匀定容稀释。(1) Use a pipette to accurately measure 10 ml of 6 wt% glycine aqueous solution and 1 ml of 2 wt% glutaraldehyde disinfectant. Add the above solution into a 25 ml volumetric flask and mix well. After sealing the volumetric flask, place it in a water bath at about 50°C and heat for 20 minutes. After the reaction is completed, cool the mixture to room temperature and measure 5 ml of the dark brown reaction solution. Add the above reaction solution into a 100 ml volumetric flask, add water, mix and dilute to constant volume.
(2)量取20ml上述稀释液,并加入250ml锥形瓶中,再加水60ml,插入酸度计电极测量pH值。用0.05-0.1mol/L左右的氢氧化钠标准滴定溶液振摇调节至pH 8.2。(2) Measure 20ml of the above diluent, add it to a 250ml Erlenmeyer flask, add 60ml of water, and insert the acidimeter electrode to measure the pH value. Shake and adjust to pH 8.2 with a sodium hydroxide standard titration solution of about 0.05-0.1mol/L.
(3)量取10ml甲醛溶液(分析纯,含量35-40重量%),并加入到上述锥形瓶中摇匀。用50ml烧杯盖住锥形瓶口,随后将锥形瓶置于50℃左右的水浴锅中加热反应10分钟。反应完毕,冷却至室温后再插入酸度计电极测量pH值,继续用上述氢氧化钠标准滴定溶液振摇滴定至pH 9.2,记下消耗的滴定液体积V 1(mL)。 (3) Measure 10 ml of formaldehyde solution (analytically pure, content 35-40% by weight), and add it to the above-mentioned Erlenmeyer flask and shake well. Cover the mouth of the conical flask with a 50 ml beaker, and then place the conical flask in a water bath at about 50°C to heat for 10 minutes. After the reaction is completed, cool to room temperature and then insert the acidimeter electrode to measure the pH value. Continue the shaking titration with the above-mentioned sodium hydroxide standard titration solution to pH 9.2, and record the consumed titrant volume V 1 (mL).
(4)将80ml水加入到250ml锥形瓶中,用上述氢氧化钠标准滴定溶液调节至pH8.2,再加入10ml甲醛溶液,继续用上述氢氧化钠标准滴定溶液振摇滴定至pH 9.2,记下消耗的滴定液体积V 2(mL)。操作时注意通风以免吸入过多甲醛蒸汽。 (4) Add 80ml of water into a 250ml Erlenmeyer flask, adjust to pH 8.2 with the above sodium hydroxide standard titration solution, then add 10ml of formaldehyde solution, and continue shaking and titrating with the above sodium hydroxide standard titration solution to pH 9.2. Note down the consumed titrant volume V 2 (mL). Pay attention to ventilation during operation to avoid inhaling too much formaldehyde vapor.
根据上述公式(II)计算获得1ml戊二醛消毒液中氨基酸物质浓度C amino acid(重量%)。 Calculate according to the above formula (II) to obtain the concentration of amino acid substance C amino acid (weight %) in 1 ml of glutaraldehyde disinfectant solution.
其中,本发明实施例使用的氨基酸为甘氨酸,其摩尔分子重量为75.07g/mol。Among them, the amino acid used in the embodiment of the present invention is glycine, and its molar molecular weight is 75.07g/mol.
表5为戊二醛消毒液与甘氨酸反应终点测试结果。Table 5 shows the end-point test results of the reaction between glutaraldehyde disinfectant and glycine.
表5戊二醛消毒液与甘氨酸反应比例的测试结果Table 5 Test results of the reaction ratio between glutaraldehyde disinfectant and glycine
Figure PCTCN2022092725-appb-000009
Figure PCTCN2022092725-appb-000009
通过上述具体实施例可知,滴定6%甘氨酸溶液后,根据计算得出的浓度结果为5.884%,滴定分析回收率98.07%,达到了国家标准的分析要求。1ml 2%的戊二醛消毒液与10ml 6%的甘氨酸反应后体积仍为11ml,因此2%的戊二醛消毒液与甘氨酸反应的化学计量点可表述为:It can be seen from the above specific examples that after titrating the 6% glycine solution, the calculated concentration result is 5.884%, and the titration analysis recovery rate is 98.07%, which meets the analysis requirements of the national standard. The volume of 1ml of 2% glutaraldehyde disinfectant and 10ml of 6% glycine is still 11ml. Therefore, the stoichiometric point of the reaction between 2% glutaraldehyde disinfectant and glycine can be expressed as:
1ml 2重量%戊二醛消毒液消耗甘氨酸10×5.884%-11×5.212%=0.01508g。1ml of 2 wt% glutaraldehyde disinfectant consumes 10×5.884%-11×5.212%=0.01508g of glycine.
本发明的分析方法能够准确地获得戊二醛与氨基酸类物质中和反应的物料消耗比例的化学计量点,即准确地得到中和反应的终点,并获得所消耗的氨基酸的量。The analysis method of the present invention can accurately obtain the stoichiometric point of the material consumption ratio of the neutralization reaction between glutaraldehyde and amino acid substances, that is, accurately obtain the end point of the neutralization reaction and obtain the amount of consumed amino acids.
实施例10本发明的口罩的防护极限性能及显色性能实验Example 10 Experiment on the protective ultimate performance and color rendering performance of the mask of the present invention
为了进一步证实本发明的口罩的实用性,通过以下方法检测本发明的口罩的防护极限性能及显色性能。In order to further confirm the practicability of the mask of the present invention, the protective limit performance and color rendering performance of the mask of the present invention were tested by the following methods.
(I)口罩防护极限性能检测实验(I) Mask protective limit performance testing experiment
口罩防护极限性能检测试验的步骤与实施例4的方法(II)相似,其区别在于:The steps of the mask protective limit performance detection test are similar to the method (II) of Example 4, with the difference being:
(i)通过熏蒸的方法加热口罩,以模拟口罩多次重复使用后的情景;(i) Heating the mask through fumigation to simulate the situation after the mask is reused multiple times;
(ii)在特定实施例中,口罩经过熏蒸后,在熏蒸后的余热环境下放置一段时间;(ii) In a specific embodiment, after the mask is fumigated, it is placed in the residual heat environment after fumigation for a period of time;
(iii)口罩经过熏蒸后,通过实施例1的方法进行滴定实验。(iii) After the mask is fumigated, a titration experiment is performed according to the method of Example 1.
(II)口罩的显色性能实验(II) Color rendering performance experiment of masks
口罩显色性能与口罩防护极限性能实验相似,其区别在于:The color rendering performance of the mask is similar to the mask protective limit performance experiment. The difference is:
口罩经过熏蒸后,观察口罩颜色的变化,以获得口罩内活性成分的含量的情况。After the mask is fumigated, observe the color change of the mask to obtain the content of the active ingredients in the mask.
为了证实本发明的口罩的防护极限性能及显色性能,使用3M TM职业暴露防护口罩作为对比例。 In order to confirm the protective ultimate performance and color rendering performance of the mask of the present invention, 3M TM occupational exposure protective mask was used as a comparative example.
戊二醛消毒液防护极限性能检测Glutaraldehyde disinfectant protective limit performance test
在口罩D的内表面粘贴一张戊二醛检测试纸,试纸用防水透气材料(如医用口罩的蓝色防水层)包裹,以防止被口罩D的活性成分沾染。将水浴锅设置在约95℃,在水浴锅上放置1个100ml蒸发皿充分预热。用移液管量取2重量%戊二醛消毒液25ml,加入到预热的蒸发皿中。在蒸发皿上方覆盖口罩D,其外表面朝下,面对蒸发皿,再把防水透气材料包裹的试纸粘贴在口罩D内表面,试纸朝下。将一个100ml蒸发皿覆盖在口罩上方作为盖子,两个蒸发皿对齐,并用重物压实密封,使戊二醛蒸汽通过口罩D,用以观察口罩D对戊二醛蒸汽的防护能力。加热熏蒸3小时左右后观察戊二醛检测试纸以及口罩的变色情况。Paste a piece of glutaraldehyde test paper on the inner surface of mask D, and wrap the test paper with waterproof and breathable material (such as the blue waterproof layer of a medical mask) to prevent it from being contaminated by the active ingredients of mask D. Set the water bath to about 95°C and place a 100ml evaporating dish on the water bath to fully preheat. Use a pipette to measure 25 ml of 2 wt% glutaraldehyde disinfectant solution and add it to the preheated evaporating dish. Cover the mask D on top of the evaporation dish, with its outer surface facing down, facing the evaporation dish, and then paste the test paper wrapped with waterproof and breathable material on the inner surface of the mask D, with the test paper facing down. Place a 100ml evaporating dish on top of the mask as a lid. The two evaporating dishes are aligned and sealed with a heavy object to allow glutaraldehyde vapor to pass through mask D to observe the protective ability of mask D against glutaraldehyde vapor. After heating and fumigating for about 3 hours, observe the discoloration of the glutaraldehyde test paper and the mask.
对比例使用3M TM 8247有机蒸汽及颗粒物防护口罩,其在相同条件下进行上述实验。为确保活性炭的吸附性能,试验前将口罩放置于干燥皿中真空干燥24小时以上。 The comparative example uses 3M TM 8247 organic vapor and particle protective mask, which conducts the above experiments under the same conditions. In order to ensure the adsorption performance of activated carbon, the mask was placed in a drying dish and vacuum dried for more than 24 hours before the test.
次氯酸类含氯消毒液防护极限性能检测Testing of protective limit performance of hypochlorous acid chlorine-containing disinfectants
次氯酸类含氯消毒液防护性能的实验方法与戊二醛消毒液防护性能检测类似,其区别在于:使用有效氯浓度30,000ppm的含氯消毒液,使用的检测试纸为测氯试纸。将水浴锅设置在45℃左右,加热熏蒸4小时。对比例选用3M TM 8246酸性气体及颗粒物防护口罩。 The experimental method for the protective performance of hypochlorous acid chlorine-containing disinfectant is similar to the protective performance test of glutaraldehyde disinfectant. The difference is that a chlorine-containing disinfectant with an effective chlorine concentration of 30,000 ppm is used, and the test paper used is a chlorine test paper. Set the water bath at about 45°C and heat and fumigate for 4 hours. For the comparison example, 3M TM 8246 acid gas and particle protective mask was used.
过氧乙酸消毒液防护极限性能检测Testing of protective limit performance of peracetic acid disinfectant
过氧乙酸消毒液防护性能的实验方法与含氯消毒液防护性能检测类似,其区别在于:使用15000ppm的过氧乙酸消毒液,检测试纸为过氧乙酸试纸。将水浴锅设置在45℃左右,加热熏蒸6小时后关闭水浴锅,利用余热放置17.5小时。对比例选用3M TM 8246酸性气体及颗粒物防护口罩。 The experimental method for the protective performance of peracetic acid disinfectant is similar to the test for the protective performance of chlorine-containing disinfectant. The difference is that 15000 ppm peracetic acid disinfectant is used, and the test paper is peracetic acid test paper. Set the water bath at about 45°C, heat and fumigate for 6 hours, then close the water bath and use the residual heat to leave it for 17.5 hours. For the comparison example, 3M TM 8246 acid gas and particle protective mask was used.
过氧化氢消毒液防护极限性能检测Hydrogen peroxide disinfectant protective limit performance testing
过氧化氢消毒液防护性能实验方法与含氯消毒液防护性能检测类似,其区别在于:使用30000ppm的过氧化氢消毒液,检测试纸为过氧化氢试纸。将水浴锅设置在45℃左右,加热熏蒸6小时后关闭水浴锅。对比例选用3M TM 8246酸性气体及颗粒物防护口罩。 The experimental method for the protective performance of hydrogen peroxide disinfectant is similar to the protective performance test of chlorine-containing disinfectant. The difference is that 30,000 ppm hydrogen peroxide disinfectant is used, and the test paper is a hydrogen peroxide test paper. Set the water bath at about 45°C, heat and fumigate for 6 hours and then close the water bath. For the comparison example, 3M TM 8246 acid gas and particle protective mask was used.
二氧化氯消毒液防护极限性能检测Testing of protective limit performance of chlorine dioxide disinfectant
二氧化氯消毒液防护性能实验方法试验方法与含氯消毒液防护性能检测类似,其区别在于:使用20000ppm的二氧化氯消毒液,检测试纸为过氧化氢试纸。将水浴锅设置在45℃左右,加热熏蒸6小时后关闭水浴锅,利用余热放置18小时。对比例选用3M TM8246酸性气体及颗粒物防护口罩。 Experimental method for the protective performance of chlorine dioxide disinfectant The test method is similar to the protective performance test of chlorine-containing disinfectant. The difference is that 20,000 ppm chlorine dioxide disinfectant is used, and the test paper is hydrogen peroxide test paper. Set the water bath at about 45°C, heat and fumigate for 6 hours, then close the water bath and use the residual heat to leave it for 18 hours. For the comparison example, 3M TM 8246 acid gas and particle protective mask was used.
在上述防护极限性能试验中,蒸发皿中用于熏蒸的液体也可通过逐渐滴定的方式额 外加入,直至使测试试纸变色为止,以便于模拟口罩D经过多次重复使用后的情景,与对比例进行比较。In the above protective limit performance test, the liquid used for fumigation in the evaporating dish can also be added by gradual titration until the test paper changes color, so as to simulate the situation of mask D after repeated use. Compared with the comparative example Compare.
表6口罩D与3M TM职业防护口罩的防护极限性能及显色性能 Table 6 Protection limit performance and color rendering performance of mask D and 3M TM occupational protective mask
Figure PCTCN2022092725-appb-000010
Figure PCTCN2022092725-appb-000010
在本实施例中,使用3M TM口罩作为对比例,具体使用的口罩包括3M TM 8246型口罩和3M TM 8247型口罩。 In this embodiment, 3M TM masks are used as a comparative example. The specific masks used include 3M TM 8246 type masks and 3M TM 8247 type masks.
以上实施例可以证实,对于三氯异氰尿酸、二氧化氯、戊二醛消毒液挥发性气体的防护,本发明的口罩D明显优于对比例。对于过氧乙酸的防护,本发明的口罩D与对比例相当。而对于过氧化氢的防护,本发明的口罩D具有较为持久的效果,例如在实验进行6小时后,口罩D上的试纸才变色。上述结果表明,在上述高浓度的刺激性气体的环境下,本发明的口罩具有较强的防护能力。The above examples can confirm that the mask D of the present invention is significantly better than the comparative example in protecting the volatile gases of trichloroisocyanuric acid, chlorine dioxide, and glutaraldehyde disinfectant. Regarding the protection against peracetic acid, the mask D of the present invention is equivalent to the comparative example. As for the protection against hydrogen peroxide, the mask D of the present invention has a relatively long-lasting effect. For example, the test paper on the mask D did not change color until 6 hours after the experiment was carried out. The above results show that in the environment of the above-mentioned high concentration of irritating gas, the mask of the present invention has strong protective ability.
另外,发明人意外地发现,由于口罩组合物的配方中使用氨基酸,本发明的口罩在高浓度消毒剂刺激性气体环境下,会产生特异性的变色反应,即在不同消毒剂刺激性气体的环境中多次重复使用后,本发明的地口罩会产生不同的变色反应。例如,对于含氯消 毒液(例如次氯酸消毒剂或二氧化氯消毒剂),本发明的口罩经过多次重复使用后会变为红色。又例如,对于过氧化物消毒剂,本发明的口罩经过多次重复使用后会变为深黄色。又例如,对于戊二醛消毒剂,本发明的口罩经过多次重复使用后会变为深褐色。此外,本发明的口罩在空气中放置一段时间后,口罩中的活性成分经过氧化会使口罩变为黄色。上述颜色变化程度与消毒剂中挥发性气体的浓度,以及口罩的使用时间相关。其中,颜色变化的程度也可以反映本发明的口罩能够继续使用的时间。例如,口罩颜色变化的程度越深,本发明的口罩可以继续使用的时间越短。In addition, the inventor unexpectedly discovered that due to the use of amino acids in the formula of the mask composition, the mask of the present invention will produce a specific discoloration reaction under the irritating gas environment of high concentrations of disinfectants, that is, under the irritating gas environment of different disinfectants, After repeated use in the environment, the floor mask of the present invention will produce different discoloration reactions. For example, for chlorine-containing disinfectants (such as hypochlorous acid disinfectants or chlorine dioxide disinfectants), the mask of the present invention will turn red after repeated use. As another example, for peroxide disinfectants, the mask of the present invention will turn dark yellow after repeated use. For another example, regarding glutaraldehyde disinfectant, the mask of the present invention will turn dark brown after repeated use. In addition, after the mask of the present invention is placed in the air for a period of time, the active ingredients in the mask will oxidize and the mask will turn yellow. The degree of color change mentioned above is related to the concentration of volatile gases in the disinfectant and the use time of the mask. Among them, the degree of color change can also reflect the time that the mask of the present invention can continue to be used. For example, the deeper the color change of the mask, the shorter the time the mask of the present invention can continue to be used.
因此,本发明的口罩不仅能够高效地吸收并中和各种消毒剂中的刺激性气体,还能够根据口罩中活性成分的状态进行变色反应,及时地反映口罩能够继续使用的时间。Therefore, the mask of the present invention can not only efficiently absorb and neutralize irritating gases in various disinfectants, but can also perform a discoloration reaction according to the state of the active ingredients in the mask, and timely reflect how long the mask can continue to be used.
实施例11本发明口罩的散热能力Example 11 Heat dissipation ability of the mask of the present invention
本发明的口罩不仅能够有效地吸收并中和消毒剂中的刺激性气体,还具有额外的散热性能。其中,散热性能具体通过如下方法进行。The mask of the present invention can not only effectively absorb and neutralize irritating gases in disinfectants, but also has additional heat dissipation properties. Among them, the heat dissipation performance is specifically achieved through the following methods.
(1)提供本发明的口罩;(1) Provide the mask of the present invention;
(2)测试者佩戴步骤(1)的口罩45分钟;(2) The tester wears the mask in step (1) for 45 minutes;
(3)测试者佩戴口罩并进行热像图测温;(3) The tester wears a mask and takes a thermal image temperature measurement;
(4)测试者摘下口罩并进行热像图测温。(4) The tester takes off the mask and takes a thermal image temperature measurement.
通常口罩佩戴者从鼻孔呼出气体,热量被口罩阻挡并传递至面部皮肤,因此口罩与皮肤接触的面部皮肤具有较高的湿度和温度。上述步骤通过测量测试者佩戴和摘下口罩时面部的温度,反映不同口罩对测试者面部温度的影响。Usually when a mask wearer exhales air from the nostrils, the heat is blocked by the mask and transferred to the facial skin, so the facial skin in contact with the mask has higher humidity and temperature. The above steps reflect the impact of different masks on the tester's facial temperature by measuring the temperature of the tester's face when wearing and taking off the mask.
具体地,以本发明的口罩A作为实施例,以一次性医用无纺布护理口罩和棉布口罩作为对比例,分别检测上述温度。其中,图5-a表示佩戴一次性医用无纺布护理口罩时的热像图,图5-b表示摘下上述口罩瞬间拍摄的面部皮肤热像图;图6-a表示佩戴棉布口罩时的热像图,图6-b表示摘下上述口罩瞬间拍摄的面部皮肤热像图;图7-a表示佩戴本发明的口罩A时的热像图,图7-b表示摘下上述口罩瞬间拍摄的面部皮肤热像图。特别地,由图7-a和图7-b可知,口罩A与皮肤接触部分的皮肤表面温度明显低于未接触部分。Specifically, the mask A of the present invention is used as an example, and the disposable medical non-woven nursing mask and cotton mask are used as a comparative example to detect the above temperatures respectively. Among them, Figure 5-a shows the thermal image when wearing a disposable medical non-woven nursing mask, Figure 5-b shows the thermal image of the facial skin taken at the moment when the above mask is taken off; Figure 6-a shows the thermal image when wearing a cotton mask. Thermal image, Figure 6-b shows the thermal image of facial skin taken at the moment when the above mask is taken off; Figure 7-a shows the thermal image when wearing the mask A of the present invention, Figure 7-b shows the thermal image taken at the moment when the above mask is taken off Thermal image of facial skin. In particular, it can be seen from Figure 7-a and Figure 7-b that the skin surface temperature of the part of mask A that is in contact with the skin is significantly lower than that of the non-contact part.
表7本发明实施例口罩A与参比口罩的降温效果对比测试Table 7 Comparative test on the cooling effect of mask A according to the embodiment of the present invention and the reference mask
Figure PCTCN2022092725-appb-000011
Figure PCTCN2022092725-appb-000011
以上实施例可以证实,本发明的口罩在具备上述吸收并中和刺激性气体的能力的同时,还具备明显的散热性能。例如,测试者佩戴本发明的口罩A时,测试者面部皮肤的最高温度为36.6℃。上述温度与人体体温相近,因此佩戴本发明的口罩,佩戴者不会有闷热的感觉。此外,长时间佩戴本发明的口罩时,面部皮肤的温度也不会提高。因此本发明的口罩具有优异的散热性能。The above examples can confirm that the mask of the present invention not only has the above-mentioned ability to absorb and neutralize irritating gases, but also has obvious heat dissipation performance. For example, when a tester wears the mask A of the present invention, the maximum temperature of the tester's facial skin is 36.6°C. The above-mentioned temperature is close to the body temperature of the human body, so the wearer will not feel stuffy when wearing the mask of the present invention. In addition, when wearing the mask of the present invention for a long time, the temperature of the facial skin will not increase. Therefore, the mask of the present invention has excellent heat dissipation performance.
实施例12本发明的组合物溶液的储存Example 12 Storage of the composition solution of the present invention
本发明的组合物可放置在底部具有活塞结构的真空喷雾瓶中存储,也可以放置在如图8所示的传统带吸管的喷雾瓶中储存。例如参见图8所示的喷雾瓶,其中,1001为透明塑料瓶,其壁厚0.4-5mm;1002为旋塞喷雾按键;1003为可旋转喷嘴;1004为吸液管;1005为液封剂,用于隔离组合物溶液和空气;1006为本发明的组合物溶液。这样的包装结构可以减少组合物与空气的接触面积。优选地,喷雾瓶容量为20ml,壁厚1.2mm,液封剂使用0.6ml的液状石蜡,液封剂厚度1.5mm。取用液体时只要按动旋塞喷雾按键1002就可将组合物喷出。在一个优选的实施例中,每次按键可以喷出约0.094ml的液体。另外,也可以使用底部具有活塞AS的真空喷雾瓶储存本发明的组合物溶液。The composition of the present invention can be stored in a vacuum spray bottle with a piston structure at the bottom, or in a traditional spray bottle with a straw as shown in Figure 8. For example, see the spray bottle shown in Figure 8, where 1001 is a transparent plastic bottle with a wall thickness of 0.4-5mm; 1002 is a cock spray button; 1003 is a rotatable nozzle; 1004 is a suction tube; 1005 is a liquid sealing agent, with To isolate the composition solution and air; 1006 is the composition solution of the present invention. Such a packaging structure can reduce the contact area between the composition and air. Preferably, the capacity of the spray bottle is 20 ml, the wall thickness is 1.2 mm, the liquid sealant uses 0.6 ml of liquid paraffin, and the liquid sealant thickness is 1.5 mm. When taking the liquid, just press the cock spray button 1002 to spray the composition. In a preferred embodiment, approximately 0.094ml of liquid can be sprayed out each time the key is pressed. In addition, a vacuum spray bottle with a piston AS at the bottom can also be used to store the composition solution of the present invention.
本实施例中,所述组合物溶液为2.7%(W/V)的维生素C溶液以及口罩E的组合物溶液(参见实施例2)。将上述组合物溶液在透光的塑料瓶和透光的AS真空喷雾瓶储存一段时间,存放环境为窗户朝北的室内房间,无直射阳光,但是有自然光以及荧光灯室内照明。随后分别取1ml溶液,使用三氯异氰尿酸片配制的1000ppm浓度的含氯消毒液进行滴定,以滴定液的消耗量(ml)作为活性物质浓度C的剂量单位并根据相关数据和如下公式获得活性成分(例如维生素)的半衰期。In this embodiment, the composition solution is a 2.7% (W/V) vitamin C solution and a composition solution of mask E (see Example 2). Store the above composition solution in a light-transmitting plastic bottle and a light-transmitting AS vacuum spray bottle for a period of time. The storage environment is an indoor room with a north-facing window, no direct sunlight, but with natural light and fluorescent indoor lighting. Then take 1ml of each solution and titrate it with 1000ppm chlorine-containing disinfectant prepared from trichloroisocyanuric acid tablets. Use the consumption of the titrant (ml) as the dosage unit of active substance concentration C and obtain it based on relevant data and the following formula The half-life of an active ingredient (such as a vitamin).
lg C=-(kt/2.303)+lgC 0 lg C=-(kt/2.303)+lgC 0
t 1/2=0.693/k t 1/2 =0.693/k
其中,k表示速率常数(d -1),C 0表示初始浓度,C表示t时的浓度,t-时间为天(d),t 1/2表示半衰期。 Among them, k represents the rate constant (d -1 ), C 0 represents the initial concentration, C represents the concentration at t, t-time is days (d), and t 1/2 represents the half-life.
表8液封剂、葡萄籽提取物、包装材料减轻维生素C溶液被空气氧化的效果例示Table 8 Examples of the effects of liquid sealants, grape seed extracts, and packaging materials on reducing the oxidation of vitamin C solutions by air
Figure PCTCN2022092725-appb-000012
Figure PCTCN2022092725-appb-000012
在上述储存实验中,分别通过不同的方式储存维生素C溶液或口罩E的配方。例如,可以使用塑料瓶储存维生素C溶液。又例如,可以使用塑料瓶储存维生素C溶液,并在塑料瓶中加入液封剂进行进一步的封存。还例如,可以使用AS真空喷雾瓶储存口罩E的配方;其中,口罩E的配方中包含葡萄籽提取物(原花青素)。In the above storage experiments, the formulas of vitamin C solution or mask E were stored in different ways. For example, plastic bottles can be used to store vitamin C solution. For another example, a plastic bottle can be used to store the vitamin C solution, and a liquid sealing agent can be added to the plastic bottle for further sealing. For another example, an AS vacuum spray bottle can be used to store the formula of mask E; wherein the formula of mask E contains grape seed extract (proanthocyanidins).
以上实施例测试结果可以证实,使用图8所示的容器储存本发明的组合物溶液,本发明的组合物能够保存较长时间而不变质,半衰期长达443-3253天,最长达3253天。The test results of the above examples can confirm that using the container shown in Figure 8 to store the composition solution of the present invention, the composition of the present invention can be stored for a long time without deterioration, with a half-life of 443-3253 days, up to 3253 days. .
其中,发明人意外的发现,由于口罩E配方中的萄籽提取物在546nm具有最大吸光度,可以吸收蓝紫光,从而呈现棕色遮光剂的效果。而这样的组合物配方也大大延长了对光线敏感的维生素C保质期,其半衰期长达3253天。这使得本发明的组合物具有显著的工业适用性以及商业价值。Among them, the inventor unexpectedly discovered that because the grape seed extract in the formula of Mask E has a maximum absorbance at 546nm, it can absorb blue-violet light, thus exhibiting the effect of a brown sunscreen. This composition formula also greatly extends the shelf life of light-sensitive vitamin C, with a half-life of up to 3253 days. This makes the composition of the present invention have significant industrial applicability and commercial value.
另外根据维生素C水溶液以及本发明组合物水溶液(例如口罩E配方的水溶液)的半衰期可知,相比维生素C,本发明的组合物显然具有明显更加优异的稳定性。In addition, according to the half-life of the vitamin C aqueous solution and the aqueous solution of the composition of the present invention (such as the aqueous solution of the mask E formula), it can be seen that compared with vitamin C, the composition of the present invention obviously has significantly better stability.
通过上述方式保存本发明的组合物,不仅能够延长本发明的组合物的储存时间,还能够随时取用本发明的组合物,也提供了一种快速制备本发明的口罩的方法,其包括:Preserving the composition of the present invention in the above manner not only extends the storage time of the composition of the present invention, but also allows the composition of the present invention to be accessed at any time. It also provides a method for quickly preparing the mask of the present invention, which includes:
(1)提供本发明的组合物溶液;(1) Provide the composition solution of the present invention;
(2)通过喷洒的方式将步骤(1)的组合物液体喷涂到口罩的内和/或外侧。(2) Spray the composition liquid of step (1) onto the inside and/or outside of the mask by spraying.
其中,步骤(2)中使用的口罩可以为市售的一次性口罩或棉布口罩等。Among them, the mask used in step (2) can be a commercially available disposable mask or a cotton mask, etc.
例如,参见图9所示的制备本发明的口罩的过程,其中,将喷雾瓶体1001倾斜,并把可旋转喷嘴1003调整到距离口罩D约5-10cm的距离,在棉布口罩正、反两面的均匀地喷洒组合物液体,各按下喷雾按键17次,总共34次,大约可以喷洒约3.2ml的组合物液体,从而快速完成职业暴露防护口罩D的制备。For example, refer to the process of preparing the mask of the present invention shown in Figure 9, in which the spray bottle body 1001 is tilted, and the rotatable nozzle 1003 is adjusted to a distance of about 5-10cm from the mask D, and the front and back sides of the cotton mask are Spray the composition liquid evenly, press the spray button 17 times each, a total of 34 times, approximately 3.2 ml of the composition liquid can be sprayed, thereby quickly completing the preparation of the occupational exposure protective mask D.
由此可见,可以将含有本发明的组合物溶液的喷雾瓶与普通口罩分别保存,在需要时,立即在普通口罩的内和/或外侧喷洒本发明的组合物,获得本发明的口罩,用于吸收消毒剂中的刺激性气体。因此,口罩可以在干燥的环境下进行保存,仅在使用时喷洒溶液。由于现有技术的口罩的中间层大多采用聚丙烯熔喷布并采用驻极体静电工艺,这类口罩必须在极干燥的环境中贮存以免静电荷丢失。上述方法不仅能够快速获得本发明的口罩,还能够在不同条件下分别保存组合物和口罩,以进一步延长组合物和口罩的储存时间。It can be seen that the spray bottle containing the composition solution of the present invention can be stored separately from the ordinary mask. When necessary, the composition of the present invention can be immediately sprayed on the inside and/or outside of the ordinary mask to obtain the mask of the present invention. To absorb irritating gases in disinfectants. Therefore, the mask can be stored in a dry environment and sprayed with the solution only when used. Since the middle layer of existing masks is mostly made of polypropylene melt-blown cloth and electret electrostatic process, such masks must be stored in an extremely dry environment to avoid loss of static charge. The above method can not only quickly obtain the mask of the present invention, but also store the composition and the mask separately under different conditions to further extend the storage time of the composition and the mask.
实施例13本发明组合物的消毒效果及其与酒精类消毒剂的相容性Example 13 Disinfection effect of the composition of the present invention and its compatibility with alcohol-based disinfectants
为验证本发明的组合物是否会对酒精类消毒剂的性能产生影响,同时为确定本发明的组合物是否具有潜在的抑制微生物活性效果,本发明设计相关试验检测组合物与酒精类消毒剂的相容性。其中,组合物的消毒效果及其与酒精类消毒剂的相容性通过以下方法进行测试。In order to verify whether the composition of the present invention will have an impact on the performance of alcohol-based disinfectants, and to determine whether the composition of the present invention has potential inhibitory effect on microbial activity, the present invention designs relevant tests to detect the performance of the composition and alcohol-based disinfectants. compatibility. Among them, the disinfection effect of the composition and its compatibility with alcohol-based disinfectants were tested by the following methods.
(1)取50mL的锥形瓶或15mL的试管;(1) Take a 50mL Erlenmeyer flask or a 15mL test tube;
(2)根据下表9的顺序,向步骤(1)的容器中依次添加水和/或消毒酒精和/或丙二醇和/或组合物1(水-甘油溶剂,不含蛋白质凝固剂以及植物提取物)和/或组合物2(水-丙二醇溶剂,含有蛋白质凝固剂以及植物提取物);其中,添加的蛋白质凝固剂为葡萄糖酸-δ-内酯,添加的植物提取物为葡萄籽提取物;(2) According to the sequence of Table 9 below, add water and/or disinfecting alcohol and/or propylene glycol and/or composition 1 (water-glycerin solvent, without protein coagulant and plant extract) to the container in step (1). ) and/or composition 2 (water-propylene glycol solvent, containing protein coagulant and plant extract); wherein, the added protein coagulant is glucono-delta-lactone, and the added plant extract is grape seed extract ;
(3)向步骤(3)的混合液中加入鸡蛋清;(3) Add egg white to the mixture in step (3);
(4)振摇步骤(3)的容器5分钟,随后观察蛋白质变性沉淀效果。(4) Shake the container in step (3) for 5 minutes, and then observe the protein denaturation and precipitation effect.
在实验过程中,控制组合物1和2的pH为约5.5-6.2。During the experiment, the pH of compositions 1 and 2 was controlled to be about 5.5-6.2.
表9鸡蛋清沉淀法测试组合物与消毒酒精的相容性Table 9 Egg white precipitation method test composition and compatibility of disinfectant alcohol
Figure PCTCN2022092725-appb-000013
Figure PCTCN2022092725-appb-000013
根据上述实验A和B可知,不含有蛋白质凝固剂以及植物提取物的水-甘油溶剂组合物与鸡蛋清混合后(实验A),容器内为澄明胶体。由此可见,组合物1具有良好的蛋白质保护效果。另外,组合物1与消毒酒精混合使用时(实验B),仍能够实现蛋白质变性沉淀的效果,因此组合物1不会降低消毒酒精的效果。According to the above-mentioned experiments A and B, it can be seen that after the water-glycerin solvent composition containing no protein coagulant and plant extract is mixed with egg white (experiment A), the container is a clear colloid. It can be seen that composition 1 has good protein protection effect. In addition, when Composition 1 is mixed with disinfectant alcohol (Experiment B), the effect of protein denaturation and precipitation can still be achieved, so Composition 1 will not reduce the effect of disinfectant alcohol.
根据上述实验C和D可知,组合物2(水-丙二醇溶剂,含蛋白质凝固剂以及植物提取物)与鸡蛋清混合后(实验C),产生蛋白质的缓慢沉淀效果。由此可知,组合物2能够用于缓慢地抑制微生物表面蛋白的生物活性。另外,组合物2与消毒酒精混合使用时(实验D),即,向组合物中添加蛋白质凝固剂和植物提取物时,仍然能够实现蛋白质变性沉淀效果。由此可知,组合物2与消毒酒精联用时,蛋白质凝固剂和植物提取物的添加不仅不会影响消毒酒精的效果,还能够与消毒酒精发挥协同作用,快速抑制蛋白活性的同时,还可以持续抑制蛋白活性,从而起到更强的消毒效果,实现长效消毒。According to the above experiments C and D, it can be seen that composition 2 (water-propylene glycol solvent, containing protein coagulant and plant extract) is mixed with egg white (experiment C), resulting in a slow precipitation effect of protein. It can be seen from this that composition 2 can be used to slowly inhibit the biological activity of microbial surface proteins. In addition, when composition 2 is mixed with disinfectant alcohol (experiment D), that is, when protein coagulant and plant extract are added to the composition, the protein denaturation and precipitation effect can still be achieved. It can be seen that when Composition 2 is used in combination with disinfectant alcohol, the addition of protein coagulants and plant extracts will not only not affect the effect of disinfectant alcohol, but can also work synergistically with disinfectant alcohol to quickly inhibit protein activity while also sustaining the effect. Inhibit protein activity, thereby achieving stronger disinfection effect and achieving long-term disinfection.
另外,根据试验E可知,仅加入丙二醇即可实现快速使蛋白质变性沉淀的效果。因此高浓度的丙二醇也具有较强的消毒效果。In addition, according to Test E, it can be seen that only adding propylene glycol can achieve the effect of quickly denaturing and precipitating proteins. Therefore, high concentrations of propylene glycol also have strong disinfection effects.
根据上文内容可知,在本发明的组合物中,可以使用丙二醇作为引湿剂,且引湿剂吸收空气中的水分后可以使组合物形成溶液的状态。由此可见,本实施例的水-丙二醇体系对应本发明的组合物水溶液体系。因此,加入蛋白质凝固剂以及植物提取物,本发明的组合物不仅不会影响消毒酒精的消毒效果,还能够进行协同消毒,快速抑制蛋白活性 并实长效消毒,起到更强且持久的消毒效果。According to the above content, it can be known that in the composition of the present invention, propylene glycol can be used as a moisture absorbing agent, and the moisture absorbing agent can make the composition form a solution state after absorbing moisture in the air. It can be seen from this that the water-propylene glycol system in this embodiment corresponds to the aqueous composition solution system of the present invention. Therefore, by adding protein coagulants and plant extracts, the composition of the present invention will not only not affect the disinfection effect of disinfectant alcohol, but can also perform collaborative disinfection, quickly inhibit protein activity and achieve long-term disinfection, achieving stronger and lasting disinfection. Effect.
另外,引湿剂(例如丙二醇)和植物提取物(如葡萄籽提取物)也是护肤品常用的物质,并且根据上述实验可知,其也具有抑制蛋白质活性的作用,因此向本发明的组合物中添加上述植物提取物和引湿剂能够减少酒精类消毒剂的使用,从而减少其对皮肤的刺激。In addition, moisture-absorbing agents (such as propylene glycol) and plant extracts (such as grape seed extract) are also commonly used substances in skin care products, and according to the above experiments, it is known that they also have the effect of inhibiting protein activity, so they are added to the composition of the present invention. Adding the above-mentioned plant extracts and moisture attractants can reduce the use of alcohol-based disinfectants, thereby reducing their irritation to the skin.
以上所述仅为本发明的具体实施例,并非因此限制本发明的专利范围,凡是利用本发明作的等效变换,或直接或间接运用在其它相关的技术领域,均同理包括在本发明的专利保护范围之中。The above are only specific embodiments of the present invention, and are not intended to limit the patent scope of the present invention. Any equivalent transformations using the present invention, or direct or indirect application in other related technical fields, are equally included in the present invention. within the scope of patent protection.
最后感谢我的朋友和领导们尤其是胡燕峰(教导我如何使用刻度移液管快速滴定的手法),孙朝荣,杜毅,黄亦成,李逸明,卜书红,杨玲,刘芳、于瀛、陈书艳、潘志红、张健,周佳,陆晓彤,刘海涛,刘瑛、陈峰、陶晓勤(负责了微生物鉴定部分)、徐玉兰、徐鸣(很抱歉,我的嗅觉不是很好,徐鸣是我们工勤保障人员,她的嗅觉特别好,因此承担了定性测试的工作)、陈伦(负责了热成像照片拍摄工作),卜丽萍等提供的热心帮助。Finally, I would like to thank my friends and leaders, especially Hu Yanfeng (who taught me how to use graduated pipettes for rapid titration), Sun Chaorong, Du Yi, Huang Yicheng, Li Yiming, Bu Shuhong, Yang Ling, Liu Fang, Yu Ying, Chen Shuyan, Pan Zhihong, Zhang Jian, Zhou Jia, Lu Xiaotong, Liu Haitao, Liu Ying, Chen Feng, Tao Xiaoqin (responsible for the microbial identification part), Xu Yulan, Xu Ming (I'm sorry, my sense of smell is not very good, Xu Ming is our work support staff, she (who has a particularly good sense of smell, so he undertook the work of qualitative testing), Chen Lun (responsible for taking thermal imaging photos), Bu Liping and others provided enthusiastic help.

Claims (17)

  1. 一种组合物,其特征在于,基于组合物的总重量,所述组合物包含:A composition characterized in that, based on the total weight of the composition, the composition contains:
    (A)约0.1-99重量%的生物吸附剂和(A) about 0.1 to 99% by weight of biosorbent and
    (B)约0.0001-99重量%的引湿剂;(B) About 0.0001-99% by weight of moisture attractant;
    优选地,所述组合物包含:Preferably, the composition contains:
    (A)约26-46重量%的生物吸附剂和(A) about 26-46% by weight of biosorbent and
    (B)约44-64重量%的引湿剂;(B) About 44-64% by weight of moisture attractant;
    更优选地,所述组合物包含:More preferably, the composition contains:
    (A)约36重量%的生物吸附剂和(A) approximately 36% by weight of biosorbent and
    (B)约54重量%的引湿剂。(B) About 54% by weight of moisture attractant.
  2. 权利要求1所述的组合物,其特征在于,The composition of claim 1, characterized in that:
    所述生物吸附剂选自以下的一种或多种:The biosorbent is selected from one or more of the following:
    (a)含烯醇结构的化合物;(a) Compounds containing enol structure;
    (b)含巯基的化合物;(b) Compounds containing sulfhydryl groups;
    (c)氨基酸;(c)Amino acids;
    (d)生物酶。(d) Biological enzymes.
  3. 权利要求2所述的组合物,其特征在于,The composition of claim 2, characterized in that:
    所述含烯醇结构的化合物为含有0、1或2个额外的独立选自氧、硫、氮和磷的杂原子的3-18元环状烯醇化合物及其衍生物,该环可任选地被一个或多个选自如下的取代基所取代,C 1-10烷基、C 3-10环烷基、芳基、芳基-C 1-4烷基,其中每个烷基、环烷基、芳基是未被取代的或被至少一个独立选自羟基、CN、氨基、酰基、羧基、卤素、C 1-10烷基、C 3-10环烷基、C 1-10烷氧基的取代基取代;乙烯醇;丙酮醇; The compound containing an enol structure is a 3-18 membered cyclic enol compound and its derivatives containing 0, 1 or 2 additional heteroatoms independently selected from oxygen, sulfur, nitrogen and phosphorus. The ring can be any Optionally substituted by one or more substituents selected from the group consisting of C 1-10 alkyl, C 3-10 cycloalkyl, aryl, aryl-C 1-4 alkyl, wherein each alkyl, Cycloalkyl and aryl are unsubstituted or at least one independently selected from hydroxyl, CN, amino, acyl, carboxyl, halogen, C 1-10 alkyl, C 3-10 cycloalkyl, C 1-10 alkyl Substituent substitution of oxygen group; vinyl alcohol; acetol;
    优选选自以下的一种或多种,维生素C、维生素B6、维生素B9、邻苯二酚、乙烯醇、丙酮醇、豆甾烯醇、生育三烯酚、大戟二烯醇、异抗坏血酸、抗坏血酸棕榈酸酯、抗坏血酸葡糖苷及其衍生物;Preferably, one or more selected from the group consisting of vitamin C, vitamin B6, vitamin B9, catechol, vinyl alcohol, acetol, stigmastenol, tocotrienol, euphorbienol, erythorbic acid, Ascorbyl palmitate, ascorbyl glucoside and their derivatives;
    更优选选自以下的一种或多种,维生素C、维生素B6、维生素B9;More preferably, one or more selected from the group consisting of vitamin C, vitamin B6, and vitamin B9;
    特别优选为维生素C。Vitamin C is particularly preferred.
  4. 权利要求2或3所述的组合物,其特征在于,The composition of claim 2 or 3, characterized in that,
    所述含巯基的化合物选自半胱氨酸、巯基乙酸、二巯基丙醇、二巯丙磺钠、硫普罗宁、二巯丁二钠、半胱胺、青霉胺、硫辛酸、甲巯丙脯酸、谷胱甘肽、α-硫辛酸、二硫苏糖醇及其组合;The thiol-containing compound is selected from the group consisting of cysteine, thioglycolic acid, dimercaprol, sodium dimercaptopropanesulfonate, tiopronin, disodium dimercapto, cysteamine, penicillamine, lipoic acid, and methcapto propionic acid, glutathione, alpha-lipoic acid, dithiothreitol and combinations thereof;
    优选选自N-酰基-半胱氨酸、N-烷基-半胱氨酸、二巯基丙醇、二巯丁二钠、二硫苏糖醇及其组合;Preferably selected from N-acyl-cysteine, N-alkyl-cysteine, dimercaprol, disodium dimercaptobutyrate, dithiothreitol and combinations thereof;
    更优选选自N-乙酰-L-半胱氨酸、N-甲基-L-半胱氨酸、N-乙基-L-半胱氨酸、二巯基丙醇、二巯丁二钠、二硫苏糖醇及其组合;More preferably, it is selected from N-acetyl-L-cysteine, N-methyl-L-cysteine, N-ethyl-L-cysteine, dimercaprol, disodium dimercapto, dithiothreitol and combinations thereof;
    特别优选为N-乙酰-L-半胱氨酸。Particularly preferred is N-acetyl-L-cysteine.
  5. 权利要求2-4中任一项所述的组合物,其特征在于,The composition according to any one of claims 2-4, characterized in that,
    所述氨基酸选自丙氨酸、缬氨酸、亮氨酸、异亮氨酸、甲硫氨酸、脯氨酸、色氨酸、丝氨酸、酪氨酸、半胱氨酸、苯丙氨酸、天冬酰胺、谷氨酰胺、苏氨酸、天冬氨酸、谷氨酸、赖氨酸、精氨酸、组氨酸、甘氨酸及其组合;The amino acid is selected from alanine, valine, leucine, isoleucine, methionine, proline, tryptophan, serine, tyrosine, cysteine, and phenylalanine , asparagine, glutamine, threonine, aspartic acid, glutamic acid, lysine, arginine, histidine, glycine and combinations thereof;
    优选选自甘氨酸、谷氨酸及其组合;Preferably selected from glycine, glutamic acid and combinations thereof;
    更优选为甘氨酸。More preferred is glycine.
  6. 权利要求2-5中任一项所述的组合物,其特征在于,The composition according to any one of claims 2-5, characterized in that,
    所述生物酶选自过氧化氢酶和辣根过氧化物酶;The biological enzyme is selected from catalase and horseradish peroxidase;
    优选为过氧化氢酶。Catalase is preferred.
  7. 权利要求1-6中任一项所述的组合物,其特征在于,The composition according to any one of claims 1-6, characterized in that,
    所述引湿剂选自二甘醇、聚乙二醇、丙二醇、双丙甘醇、甘油、甘油聚醚、木糖醇、山梨(糖)醇、丙二醇葡糖苷、乳酸钠及其组合;The moisture-drawing agent is selected from the group consisting of diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, glycerol polyether, xylitol, sorbitol, propylene glycol glucoside, sodium lactate and combinations thereof;
    优选选自甘油、丙二醇及其组合;Preferably selected from glycerol, propylene glycol and combinations thereof;
    更优选为丙二醇。More preferred is propylene glycol.
  8. 权利要求2-7中任一项所述的组合物,其特征在于,The composition according to any one of claims 2-7, characterized in that,
    基于组合物的总重量,Based on the total weight of the composition,
    所述含烯醇结构的化合物的含量为约0.01-95重量%,优选为约1-50重量%,更优选为约13.6重量%;The content of the compound containing an enol structure is about 0.01-95% by weight, preferably about 1-50% by weight, and more preferably about 13.6% by weight;
    所述含巯基的化合物的含量为约0.0001-99重量%,优选为约0.1-20重量%,更优选为约3.28重量%;The content of the thiol-containing compound is about 0.0001-99% by weight, preferably about 0.1-20% by weight, and more preferably about 3.28% by weight;
    所述氨基酸的含量为约0.0001-95重量%,优选为约0.0001-85重量%,更优选为约20重量%;The content of the amino acid is about 0.0001-95% by weight, preferably about 0.0001-85% by weight, and more preferably about 20% by weight;
    所述生物酶的含量为约0.0000001-20重量%,优选为约0.02-0.2重量%;The content of the biological enzyme is about 0.0000001-20% by weight, preferably about 0.02-0.2% by weight;
    所述引湿剂的含量为约0.0001-99重量%,优选为约44-64重量%,更优选为约54重量%。The content of the moisture attracting agent is about 0.0001-99% by weight, preferably about 44-64% by weight, and more preferably about 54% by weight.
  9. 权利要求1-8中任一项所述的组合物,其特征在于,The composition according to any one of claims 1-8, characterized in that,
    基于组合物的总重量,Based on the total weight of the composition,
    所述组合物还包含以下成分中的至少一种:The composition further includes at least one of the following ingredients:
    (e)约0.00000001-1重量%的防腐剂;(e) about 0.00000001-1% by weight of preservative;
    (f)约0.00001-90重量%的酸碱缓冲剂;(f) About 0.00001-90% by weight of acid-base buffer;
    (g)约0.000001-5重量%的抗氧化剂;(g) about 0.000001-5% by weight antioxidant;
    (h)约0-1重量%的乳化剂;(h) about 0-1% by weight of emulsifier;
    (i)约0-20重量%的液封剂;(i) About 0-20% by weight liquid sealant;
    (j)约0-20重量%的蛋白质凝固剂;(j) about 0-20% by weight of protein coagulant;
    (k)约0-20重量%的植物提取物;(k) about 0-20% by weight of plant extracts;
    (l)约0.0001-2重量%的气味掩盖剂;(l) About 0.0001-2% by weight of odor masking agent;
    优选地,所述组合物所述组合物还包含以下成分中的至少一种:Preferably, the composition further comprises at least one of the following ingredients:
    (e)约0.001-0.5重量%的防腐剂;(e) about 0.001-0.5% by weight of preservative;
    (f)约0.01-5重量%的酸碱缓冲剂;(f) About 0.01-5% by weight of acid-base buffer;
    (g)约0.001-0.04重量%的抗氧化剂;(g) about 0.001-0.04% by weight antioxidant;
    (h)约0.001-0.01重量%的乳化剂;(h) about 0.001-0.01% by weight of emulsifier;
    (i)约1重量%的液封剂;(i) About 1% by weight of liquid sealant;
    (j)约0.0001-20重量%的蛋白质凝固剂;(j) about 0.0001-20% by weight of protein coagulant;
    (k)约0.0001-20重量%的植物提取物;(k) About 0.0001-20% by weight of plant extract;
    (l)约0.01-0.9重量%的气味掩盖剂。(l) About 0.01-0.9% by weight of odor masking agent.
  10. 一种水溶液,其特征在于,其包含权利要求1-9中任一项所述的组合物;An aqueous solution, characterized in that it contains the composition of any one of claims 1-9;
    优选地,基于所述水溶液的总重量,Preferably, based on the total weight of the aqueous solution,
    所述组合物的含量为约30-80重量%,更优选为约56-76重量%,特别优选为约66重量%。The content of the composition is about 30-80% by weight, more preferably about 56-76% by weight, particularly preferably about 66% by weight.
  11. 一种基材,其特征在于,A base material characterized by:
    所述基材含有权利要求1-9中任一项所述的组合物,The substrate contains the composition of any one of claims 1-9,
    所述基材选自无纺布料、金属网格、玻璃纤维、棉布、亚麻布和过滤棉,优选为无纺布料。The substrate is selected from non-woven fabrics, metal mesh, glass fiber, cotton cloth, linen cloth and filter cotton, preferably non-woven fabrics.
  12. 一种多层材料A,其特征在于,所述多层材料包含A multi-layer material A, characterized in that the multi-layer material contains
    权利要求11所述的基材作为基层材料;The substrate according to claim 11 is used as a base material;
    活性炭层作为第一过滤层;The activated carbon layer serves as the first filter layer;
    优选地,在基层材料和第一过滤层之间还包含第二过滤层。Preferably, a second filter layer is further included between the base material and the first filter layer.
  13. 权利要求12所述的多层材料,其特征在于,The multilayer material of claim 12, characterized in that:
    所述第二过滤层选自无纺布料、金属网格、玻璃纤维;The second filter layer is selected from non-woven fabrics, metal mesh, and glass fiber;
    优选为无纺布料;Preferably non-woven fabric;
    特别优选为熔喷无纺布料。Melt-blown nonwoven fabric is particularly preferred.
  14. 一种多层材料B,其特征在于,所述多层材料包含A multi-layer material B, characterized in that the multi-layer material contains
    权利要求11所述的基材作为第一基层材料;The base material according to claim 11 as the first base layer material;
    中间隔离层,其包含不被水浸润的多孔透气材料;an intermediate isolation layer comprising a porous breathable material that is impervious to water;
    第二基层材料,其包含生物酶、引湿剂、防腐剂和酸碱缓冲剂。The second base material contains biological enzymes, moisture absorbing agents, preservatives and acid-base buffers.
  15. 权利要求14所述的多层材料,其特征在于,The multilayer material of claim 14, characterized in that:
    所述多孔透气材料选自聚酯过滤棉、玻璃棉、岩棉、空气过滤棉、泡沫海绵;The porous breathable material is selected from polyester filter cotton, glass wool, rock wool, air filter cotton, and foam sponge;
    优选为聚酯过滤棉;Polyester filter cotton is preferred;
    和/或and / or
    所述中间隔离层的厚度为约0.1-15mm;The thickness of the middle isolation layer is about 0.1-15mm;
    优选为约3mm。Preferably it is about 3mm.
  16. 一种口罩,其特征在于,所述口罩包含权利要求11所述的基材或权利要求12-15中任一项所述的多层材料。A mask, characterized in that the mask includes the base material of claim 11 or the multi-layer material of any one of claims 12-15.
  17. 制备权利要求16所述的口罩的方法,其包括:The method for preparing the mask of claim 16, comprising:
    (1)提供本发明的组合物溶液;(1) Provide the composition solution of the present invention;
    (2)通过喷洒的方式将步骤(1)的组合物液体喷涂到口罩的内侧和/或外侧。(2) Spray the composition liquid of step (1) onto the inside and/or outside of the mask by spraying.
PCT/CN2022/092725 2022-05-13 2022-05-13 Composition and use thereof, and materials comprising same WO2023216238A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2022/092725 WO2023216238A1 (en) 2022-05-13 2022-05-13 Composition and use thereof, and materials comprising same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2022/092725 WO2023216238A1 (en) 2022-05-13 2022-05-13 Composition and use thereof, and materials comprising same

Publications (1)

Publication Number Publication Date
WO2023216238A1 true WO2023216238A1 (en) 2023-11-16

Family

ID=88729512

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/092725 WO2023216238A1 (en) 2022-05-13 2022-05-13 Composition and use thereof, and materials comprising same

Country Status (1)

Country Link
WO (1) WO2023216238A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012826A1 (en) * 1990-02-27 1991-09-05 Allergan, Inc. Hydrogen peroxide destroying compositions and methods of using same
US5312588A (en) * 1990-02-27 1994-05-17 Allergan, Inc. Hydrogen peroxide destroying compositions and methods of making and using same
US6022732A (en) * 1997-04-09 2000-02-08 Allergan Hydrogen peroxide destroying compositions and methods of using same
US20110305736A1 (en) * 2010-06-10 2011-12-15 Dr. Suwelack Skin & Health Care Ag Stratiform Perforated Biomatrices
CN107126643A (en) * 2017-06-16 2017-09-05 王宇 A kind of composite layer and the nostril Sticky Note containing the composite layer
CN112493575A (en) * 2020-09-18 2021-03-16 安徽云飞芳植生物科技有限公司 Novel mask manufacturing method

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012826A1 (en) * 1990-02-27 1991-09-05 Allergan, Inc. Hydrogen peroxide destroying compositions and methods of using same
US5312588A (en) * 1990-02-27 1994-05-17 Allergan, Inc. Hydrogen peroxide destroying compositions and methods of making and using same
US6022732A (en) * 1997-04-09 2000-02-08 Allergan Hydrogen peroxide destroying compositions and methods of using same
US20110305736A1 (en) * 2010-06-10 2011-12-15 Dr. Suwelack Skin & Health Care Ag Stratiform Perforated Biomatrices
CN107126643A (en) * 2017-06-16 2017-09-05 王宇 A kind of composite layer and the nostril Sticky Note containing the composite layer
CN112493575A (en) * 2020-09-18 2021-03-16 安徽云飞芳植生物科技有限公司 Novel mask manufacturing method

Similar Documents

Publication Publication Date Title
US7858124B2 (en) Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use
US7976876B2 (en) Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use
CN109260927A (en) A kind of deodorization taste removal concentrate composition of the oil of another name for containing Chinese juniper and preparation method thereof
JP2012072134A (en) Silver ion production liquid for antibacterial use, silver ion antibacterial liquid produced from the liquid, and production method for producing the antibacterial liquid
US20210178106A1 (en) Nitric oxide generating systems for inhalation
CN108743702A (en) A kind of anti-haze poison spray and preparation method thereof
Gottardi Iodine as disinfectant
CN109846113A (en) One kind can be from the nitric oxide production mouth and nose amenities of offer
WO2023216238A1 (en) Composition and use thereof, and materials comprising same
JP2024052763A (en) Nitric Oxide Generating System
JP2005218613A (en) Sanitary mask
CN105381454B (en) A kind of nasal cavity wetting agent containing trehalose
CN111388421A (en) Oral-nasal-throat bi-component spray with antibacterial and antiviral functions and preparation method thereof
RU2644316C1 (en) Preventive facial mask for antimicrobial protection in the airborne upper respiratory tract diseases
CN116471936A (en) Method and use for producing a composition that stably contains free available chlorine species and peroxide
JPH02116302A (en) Shoe insole having deodorizing and sterilizing properties
CN102283450A (en) Silver ion sterilization mask and manufacturing method thereof
Lachenmeier Antiseptic drugs and disinfectants with experience of the second year of COVID-19 pandemic-related side effects
CN110272023A (en) A kind of all-weather indoor removes aldehyde device and its application method
Chooi et al. COVID 19: The safety profile of common disinfectants used for sanitization
EP1576880A1 (en) Anti-bacterial, anti-viral, and anti-fungus composition, its preparation and use
JPH0639367B2 (en) Deodorizing and sterilizing composition
Shambhavi et al. BT100, a three-in-one, multipurpose disinfecting, deodorizing, and air-cleaning solution with an effective, gradual, and continuous gaseous chlorine dioxide-releasing substance
US20230110299A1 (en) Hygiene Base Composition, and Production Method and Application Method Thereof
CN106472560A (en) A kind of oxygen humidifying liquid bacteriostatic agent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22941192

Country of ref document: EP

Kind code of ref document: A1